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  Summary 




Pseudomonas putida KT2440 is a model environmental bacterium attracting 
considerable interest as a cell-factory through synthetic and systems biology 
approaches. Its metabolism has been extensively characterized and a high-quality 
metabolic model is available (iJN1441), allowing for the systems evaluation of its 
metabolic capabilities. Among its biotechnological applications, KT2440 is widely used 
for the production of polyhydroxyalkanoates (PHA), also known as bacterial polyesters 
or bioplastics. This family of polyesters presents interesting properties for replacing fossil 
fuel-based plastics. PHA metabolism in P. putida is mediated through the PHA 
polymerase (PhaC) and the PHA depolymerase (PhaZ) that synthesizes and degrades 
PHA, respectively, in a continuous cycle. The PHA are accumulated in the cytoplasm as 
carbon and energy stores, and contrary to oil-based plastic, they are produced from 
renewable resources. PHA metabolism goes beyond solely having a role in carbon 
storage since recent findings have highlighted its function as a balancing route that 
increases P. putida fitness during environmental perturbations.  
In the first Results chapter, validations of the PHA cycle in conferring robustness 
to P. putida will be described in depth. In order to assess the effect of blocking the PHA 
turnover in the cell, a phaZ null strain was constructed. We then validated a library of 
strains expressing phaZ over a range of levels in this ΔphaZ background. To investigate 
the impact of tuning phaZ expression on Pseudomonas metabolism, key physiological 
parameters were analyzed under PHA production conditions. A variety of physiological 
responses were observed, resulting in changes in cell number, cell size, PHA 
accumulation and production of extracellular (R)-Hydroxyalkanoic acids ((R)-HAs) as 
compared between wild type and phaZ null strains. These observations suggest a 
rerouting of the cellular carbon flux when the PHA cycle is disrupted. Overall, phaZ 
variant strains have shown important differences including growth rate, octanoate 
consumption rate, residual octanoate and a panel of extracellular metabolites. To get a 
glance of the overall metabolism, these experimental data were contextualized into the 
in silico metabolic model (iJN1411). The systems impact of the PHA cycle in the 
physiology of this model bacterium, including the presence of a residual oxidative 
metabolism under stationary growth phase, associated to high flux through PHA cycle 
will be discussed.  
In the second Results chapter, studies were carried out to address the 
physiological roles of the prokaryotic isocitrate dehydrogenase isoenzymes (PIDH) in P. 




this bacterium. PIDH is an ancient and highly diverse enzyme. There are many examples 
in the literature of works characterizing the biochemical and enzymatic properties of 
these enzymes in a variety of microorganisms. However, it is not clear why two PIDH are 
present in pseudomonads in terms of microbial physiology, since this is a characteristic 
more commonly observed and studied in psychrophiles. The results for the purification 
and enzymatic characterization of the two PIDH from P. putida is presented. The key 
amino acid residues for catalytic activity of the monomeric PIDH (idh) were verified by 
site-directed mutagenesis experiments. In order to study the impact of having two PIDH, 
the expression levels of both genes were assessed by qRT-PCR experiments under 
different growth conditions. Finally, in order to study the role of the two PIDH in P. putida 
physiology and metabolism, different isocitrate dehydrogenase deletion mutants were 
designed. After several tries, we were capable to obtain only the dimeric PIDH (icd) 
deletion mutant, suggesting that monomeric idh could be an essential gene in P. putida. 
The third Results chapter delves into the creation of biofactories producing PHAs 
from complex and poor PHA substrates. In particular, PHA substrates generated from 
the breakdown of lignin and the fossil fuel-based plastics, polyethylene terephthalate 
(PET) and polyurethane (PU). We present a set of in silico growth-coupled PHA 
overproducer P. putida strains, using monomers derived from the hydrolysis of these 
polymers, as carbon sources. We applied an iterative DBTL cycle in order to achieve this 
goal. The model of P. putida, iJN1411, was used as a computational platform to in silico 
designing of growth-coupled strains. Subsequently, these in silico designs were 
implemented, evaluated and optimized in vivo. Cutting edge synthetic biology 
approaches were used to generate the high number of gene knockouts and knockins 
required to systematically remove all potential competing pathways and to reroute the 
carbon flux towards PHA biosynthesis. The effect on PHA production of the iterative 
rounds of model-guided genetic modifications was subsequently evaluated by means of 
high-throughput physiological experiments. Finally, we discuss the impact of synthetic 
and systems approaches towards the industrial production of PHA from other 
inexpensive substrates such as sugars and glycerol using P. putida as a bacterial 
chassis.
  Resumen 




Pseudomonas putida KT2440 es una bacteria modelo en biotecnología que 
suscita mucho interés como catalizador celular, y que es susceptible de ser optimizado 
mediante herramientas de biología sintética y de sistemas. Su metabolismo se ha 
caracterizado ampliamente y se cuenta con un modelo metabólico muy preciso 
(iJN1411), que permite la evaluación de sus capacidades metabólicas mediante una 
aproximación de biología de sistemas. Entre las aplicaciones biotecnológicas, KT2440 
se ha usado ampliamente para la producción de PHA. Esta familia de poliésteres 
presenta propiedades interesantes para reemplazar a los plásticos de origen 
petroquímico. El metabolismo de PHA en P. putida está mediado por la PHA sintasa 
(PhaC) y la PHA despolimerasa (PhaZ), que sintetiza y degrada el PHA, 
respectivamente, en un ciclo continuo. Los PHA se producen a partir de fuentes 
renovables y se acumulan en el citoplasma bacteriano como fuente de reserva de 
carbono y energía. Sin embargo el metabolismo de PHA va más allá de ser una mera 
reserva de carbono, ya que estudios recientes han determinado su función como un 
ciclo “amortiguador”, capaz de mejorar la adaptación del microorganismo ante diferentes 
perturbaciones ambientales.  
En el primer capítulo de la sección de Resultados se describe en profundidad la 
evaluación del carácter amortiguador del ciclo de PHA, validándose su capacidad de 
conferir robustez metabólica a P. putida. Con el fin de evaluar el efecto del bloqueo del 
ciclo continuo de PHA en la fisiología de la bacteria, se ha construido una cepa mutante 
donde se ha delecionado el gen phaZ. Se ha validado una librería de cepas derivadas 
de la cepa mutante ΔphaZ con diferentes niveles de expresión del gen phaZ. Para 
investigar el impacto de la variación en la producción de PhaZ en el metabolismo de 
Pseudomonas, se han determinado en cada cepa diferentes parámetros fisiológicos en 
condiciones de producción de PHA. Estos resultados sugieren un cambio del flujo de 
carbono cuando se interrumpe el ciclo de PHA. En general, las cepas con diferente 
expresión de phaZ han mostrado cambios importantes, como por ejemplo, la tasa de 
crecimiento, la tasa de consumo de octanoato, el octanoato residual y la presencia de 
metabolitos extracelulares. Para relacionar estos resultados con el metabolismo general 
del carbono, estos datos experimentales se han contextualizado in silico en el modelo 
metabólico iJN1411, incluyendo la presencia del metabolismo oxidativo residual, 
durante la fase estacionaria del crecimiento asociada en el alto flujo mediante el ciclo de 
PHA. Por último, se discute en profundidad el impacto del ciclo de PHA en la fisiología 




En el segundo capítulo de los Resultados, se estudia cómo la redundancia 
funcional puede ser un mecanismo de robustez en relación con los roles fisiológicos de 
las isoenzimas de la isocitrato deshidrogenasa procariota (PIDH). La PIDH es una 
enzima ancestral y muy diversa en cuanto a su origen y estructura primaria. Hay gran 
cantidad de trabajos disponibles sobre la caracterización de las propiedades 
bioquímicas de estas enzimas en una variedad de organismos. Sin embargo, no está 
claro cuál es la relevancia de la existencia de dos PIDH diferentes en las bacterias de 
género Pseudomonas, ya que esto es una característica observada principalmente en 
psicrófilos. En este capítulo, se presentan los resultados de la purificación y 
caracterización enzimática de las dos PIDH de P. putida. Los aminoácidos clave para la 
actividad catalítica en la Idh monomérica se verifican mediante mutagénesis dirigida. 
Para estudiar el impacto de la presencia de dos PIDH, se han evaluado los niveles de 
expresión de ambos genes mediante experimentos de qRT-PCR en diferentes 
condiciones de crecimiento. Finalmente, para estudiar el papel de las dos PIDH en la 
fisiología y metabolismo de P. putida, se diseñaron diferentes mutantes de deleción de 
la isocitrato deshidrogenasa. Los resultados indican que sólo se puede obtener el 
mutante de deleción de la Icd dimérica, lo que sugiere que la Idh monomérica podría ser 
un gen esencial en P. putida.  
El tercer capítulo de Resultados profundiza en la creación de factorías celulares 
para producir PHA a partir de sustratos complejos. En particular, los sustratos generados 
a partir de la descomposición de la lignina y de los plásticos basados en combustibles 
fósiles, como el tereftalato de polietileno (PET) y el poliuretano (PU). Presentamos un 
conjunto de cepas de P. putida super-productoras de PHA capaces de utilizar in silico 
hidrolizados PET y PU como fuentes de carbono. Se adoptan abordajes de vanguardia 
de biología sintética y de sistemas integrados en ciclos interactivos de optimización de 
Diseño, Construcción, Prueba, y Aprendizaje (DBTL). El modelo de P. putida, iJN1411, 
se utilizó como plataforma computacional para lograr la producción de PHA acoplada al 
crecimiento. Además, estos diseños in silico fueron implementados, evaluados y 
optimizados in vivo. Para ello se utilizan técnicas clásicas de biología molecular para 
delecionar un gran número de genes necesarios e introducir otros, para eliminar 
sistemáticamente todas las vías potencialmente competidoras con nuestro diseño in 
silico, y redirigir el flujo de carbono hacia la biosíntesis de PHA. El efecto de las rondas 
iterativas de modificaciones genéticas guiadas por el modelo iJN1411 sobre la 
producción de PHA, se evalúan mediante experimentos fisiológicos. Finalmente, se 
discute el posible impacto de las herramientas de biología sintética y de sistemas en la 
producción industrial de PHA a partir de sustratos sostenibles como azúcares y glicerol, 
utilizando P. putida como chasis bacteriano.  
 









  Introduction 




1.1 Plastic pollution, moving towards a sustainable society  
 
The term “plastic” originates from the Greek word “plastikos” (πλαστικός), used to 
describe something capable to mold or suitable for molding. Nowadays, plastic is a term 
used to describe a very large family of materials with diverse characteristics, properties 
and uses. Thanks to their versatility, the plastic materials provide personalized solutions 
for a huge variety of necessities and applications. Their massive production and their 
inappropriate waste management during the last decades, led to plastic pollution of 
lands, seas, oceans etc., causing environmental worries. Nowadays, the European 
Commission takes the challenge to transform the European economy into a circular and 
efficient strategy as far as it concerns the use of resources. New challenges must be 
addressed concerning the indiscriminate plastic abandonment (“littering”) and the 
options at the end of life of certain types of plastic wastes (especially plastic packaging), 
if we want to take advantage of their full potential in efficient and circular economy in the 
use of resources (https://ec.europa.eu/environment/circular-economy/index_en.htm).  
In 2017, the global plastic production reached up to almost 350 million tons with 
64.4 million tons only produced in Europe. China (50.1%) is the major producer of 
plastics followed by Europe (18.5%) and North America (17.7%). These data were 
obtained from market studies provided by PlasticsEurope (PEMRG) and Converted 
Market and Strategy GmbH and can be downloaded in th following link: 
(https://www.plasticseurope.org/application/files/6315/4510/9658/Plastics_the_facts_20
18_AF_web.pdf). 
Nowadays, plastics can be based on fossil or biological origins. A quite new bio-
based plastic terminology is referred to bio-based “drop in” polymers (e.g. PET). They 
are chemically identical to petrochemical counterparts but derived from biomass and they 
are usually no biodegradable. They differ from the biodegradable new bio-based plastics 
such as PHA (polyhydroxyalkanoate) and PLA (polylactic acid). Recent economic 
studies have revealed that bio-based polymers can create new business opportunities 
and stable growth in new plastic markets (Prieto, 2016). Currently, bioplastics represent 
roughly one percent of the 359 million tons of plastic produced annually. However, as 
demand is rising, and more sophisticated biopolymers, application and products are 
emerging while the market is continuously growing. According to the latest market data 
compiled by European Bioplastics in cooperation with the research institute nova-




tons in 2019 to approximately 2.43 million tons in 2024 (see Figure 1 and the following 
link https://www.european-bioplastics.org/market/). 
Bio-based drop-in PET (polyethylene terephthalate), PE (polyethylene), PP 
(polypropylene) polymers and new biopolymers, PLA and PHA show the highest growth 
rates on the market. The most capital investment is expected to take place in Asia and 
South America due to better access to feedstock and a favourable political framework. 
Synthetic and systems biology approaches will provide improved strains that can utilize 
low-cost substrates such as glucose, glycerol, and lignin-derived compounds for bio-
based polymers widespread production (Prieto, 2016). 
The durability of plastics is not always considered as a virtue, since it may impede 
the up-cycling of these materials in terms of circular economy and sustainably. PLA, PHA 
and succinate (PBS) polymers are the most common bio-based polymers since they 
have been successfully applied in the biodegradable plastic industry. The 
biodegradability of these polymers has been utilized to solve environmental issues, such 
as waste and public pollution. In this Doctoral Thesis, P. putida strain metabolism was 
redesigned in order to transform recalcitrant plastic wastes derivatives into new-high 
added alternatives, such as the bio-plastics, PHA by using synthetic and systems biology 
approaches. 
 
Figure 1. Global production capacities of bioplastics in 2018 (by material type); among the 
biodegradable bio-based plastics, the PBAT (polybutylene adipate terephthalate), PBS (polybutylene 
succinate), PLA (polylactic acid), PHA (polyhydroxyalkanoates), starch blends and others are presented. 
Among the bio-based non-biodegradable, PE (polyethylene), PET (polyethylene terephthalate), PA 
(polyamides), PP (polypropylene), PTT (polytrimethylene terephthalate) and others are distinguished. The 
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1.2 General characteristics of polyhydroxyalkanoates 
 
1.2.1 A general overview of PHA  
 
PHA were first described in 1926 by M. Lemoigne in France, who reported the 
presence of poly(3-hydroxybutyrate) (P(3HB)) in the cytoplasm of Bacillus megaterium 
(Lemoigne, 1926). PHA are naturally produced in a great range of bacteria (>300 
species) and are non-toxic and biodegradable. They are biocompatible without 
producing noxious effects to the human body. There have been found in many Gram-
negative and Gram-positive genera, as well as some archaea and consist of 3-(R)-
hydroxyalkanoate monomers (Han et al., 2010).  
PHA are accumulated in the cell cytoplasm under nutrient imbalances, including 
carbon excess coupled with a limitation of at least one nutrient such as nitrogen, oxygen, 
or phosphorus (Lee et al., 2000; Poblete-Castro et al., 2012). PHA are not solely a source 
of carbon and energy during nutrient starvation, but rather a key element in resource 
balancing (De Eugenio et al., 2010a). Depending on the microorganism, the PHA 
production could reach up to 90% of cell dry weight (Kniewel et al., 2017). 
These insoluble and highly hydrophobic intracellular inclusions are well known as 
PHA granules or carbonosomes that traditionally have been proposed to be coated by a 
layer of proteins and phospholipids (Jendrossek and Pfeiffer, 2014). The presence of 
phospholipids though is still a controversial issue and is under discussion (Pötter and 
Steinbüchel, 2006; Bresan et al., 2016). On the contrary, the presence of proteins on the 
surface of PHA granules is widely accepted. The so-called granule associated proteins 
(GAPs) play structural, biosynthetic, catabolic and regulatory functions. These include 
PHA synthases, depolymerases and a group of low weight molecular proteins called 
phasins. Other proteins such as transcriptional regulators, hydrolases or reductases can 
also be found on the surface of the granule (Jendrossek and Pfeiffer, 2014). 
The PHA synthases are key enzymes in the biosynthesis of these polyesters; they 
transform the (R)-hydroxyalkanoate-CoA ((R)-HA-CoA) thioesters monomers in a 
polyester chain by liberating one CoA molecule. The resulting polyester molecule is 
further degraded into free monomers (R)-HAs by PHA depolymerases (see section 1.4.4 
and 1.4.5 for more details).  
The phasins are amphipathic proteins located in the interphase between PHA and 
the cytoplasm. In general, the phasins play regulatory and functional roles, by regulating 
the formation, the localization, the number and size of the granules (Moldes et al., 2004; 




immobilization platforms (Wong and Rehm, 2018), biomedical (tissue engineering) and 
drug delivery (biosurfactant properties) applications (Parlane et al., 2017). A detailed 
description of these enzymes in P. putida could be found in 1.4.4 and 1.4.5 sections. 
 
Figure 2. PHA production and granule schematic structure. The presence of granules is observed by 
Transmission electron microscopy (TEM) and phase contrast microscopy pictures of P. putida KT2440 
growing under PHA production conditions, A. and C., respectively.  B. Schematic representation of a PHA 
granule from P. putida KT2440. The hydrophobic polymer core (PHA) is surrounded by a layer of granule-
associated proteins (GAPs) (Galán et al., 2011).   
 
1.2.2 Mechanical, thermal and chemical properties of PHA  
 
The PHA monomeric composition can be influenced by several factors including 
among others i) the genetic background of the producer organism, ii) the carbon source 
used which influence the metabolic pathway used and iii) the PHA synthases substrate 
specificity (Sudesh et al., 2000). As far as it concerns the PHA synthase stereospecificity, 
only monomers with R configuration have been reported until now (De Eugenio et al., 
2010a). PHAs are built of 3-hydroxyfatty acid monomers ((R)-HAs) where the carboxyl 
group of one monomer forms an ester bond with the hydroxyl group of the following 
monomer.  
Depending on the total number of carbon atoms within a PHA monomer, they can 
be classified into short chain length (scl-PHA; 3 to 5 carbon atoms; such P(3HB)), 
medium chain length (mcl-PHA; 6 to 14 carbon atoms, such as P(3HO)) and long chain 
length (lcl-PHA; 15 or more carbon atoms) (Li et al., 2016). Several bacteria produce scl-
PHA including the model bacterium Cupriavidus necator H16 (Kniewel et al., 2017). The 
mcl-PHA producers belong mainly from the genus Pseudomonas (Rai et al., 2011), 
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whereas lcl-PHA are more scarcely found, such as that produced by a local isolate of P. 
aeruginosa MTCC (Singh and Mallick, 2009). For the purpose of this Doctoral Thesis, 
we will focus on the mcl-PHA production from Pseudomonas putida KT2440. 
 
Figure 3. PHA chemical structure. Classification is based on the length of the aliphatic side chain (X) and 
has been divided into short-length PHA (scl-PHA), medium-chain length PHA (mcl-PHA) and long-chain 
length PHA (lcl-PHA) depending on the number of carbons. All monomeric units have an asymmetric carbon 
centre (*) and R enantiomer configuration. 
 
Given their natural origin and their physicochemical properties, PHA have attracted 
much attention as alternative polymeric materials. However, several disadvantages, 
such as high production costs and incompatibility to thermal approaches due to 
susceptibility to thermal degradation, limit their application as thermoplastics (Raza et 
al., 2018). Therefore, it became needed to modify the thermomechanical properties of 
these polymers, in order to improve their processability. 
The diversity of the PHA lays on the side substitution on the position 3. More than 
150 different monomer constituents have been described including unsaturated, aliphatic 
and aromatic groups among others (Zinn et al., 2001). PHA may be composed by only 
one type of monomer (homopolymers) or by various types of monomers, called 
copolymers or heteropolymers (Olivera et al., 2010). Depending on the monomer 
composition and the length of the side chain, the thermomechanical and 
physicochemical properties such as stiffness, brittleness, melting point, glass transition 
temperature, degree of crystallinity and resistance to organic solvents may vary. scl-PHA 
tend to be stiff and brittle with a high degree of crystallinity (60-80%), while mcl-PHA are 




melting point and glass transition temperature below room temperature (Anjum et al., 
2016). A summary of the thermal and mechanical properties of two prototype PHA 
polymers are listed in the Table 1.  











P(3HB) 100% 40 3-8 173-180 5-9 (Sudesh et al., 2000; 
Anjum et al., 2016) 
P(3HHx-co-3HO) (12-88%) 9 380 61 -31 (Valappil et al., 2006) 
Table 1. Thermal and mechanical properties of some representative polymers from the PHA family. 
Tm, melting temperature; Tg, glass transition temperature. E, Young’s modulus; σt, tensile strength; εb, 
elongation at break. 3HB: 3-hydroxy-butyrate, 3HHx: 3-hydroxy-hexanoate, 3HO: 3-hydroxy-octanoate.  
 
1.3 An introduction to Pseudomonas putida: a model 
bacterium in biotechnology 
 
Pseudomonas spp, is a continuously growing genus (approximately 300 species) 
of Gram negative, aerobic, bacillus, belonging to γ-proteobacteria class (Stanier et al., 
1966). First description of the genus was due to the professor Migula of the Karlsruhe 
Institute in Germany at 1894-1900. The etymology of Pseudomonas derived from the 
Greek terminology pseudes (ψευδές) which means false and the monas (μονάς) which 
means one unit (Palleroni, 2010). There are rod-shaped, non-sporulating, motile with 
polar flagella bacteria (Nikel et al., 2014b).  
One of the early discoveries of the genus was its remarkable metabolic versatility 
and adaptability to endogenous and exogenous stresses. L.E. Den Dooren in 1926, first 
observed the ability of Pseudomonas to degrade a great range of substrates such as 
carbohydrates, organic acids, aromatic, amino acids, alcohols and nitrogen compounds 
(Stanier et al., 1966; Clarke, 1982). Furthermore, Pseudomonas spp. could be tolerant 
to harmful agents present in soils such as disinfectants, detergents, organic solvents and 
heavy metals (Jimenez et al., 2002; dos Santos et al., 2004). However, pseudomonads 
are not tolerant to extreme changes concerning temperature and hydrogen ion 
concentrations resulting in the absence of thermophilic and acidophilic strains included 
in this genus (Palleroni, 2010).  Finally, among the variety of Pseudomonas species, can 
be distinguished some human and plant pathogens, such as P. aeruginosa and P. 
syringae, respectively, due to the production of virulence factors (Morris et al., 2008; 
Gellatly and Hancock, 2013). 
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P. putida is a “paradigm of a class of cosmopolitan bacteria” isolated from a variety 
of environments such as soils, plant rhizosphere and water (Nelson et al., 2002; dos 
Santos et al., 2004). P. putida KT2440 (KT stands for Kenneth Timmis) strain derives 
from the toluene-degrading organism initially isolated in Japan (1960 from an 
undergraduate student Hosokawa) and designated as P. arvilla mt-2 (mt-2, stands for 
“meta-toluate degrader, isolate 2”) and later renamed to P. putida mt-2 (Nakazawa, 2002; 
Timmis, 2002). This strain harbours the TOL plasmid pWW0, which encodes a pathway 
for toluene and m/p-xylene biodegradation (Williams and Murray, 1974). Recently, 
genomic, phylogenetic and catabolic re-assessment of the P. putida clade supports the 
delineation of 4 new species P. alloputida sp. nov., P. inefficax sp. nov., P. persica sp. 
nov. and P. shirazica sp. nov. The P. putida KT2440 is reclassified in cluster Pp5, as P. 
alloputida KT2440 (derived from the Greek allos “άλλος”, meaning another putida) 
(Keshavarz-Tohid et al., 2019). 
The P. putida KT2440 is the best-characterized strain of its species and it is 
classified by the FDA (Food and Drug Regulation Administration) as HV1 (Host vector 
system safety level 1) certified strain, suggesting that it is safe to use in a P1 or ML1 
environment, but it should not be used as food additive (Kampers et al., 2019). Taking 
advantage this characteristic, P. putida KT2440 was converted to a model organism for 
biotechnological, environmental and industrial applications such as biodegradation and 
chemical biotransformation studies (Nikel et al., 2014b). For the purpose of this Doctoral 
Thesis, we are going to focus our attention and describe in depth the production, 
characteristics and the PHA metabolism in P. putida KT2440.  
 
1.3.1 Available synthetic biology tools in P. putida KT2440 
 
Since the publication and the recent revision of the P. putida KT2440 genome, 
much effort has been invested in exploiting these capacities in biotechnological 
applications (Nelson et al., 2002; Belda et al., 2016). Some of the synthetic biology 
challenges are the removal of non-desirable traits and the enhancement of the 
advantageous ones, the insertion of new activities and understand the functionality of 






1.3.1.1 Plasmid availability and genome integration tools 
 
A “Standard European Vector Architecture” database (SEVA-DB, 
http://seva.cnb.csic.es) is available, where a wide variety of pSEVA plasmid collection is 
listed (Silva-Rocha et al., 2013; Martínez-García et al., 2015). Many of these plasmids 
are used in P. putida, since it is easily genetically manipulated and can maintain a range 
of plasmids, containing common broad-host-range multicopy replicons including pBBR1, 
pRO1600/ColE1 and RK2. On the average, in P. putida the plasmid copy number is 
higher than in E. coli (Cook et al., 2018). However, since P. putida is naturally resistant 
to some antibiotics (such as Ampicillin), care must be taken on selecting bacterial 
markers present in these vectors (Martínez-García and de Lorenzo, 2011).  
As far as it concerns the genomic integration approaches using transposons 
elements, the most studied bacterial transposition systems have been Tn5 and Tn7 (Choi 
and Kim, 2009; Hickman and Dyda, 2016). In this work, the site-directed Tn7-mediated 
insertion system was used, which it is targeted at high frequency into the attTn7 site and 
it integrates unidirectionally as a single copy located downstream of the glmS gene 
(Lambertsen et al., 2004; Silva-Rocha and de Lorenzo, 2014). Recently, serine 
recombinases were also tested in P. putida KT2440 as a promising tool for high efficiency 
integration system (Elmore et al., 2017).  
 
1.3.1.2 Gene expression approaches and functional parts  
 
Nowadays, synthetic biology approaches are searching for the best combination 
of biological parts such as promoters, ribosome binding sites (RBS), coding sequence of 
the gene(s) of interest, terminators, in order to meet the desired performance criteria for 
the metabolic engineering purposes. Several advanced cloning methods have been 
reported so far, such as Sequence and Ligation-Independent Cloning (SLIC) (Li and 
Elledge, 2012), Gibson DNA assembly (Gibson et al., 2009), BioBricks or BglBricks 
standards (Anderson et al., 2010; Lee et al., 2011) and Modular Cloning assembly 
system (Golden Gate-MoClo), among others (Engler et al., 2008; Weber et al., 2011). 
The latter system is based on type II restriction endonucleases, that cleave DNA outside 
of the recognition site, allowing up to 256 overhangs by producing a 4 nucleotide 
overhang. These unique overhangs allow multiple DNA fragments assemblies in a single 
reaction mix (Engler et al., 2008).  
Prior metabolic engineering studies in P. putida have majorly relied on the lac 
family promoters (lac, lacUV5, tac, trc) from E. coli (Borrero-de Acuña et al., 2014; 
Johnson and Beckham, 2015; Elmore et al., 2017). Additionally, works are available on 
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using native promoters such as rrn (Wang et al., 2010), Pm (Gemperlein et al., 2016) or 
PP_1099 promoter (Lin et al., 2016). For chromosomal expression, constitutive 
promoters libraries have been described in P. putida with variable expression levels 
(Zobel et al., 2015; Elmore et al., 2017; Cook et al., 2018). In this concept, a library of 
synthetic promoters with various upstream elements, -35 and -10 sequences and 
different ribosome binding sites have been tested in P. putida KT2440 (Elmore et al., 
2017). In this Doctoral Thesis, Pm/XylS native activator, induced by 3-methylbenzoate, 
Plac/LacI heterologous activator, induced by IPTG or constitutive promoters have been 
used (Zobel et al., 2015; Tiso et al., 2016).  
 
1.3.1.3 Genome editing approaches 
 
In many Gram negative bacteria, different markless and scarless gene editing 
methods have been proposed. These approaches remove any antibiotic marker and 
require the application of a counterselection system, for instance the sucrose sensitivity 
conferred by sacB gene (Schäfer et al., 1994). pK18mobsacB strategy has been widely 
used in P. putida and it was also applied in this Doctoral Thesis (Cai et al., 2009; Galán 
et al., 2011). Additionally, deletion strategies that apply a counterselection system based 
on 5-fluorouracil, in order to function, require a strain carrying the upp deletion, a gene 
encoding for uracil phosphoribosyltransferase (Graf and Altenbuchner, 2011). 
Furthermore, similar homologous recombination process is realized by the 
cleavage of the chromosome with unique endonuclease I-Sce-I sites from 
Saccharomyces cerevisiae, added to the segment of interest by the vector system 
(Martínez-García and de Lorenzo, 2011, 2012). Recently, this system has been updated 
into new pSEVA variants called as pSEVAn28S, where n means different antibiotic 
resistance marker such as Amp, Kan, Cm, Sm, Tc and Gm. This novelty also includes 
the Gibson assembly implementation (Gibson et al., 2009), in order to avoid the use of 
T4 DNA ligase (Aparicio et al., 2015). With this system 11 chromosomal deletions, 
accounting for 300 genes, were performed in P. putida KT2440, resulting in EM42 and 
EM383 strains, genetically upgraded strains, as far as it concerns growth properties and 
stress survival capabilities (Martínez-García et al., 2014).  
Other scarless gene knockout approaches include the λ/Red based deletions (Luo 
et al., 2016), customized mini-Tn5 transposons with the Flp-FRT recombination system 
(Leprince et al., 2012) and the use of CRISPR/Cas9 (Tan et al., 2018). The latter 
technique is based on Cas9 nuclease from Streptococcus pyogenes that uses a single 
guide RNA (sgRNA) to target any DNA sequence, widely used in Gram negative and 




Finally, random knockouts via transposon mediated-insertional mutagenesis 
strategies have been traditionally used to study relevant genes to a biological function. 
This approach results in a single locus mutations that can be identified by insertion 
mapping (Cebolla and Arévalo-Rodríguez, 2010). A collection of P. putida KT2440 
mutant strains obtained by mini Tn5 transposons elements is available, known as 
Pseudomonas Reference Culture Collection and it can be found in the following link: 
(https://www.gbif.es/coleccion/pseudomonas-reference-culture-collection-estacion-
experimental-del-zaidin/) (de Lorenzo et al., 1990; Herrero et al., 1990; Duque et al., 
2007). With this approach, in silico proposed conditional essential genes in P. putida 
KT2440 (iJN746 (Nogales et al., 2008), iJP850 (Puchałka et al., 2008)) have been 
evaluated (Molina-Henares et al., 2010). 
 
1.3.2 Available genome-scale metabolic models  
 
With available publications of full genome sequence, it was possible to identify the 
gene products and the reactions that make up an organism. Thus, it was feasible 
reconstruct on a genome-scale, metabolic networks (known as GENREs) for a target 
organism in a biochemically manner (Monk et al., 2014). Network reconstruction is a long 
and laborious process and it consists in collecting all the available biochemical, genetic, 
genomic (BiGG) information and then organizes it into a mathematical format yielding 
mechanistic genotype-phenotype relationships for microbial metabolism (Figure 4). 
Since the first GENRE, many more in silico models have been followed including that for 
human metabolism (Edwards and Palsson, 1999). The scope and content of network 
reconstructions continues to grow by including more and more information about the 
given organism such as, the entire transcription and translation apparatus of a cell and 
the structural information about the metabolic enzymes (Palsson, 2015).  
Networks consist of compounds (nodes; represented as rows in a matrix) and 
reactions (links; represented by columns). When many reactions are known to share 
reactants and products, they can be graphically linked together and mathematically 
represented. Mathematical representation is based on the stoichiometric coefficients that 
count the molecules that are consumed and produced by a biochemical reaction and it 
can be organized in a stoichiometric matrix format S (a table). This means that all steady 
states of a network can be described by a linear equation, Sv=0, where v is a vector of 
fluxes through chemical reactions. Every reaction can also be given upper and lower 
bounds, which define the allowable fluxes of the reactions (Orth et al., 2010; Palsson, 
2015).  
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Figure 4. The iterative process of metabolic network reconstruction. The process starts with gathering 
the current knowledge about the microorganism from multiple sources of information. Next the construction 
and debugging of the reaction set, the building of a stoichiometric matrix, and the comparison of the in silico 
simulation results using experimental data are carried out. Once the experimental data (i.e., measured rates) 
are in agreement with the in silico predictions, the model can be used for further applications like, e.g., 
development of metabolic engineering strategies. Adapted from (Baart and Martens, 2012). 
The metabolic reconstruction could be divided in four main steps. First, based on 
the available genome annotated sequence and information of a given organism, can be 
obtained the draft reconstruction. Second, reconstruction complementation and manual 
curation process can be done by adding the detailed biochemical, genetic data and 
known metabolic functions. Third, by adding available detailed physiological data, 
deletion phenotypes (phenomics), the construction is converted into mathematical 
format. Finally, the reconstruction is validated against various data sets such as 
fluxomics, metabolomics, proteomics and transcriptomics (Palsson, 2015).  
Nowadays, there are many different reconstructions published and publicly 
available majorly from prokaryotic microorganism of specific environmental and 
bioprocessing interest (Kim et al., 2012; Gu et al., 2019). There are available some 
practical protocols for GENRE and integration of transcriptomics data from our group 
(Nogales, 2014; Nogales and Agudo, 2015) 
 P. putida´s metabolism has been extensively characterized and eight genome-
scale models (known as GEMs) are available including iJN746 (Nogales et al., 2008), 
iJP850 (Puchałka et al., 2008), PpuMBEL1071 (Sohn et al., 2010), iJP962 (Oberhardt et 




(Nogales et al., 2017) and iJN1462 (Nogales et al., 2020). An analytic comparison of the 
characteristics of each of the above-mentioned metabolic models is provided (Nogales 
et al., 2017). These genome-scale models have been widely used for studying key 
metabolic features of P. putida such as aromatic and PHA metabolism. The potential 
carbon, nitrogen, sulphur, phosphorous and iron sources supporting in silico growth were 
tested. Furthermore, using these models, identification of processes non-essential for P. 
putida growth and tolerance to different stressors are feasible. The iJN1411 metabolic 
model was widely used during this Doctoral Thesis.   
 
1.3.3 Design-build-test-learn cycle 
 
DBTL (Design-Build-Test-Learn, Figure 5) cycles are interactive designs 
combining the advances in systems and synthetic biology towards rational genetic 
modifications and strains high-throughput phenotyping leading to conclusions, further 
understanding and additional hypothesis generation (Liu et al., 2015). The Design stage 
includes the initial steps of experimental configuration, starting from the problem 
definition, adequate host selection to in silico modelling simulations using a variety of 
available novel software tools. The Build stage begins by applying synthetic biology 
processes towards host modification and optimization using recombinant DNA 
technology and different parts assembly approaches. To Test, high-throughput analyses 
can be realized, testing growth performance, gene and protein expression, PHA 
production, quantifying the metabolome among others. The Learn stage involves the 
data analysis in order to identify behaviour patterns and to reach to the conclusions. 
These steps can be repeated several times in order to reach the corresponding process 
performance. Furthermore, the goal of these DBTL cycle is the process automation. In 
this Doctoral Thesis, DBTL approaches were used in distinct Results chapters, in order 
to achieve the planned objectives.   
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Figure 5. Iterative design of DBTL (Design-Built-Test-Learn) cycle.  
 
1.4 Metabolic pathways involved in mcl-PHA production in P. 
putida 
 
1.4.1 mcl-PHA synthesis from structurally related substrates 
 
In pseudomonads, structurally PHA-related substrates like fatty acids are 
catabolized through β-oxidation pathway. The fatty acids can be incorporated into PHA 
directly as β-oxidation intermediates ((R)-HA-CoA) avoiding their complete oxidation to 
acetyl-CoA, yielding monomer chains of equal or shorter length than those of the carbon 
source applied (Durner et al., 2000). The fatty acid catabolism and the involved enzymes 
in this route (Fad) are conserved in distinct bacterial species and have been widely 




A detailed β-oxidation pathway in P. putida and its connection with PHA 
metabolism is shown in the Figure 6 and the Supplementary Table S1. In short, the fatty 
acids are activated into acyl-CoA through the acyl-CoA synthetase (FadD). 
Subsequently, an acyl-CoA dehydrogenase (FadE) catalyzes the formation of a double 
bond yielding an enoyl-CoA. In the next step, a tetrameric complex formed by FadBA 
proteins carries out the hydration, oxidation and thiolysis processes. This complex 
comprises five enzymatic reactions (enoyl-CoA hydratase, 3-hydroxyacyl-CoA 
dehydrogenase, cis-Δ3-trans-Δ2-enoyl-CoA isomerase, 3-hydroxyacyl-CoA epimerase, 
and 3-ketoacyl-CoA thiolase) and it is responsible for the removal of two carbon units of 
the acyl-chain (Pramanik et al., 1979). The intermediates of the β-oxidation enoyl-CoA, 
(S)-3-hydroxyacyl-CoA and 3-ketoacyl-CoA, can be converted into (R)-HA-CoA, PHA 
synthase substrates, through a stereospecific trans-enoyl-CoA hydratase (PhaJ), an 
epimerase (FadB), or a 3-oxoacyl-ACP reductase (FabG), respectively (Kniewel et al., 
2017). 
In P. putida KT2440, two fatty acid transporter genes, long-chain fatty acid 
transporter (fadL; PP_1689) and short-chain fatty acid transporter (PP_3124) initializing 
the pathway have been identified (Wang and Nomura, 2010). 
FadD (EC 6.2.1.3) is an ATP, CoA and Mg2+ dependent enzyme, widely distributed 
among the organisms and exhibits a broad substrate specificity. This is a cytoplasmic 
membrane-associated protein that activates exogenous fatty acids into metabolically 
active CoA thioesters, when they are transported across the cytoplasmic membrane. 
Two key studies have been performed in Pseudomonas species reporting two fadD gene 
homologues in P. putida U (named as FadD1 and FadD2) (Olivera et al., 2001a) and P. 
putida GPo1 (named as Acs1 and Acs2) (Ruth et al., 2008). FadD1 was proposed to be 
an enzyme involved in the physiological fatty acid degradation, while the FadD2 was a 
cryptic gene, induced when the FadD1 was inactivated (Olivera et al., 2001a). 
Furthermore, the Acs1 and Acs2 shared 94% and 92% identity to FadD1 and FadD2 of 
P. putida U, respectively. By fluorescent microscopy experiments, the Acs1 has been 
mainly associated with the PHA granules, activating the (R)-HAs released by the PHA 
depolymerase during the PHA degradation process, whereas the Acs2 was located in 
the cellular membrane (Ruth et al., 2008). Finally, in P. putida KT2440, three genes 
encoding putative FadD enzymes (FadD-I; PP_4549, 94% identity to FadD1 of P. putida 
U, FadD-II; PP_4550, 91% identity to FadD2 from P. putida U and fadDx; PP_2213) were 
identified, where the FadD-I was proposed to be the principal one (Wang and Nomura, 
2010).  
The second step of fatty acid degradation in P. putida KT2440 is realized by acyl-
CoA dehydrogenases, FadE. They belong to a large family of flavoproteins and show 
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activity towards a broad range of substrates. The substrate specificity of FadE classifies 
the enzyme into short, medium, long or very long chain acyl-CoA dehydrogenases. 
However, the boundary of classification is not tight as substrate specificities of particular 
enzymes may overlap (Ghisla and Thorpe, 2004). The reaction of dehydrogenation 
presents the rate limiting step in the β-oxidation, since FadE have the lowest activity 
among all β-oxidation enzymes in E. coli (Lu et al., 2003). Initial works in P. putida 
KT2440 identified PP_2216 as a specific acyl-CoA dehydrogenase for short chain 
aliphatic fatty acyl-CoAs (McMahon et al., 2005) and the PP_0368 as an inducible 
phenylacyl-CoA dehydrogenase (McMahon and Mayhew, 2007). Recently, in silico 
analysis of its genome sequence revealed 21 putative acyl-CoA dehydrogenases 
(ACADs), four (PP_1893, PP_2039, PP_2048 and PP_2437) of which were functionally 
characterized by mutagenesis studies. The PP_1893 (FadE) and PP_2437 (FadE2) 
were proposed to directly participate in fatty acid degradation, while the 19 remaining 
putative ACADs have a redundant role or overlap in terms of function when P. putida 
KT2440 is grown on aliphatic fatty acids (Guzik et al., 2014).  
 
Figure 6. Fatty acid β-oxidation pathway and its connection with PHA metabolism. Diagram with the 
main metabolic steps involved in the β-oxidation pathway (black lines), the proposed connection with PHA 
metabolism, the responsible genes involved in these metabolic pathways (red color) and the reaction 
exchanges (gray color) are shown.  
The FadBA complex is encoded by two set of genes located in two different 
operons, in P. putida KT2440, fadB and fadA (PP_2136 and PP_2137), fadBx and fadAx 
(PP_2214 and PP_2215). The first set seems to play a more important role since its lack 
causes a defective β-oxidation pathway yielding polymers with longer chain monomers 
(Ouyang et al., 2007). Various isoenzymes have been proposed to carry out some of the 




As far as it concerns the fatty acid catabolism regulation, in Pseudomonas spp. 
PsrA regulator was reported to transcriptionally control the fad genes and not an 
orthologue of FadR regulator in E. coli (Kang et al., 2008; Fonseca et al., 2014).  
 
1.4.1.1 The connection of the β-oxidation pathway to PHA cycle 
 
In the β-oxidation pathway, the acyl-CoA is sequentially oxidized into enoyl-CoA, 
(S)-3-hydroxyacyl-CoA and 3-ketoacyl-CoA. All of these intermediates are proposed to 
be converted to PhaC1 substrate (R)-HA-CoA by a stereospecific trans-enoyl-CoA 
hydratase (PhaJ), an epimerase (FadB) and/or a 3-oxoacyl-ACP reductase (FabG), 
respectively (Figure 6) (Ren et al., 1998). 
PhaJ is one of the proposed enzymes linking β-oxidation to PHA synthesis and 
catalyzes a stereospecific hydration reaction from trans-2-enoyl-CoA to (R)-3- HA-CoA. 
Studies in pseudomonads have suggested that the PhaJ enzyme can contribute to the 
monomer supply for PHA biosynthesis from fatty acids precursors (Vo et al., 2008). Four 
phaJ genes have been identified in P. aeruginosa, where only the PhaJ1 was found to 
be specific for scl-enoyl-CoAs (C4-C6) and the other three PhaJs were specific for mcl-
enoyl-CoAs (C6-C12) (Tsuge et al., 2003). From database search, three homologues of 
phaJ1pa, phaJ3pa and phaJ4pa were found in P. putida and named as phaJ1 (PP_4552), 
phaJ3 (PP_0580) and phaJ4 (PP_4817), respectively. Only the phaJ4 showed higher 
expression levels when growing in fatty acids. Additionally, PhaJ4 enzyme substrate 
specificity was shown to be mcl-enoyl-CoAs like PhaJ4 from P. aeruginosa (Fiedler et 
al., 2002; Wang and Nomura, 2010; Sato et al., 2011).  
Another linker between β-oxidation and PHA synthesis was previously proposed 
to be a NADPH-dependent-3-ketoacyl-ACP reductase, FabG. This is a reversible 
enzyme, known to catalyze the conversion of 3-ketoacyl-CoA into (R)-HA-CoA and vice 
versa (Nomura et al., 2005). Initial studies on E. coli have shown that FabGEc and FabGpa 
(from P. aeruginosa) were capable to generate (R)-HA-CoA precursors from 3-ketoacyl-
CoA in the presence of PHA synthase (Taguchi et al., 1999; Ren et al., 2000). In 
pseudomonads, its contribution to PHA biosynthesis via β-oxidation pathway is yet 
unclear. In fact, an overexpression of fabG and phaJ in P. putida strain resulted in 
controversial results, with negative and positive effect on PHA biosynthesis, respectively. 
This fabG negative effect could be due to the reversible conversion of (R)-HA-CoA into 
3-ketoacyl-CoA (Vo et al., 2008). 
Finally, FadB a putative epimerase was proposed to connect β-oxidation and PHA 
synthesis by converting (S)-HA-CoA to (R)-HA-CoA. Despite the assigned epimerase 
activity in E. coli (Pramanik et al., 1979), its role is not physiologically relevant in 
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pseudomonads. Thus, FadBA does not seem to possess the putative epimerase function 
to provide (R)-enantiomer of HA-CoA efficiently and that other linking enzymes are 
required to efficiently channel intermediates of β-oxidation towards mcl-PHA 
biosynthesis (Fiedler et al., 2002). More studies need to be done to verify this.  
 
1.4.2 mcl-PHA synthesis from non-PHA-related carbon sources  
 
Non-structurally related substrates such as acetate, ethanol, sugars (glucose, 
fructose and sucrose), glycerol and aromatic molecules can be oxidized to acetyl-CoA 
and channeled towards PHA formation via de novo fatty acid synthesis (1.4.3 section). 
When these substrates were applied for growth and PHA production, the composition of 
the resulting polyester is independent of the carbon source applied. Under these 
conditions, it was reported that the polyester produced by Pseudomonas spp. is 
composed mainly by (R)-3-hydroxydecanoate. However, in less extent other saturated 
and unsaturated monomer types were also observed. A variety of non-PHA related 
carbon sources have been applied in this Doctoral Thesis, such as glucose, sucrose, 
glycerol and aromatic substrates. For this purpose in the following introduction sections 
the metabolism of some of these carbon sources will be described in more detail.  
 
1.4.2.1 Glucose metabolism 
 
In Pseudomonas spp., fructose seems to be the only carbohydrate to be 
transported intracellularly via PEP-PTS system (Durham and Phibbs, 1982). However, 
glucose and other sugars enter the periplasmic space via the porine (OprB), which is 
located in the external membrane (Saravolac et al., 1991).  
Even though the metabolism of glucides in Pseudomonas spp. is not preferential, 
the glucose metabolism is quite complex, since three convergent peripheral pathways 
exist, able to transform it into the 6-phospho-gluconate (6PG) intermediate (Figure 7 and 
Supplementary Table S2) (del Castillo et al., 2007; Rojo, 2010). The glucose can be i) 
directly phosphorylated to glucose-6-P in the cytoplasm or ii) transformed into gluconate 
in the periplasm and then phosphorylated to 6PG intracellularly, iii) or continue the 
oxidation process up to 2-ketogluconate, then intracellularly phosphorylated and reduced 





Figure 7. Diagram of glucose catabolism in Pseudomonas. The EMP (Embden-Meyerhof-Parnas 
Pathway; shown in blue color square), the ED (Entner-Doudoroff; shown in green color square), the 
peripheral pathways (shown in orange color square) are indicated. The responsible genes involved in these 
metabolic pathways (shown in red color) are annotated. Acetyl-CoA is a key branch point to Tricarboxylic 
acid cycle or to other biosynthetic pathways like the de novo fatty acid synthesis. The figure is adapted from 
(Kukurugya et al., 2019). 
Majorly, pseudomonads metabolize the glucose through the Entner-Doudoroff 
(ED) pathway due to the absence of phosphofructokinase enzyme, that catalyzes the 
phosphorylation of fructose-6-phosphate to fructose-1,6-biphosphate (Nikel et al., 2015). 
ED starts by transforming 6PG to 2-keto-3-desoxy-6-phosphogluconate (KDPG) by the 
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6-phoshogluconate dehydratase (Edd). Then, KDPG is hydrolyzed to glyceraldehyde-3-
phosphate and pyruvate by the KDPG aldolase (Eda). The glyceraldehyde-3-phosphate 
after a series of steps is transformed to pyruvate (EMP, Embden–Meyerhof-Parnas 
process). 13C mapping experiments confirmed that glucose-derived carbons were 
catabolized through a cyclic flux connection from the ED pathway towards the upper 
EMP pathway and the non-oxidative PP pathway (Kohlstedt and Wittmann, 2019; 
Kukurugya et al., 2019). Finally, pyruvate is decarboxylated to acetyl-CoA by pyruvate 
dehydrogenase complexes (PDHCs) and it enters the tricarboxylic cycle (TCA) or 
derived to other biosynthetic pathways such as the de novo fatty acid synthesis.  
 
1.4.2.2 Sucrose metabolism 
 
From industrial point of view, sugarcane based sucrose is cheaper and 
environmentally friendlier substrate compared to corn based glucose, which is the most 
common carbon source for E. coli industrial fermentation processes. However, most 
industrial strains, including P. putida cannot utilize sucrose as sole carbon source 
compared to some enteropathogenic E. coli strains such as EC3132 (Jahreis et al., 2002) 
and W (Sabri et al., 2013).  
In E. coli, two gene clusters are responsible for sucrose degradation including the 
scr regulon that encodes for sucrose phosphotransferase system (PTS) and the csc 
regulon, encoding a sucrose non-PTS utilization system (Schmid et al., 1988; Jahreis et 
al., 2002). Even though, the scr regulon could be found either on plasmid, transposon or 
on the chromosomal DNA, the csc regulon is only located on the chromosome. For the 
purpose of this Doctoral Thesis, we will focus on the latter regulon. The sucrose 
permease, CscB transports sucrose into the cell and it is further hydrolyzed intracellularly 
into glucose and fructose by the action of sucrose  hydrolase/invertase, CscA. Finally, 
the generated sugars are phosphorylated intro glucose-6-phosphate and fructose-6-
phosphate by glucokinase, Glk and sucrose fructokinase, CscK, respectively. The 
transcriptional repressor, CscR negatively regulates the csc catabolic genes in the 
absence or at low sucrose concentration (<2 g/L) (Sabri et al., 2013). 
Recently, sucrose fermenting strains were obtained by introducing the cscA cscB 
genes from E. coli W to P. putida KT2440 (Löwe et al., 2017b). Furthermore, PHA 
production from sucrose has been achieved by P. putida cscAB and Synechococcus 





1.4.2.3 Glycerol metabolism 
 
Glycerol is a simple polyol compound, relatively cheap and readily available 
substrate for a variety of bioprocesses.  The biochemistry, genetics and biotechnology 
of glycerol utilization in Pseudomonas spp. were recently reviewed by Poblete-Castro 
and colleagues (Poblete‐Castro et al., 2019).  
glp regulon, is involved in glycerol metabolism in Gram negative bacteria and 
shares a common regulatory theme. Glycerol-3-phosphate (G3P) is the inducer for the 
glp regulon in E. coli, P. aeruginosa and P. putida (Escapa et al., 2013; Nikel et al., 
2014a). In P. putida, glycerol cross the bacterial external membrane via porine OprB 
(Figure 8 and Supplementary Table S3). From the periplasm, glycerol is transported to 
cytoplasm via glycerol transporter/facilitator, GlpF. In the cytoplasm, glycerol is 
phosphorylated to glycerol-3-phosphate (G3P) via glycerol kinase, GlpK. Then, G3P 
dehydrogenase, GlpD transforms G3P to dihydroxyacetone-phosphate DHAP, which is 
latter channeled into key glycolytic intermediates via Entner-Doudoroff metabolism 
(Escapa et al., 2013; Poblete-Castro et al., 2019).  
In some P. putida species, apart from the direct, ATP-dependent phosphorylation 
of intracellular glycerol, it can be oxidized into dihydroxyacetone (DHA) by the glycerol 
dehydrogenase (GldA). Then, it can be further phosphorylated to DHAP using as 
phosphoryl donor, the phosphoenolpyruvate (PEP) and generates pyruvate by the DHA 
kinase, DhaKLM (Poblete‐Castro et al., 2019). 
glpF, glpK and glpD expression levels were significantly higher when the cells were 
grown on glycerol, confirming that all of these enzymes are involved in glycerol 
metabolism (Wang and Nomura, 2010). The long lag phase observed by the cells grown 
using glycerol as sole carbon source, is due to the need of inducing the expression of 
glp genes for the efficient glycerol utilization. GlpR represses glycerol catabolism and it 
is responsible for the long lag-phase (Escapa et al., 2013).  
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Figure 8. Conserved pathways for glycerol metabolism. The coding genes involved in glycerol 
metabolism (shown in red) are GlpF, glycerol facilitator (transporter); GlpK, glycerol kinase; GlpD, glycerol-
3-P dehydrogenase 
 
1.4.2.4 Aromatic degradation 
 
The aromatic degradation is a mechanism highly studied, the different aromatic 
substrates are converted in mono-, di- or tri-hydroxylate derivatives via the incorporation 
of oxygen atoms by the distinct types of oxygenases. Then, the dioxygenases breakdown 
the aromatic ring of these hydroxylate intermediates. The obtained products can be 
easily oxidized up to central metabolic intermediates (Jimenez et al., 2002). The variety 
of aromatic compounds could be channeled into 5 central pathways, including 3-
oxoadipate (β-ketoadipate) pathway via protocatechuate (ferulate, vanillate, p-
coumarate, p-hydroxybenzoate), catechol (benzoate), the homogentisate pathway 
(phenylalalanine, tyrosine) the phenylacetyl-CoA pathway (phenylacetate and 
phenylalakanoate) or gallic acid degradation pathway (Jimenez et al., 2002; dos Santos 
et al., 2004; Nogales et al., 2011) (Figure 9). The classical strategies of aerobic 
degradation involve the activation of aromatic compounds to dihydroxylated 
intermediates and their dioxygenolytic ring-cleavage (the enzymes involved in these 
pathways are listed in the Supplementary Table S4).  
For the purpose of this Doctoral Thesis, we will focus on the β-ketoadipate 
pathway, which is composed of two ortho-cleavage branches, one for protocatechuate 
(pca genes) and other for catechol (cat genes) degradation. The protocatechuate branch 
pathway is widely conserved among bacteria (Jimenez et al., 2002; Jiménez et al., 2004) 
and the pca genes in sequenced Pseudomonas spp. (except in P. mendocina) have 
been identified (Jiménez et al., 2010). These genes are organized in three different 
clusters in P. putida KT2440. The protocatechuate is cleaved to a carboxy-cis,cis-




carboxymuconolactone by the action of 3-carboxy-cis,cis-muconate cycloisomerase, 
PcaB. Then, it is converted to β-ketoadipate enol-lactone by 4-carboxymuconolactone 
decarboxylase, PcaC. By the action of 3-oxoadipate enol-lactonase, PcaD it is 
transformed to β-ketoadipate and by the two-component complex PcaI/PcaJ is 
transformed to β-ketoadipyl-CoA. Finally, the beta-ketoadipyl-CoA thiolase, PcaF, 
generates acetyl-CoA and succinyl-CoA.  
One of the most widely spread peripheral pathways is that of the p-
hydroxybenzoate degradation to protocatechuate by the 4-hydroxybenzoate 3-
monooxygenase, PobA. Other common carbon sources are the phenylpropenoids such 
as ferulate, which is converted to Feruloyl-CoA by the action of feruloyl-CoA synthetase, 
Fcs and further to vanillin by enoyl-CoA hydratase, Ech. Then, vanillin generates 
protocatechuate through vanillin dehydrogenase, Vdh and vanillate O-demethylase, 
VanAB (Jimenez et al., 2002; Jiménez et al., 2004, 2010). 
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Figure 9. Pathways for the aromatic catabolism in P. putida KT2440.  The β-ketoadipate (shown in green 
colors) and the phenylacetate (shown in orange colors) degradation pathways are shown. The names of the 
metabolites and the reaction exchanges (shown in grey color) are shown. The coding genes (shown in red) 
involved in this process are listed in the Supplementary Table 4. The metabolites used in this Doctoral Thesis 
are shown in bold letters. The central metabolite protocatechuate is shown in green color. This figure was 
adapted from Jiménez and collaborators (Jiménez et al., 2004; Nogales et al., 2007). 
 
1.4.2.5 Tricarboxylic acid cycle  
 
Tricarboxylic cycle (TCA) is a conserved catabolic pathway for energy and 
reducing power generation (Figure 10 and Supplementary Table S5). The name of TCA 
or citric acid cycle is due to the first step in this pathway characterized by the attachment 
of acetyl-CoA to citrate by the action of citrate synthase, GltA. This cycle is also known 
as Szent-Gyorgyi-Krebs or just Krebs cycle, named after the scientists who described it 
(Krebs and Johnson, 1980).  
The central acetyl-CoA generated from the fatty acid, glucose, aromatics 
degradation,  or other convergent pathways, can be either channeled to TCA cycle or 
redirected to other biosynthetic pathways, such as for PHA production. The pyruvate 
generated by EMP and  ED pathways is a common source of acetyl-CoA, which is 
converted to this molecule by the action of PDHC (de Kok et al., 1998). In every turn of 
TCA cycle, one molecule of acetyl-CoA is converted to two CO2 molecules, a total of four 
molecules of NAD(P)+, respectively, and one molecule of GDP is phosphorylated to GTP. 
The reduced NAD(P)H molecules serve as electron donors for oxidative 
phosphorylation.  
Finally, a truncated form of TCA cycle, known as glyoxylate cycle, converts the 
acetyl-CoA to biosynthetic intermediates (succinate, glyoxylate, malate) without the loss 
of CO2 leading to biomass formation (Walsh and Koshland, 1984).  
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Figure 10. Tricarboxylic cycle (TCA). The involved coding genes (with red color) and the reaction 
exchanges (with grey color) are shown. The reducing power produced in each reaction is shown with green 
color and the ATP produced in orange color. The glyoxylate shunt is shown with blue color. The figure is 
adapted from Kukuruya and collaborators (Kukurugya et al., 2019). Additional information about the 
enzymes involved in this process is provided in the Supplementary Table S5.  
 
1.4.3 de novo fatty acid synthesis 
 
Non-PHA related substrates such as carbohydrates can act as indirect precursors 
of PHA through their complete oxidation to acetyl-CoA and they can be channeled 
towards the de novo synthesis pathway (Figure 11 and Supplementary Table S6). The 
genetic and biochemical characterization of the de novo fatty acid biosynthesis in 




several aspects of the fatty acid biosynthesis in different bacteria has been revised, 
focusing on different metabolic engineering approaches and their structure elucidation 
(Beld et al., 2015). 
The de novo fatty acid intermediates are activated by the acyl carrier protein (ACP). 
The fatty acid synthesis starts with the acetyl-CoA carboxylation into malonyl-CoA by the 
acetyl-CoA carboxylase, AccABCD complex (Best and Knauf, 1993). Then, the malonyl-
CoA is transtioesterified into malonyl-ACP thanks to the malonyl-CoA:ACP transacylase, 
FabD (Kutchma et al., 1999). The generated malonyl-ACP is further condensed into 3-
ketoacyl-ACP by different 3-ketoacyl-ACP synthases: first, is condensed by an acetyl-
CoA molecule, thanks to FabH, then in successive rounds of elongation a new molecule 
of malonyl-ACP is condensed with the 3-acyl-ACP formed by FabB or FabF (Campbell 
and Cronan, 2001; Schweizer, 2004). FabB has been also proposed to catalyze 
decarboxylation of malonyl-ACP into acetyl-ACP (Cronan and Rock, 2008). The 
following steps include the reduction of 3-ketoacyl-ACP into (R)-3-hydroxyacyl-ACP by 
a 3-ketoacyl-ACP reductase, FabG and the formation of a double bond into enoyl-ACP 
by 3-hydroxyacyl-ACP dehydratase, FabA or FabZ (Heath and Rock, 1996; Sullivan et 
al., 2002). Finally, one enoyl-ACP reductase, FabI, FabK or FabL transforms the enoyl-
ACP into 3-acyl-ACP (Hoang and Schweizer, 1999). In P. putida KT2440 has not been 
identified the gene that codes for the enoyl-ACP reductase activity, however it has been 
proposed to probably contain a FabK or Fab-type enoyl-ACP reductase (Schweizer, 
2004).  
 
1.4.3.1 de novo fatty acid synthesis connection to PHA cycle 
 
Hydroxyacyl-ACP intermediates can be transformed into (R)-HA-CoAs by the 
specific transacylase PhaG, present in most pseudomonads (Rehm et al., 1998). PhaG 
was reported as a 3-hydroxyacyl-acyl carrier protein (ACP)-CoA transferase, able to 
transfer the 3-hydroxyacyl group from ACP to CoA moiety in P. putida KT2440 and P. 
aeruginosa (Rehm et al., 1998; Fiedler et al., 2000; Hoffmann et al., 2000; Hoffmann and 
Rehm, 2004; Tobin et al., 2007). However, PhaG was proposed to function as a 3-HA-
ACP thioesterase. The existence of at least one 3-hydroxyacyl-CoA ligase is needed in 
order to convert 3-hydroxyalkanoate substrates into 3-HA-CoA thioester PHA precursors 
(Q. Wang et al., 2012). Based on homology studies, PP_0763 gene was predicted to 
encode a medium-chain-fatty acid CoA ligase and its transcription levels were highly 
upregulated when cells were grown under PHA producing conditions (Q. Wang et al., 
2012). In order to verify this, phaG (PP_1408) and PP_0763 genes from P. putida were 
cloned and co-expressed with the engineered phaC1 (STQK) synthase from 
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Pseudomonas sp. 61-3 in recombinant E. coli. The latter strain resulted in about 4-fold 
higher PHA production from non-fatty acid carbon sources than that in P. putida KT2440 
(Q. Wang et al., 2012). 
 
Figure 11. de novo fatty acid biosynthesis and its connection with PHA metabolism. Diagram with the 
main metabolic steps involved in the de novo fatty acid biosynthesis (black lines), the proposed connection 
with PHA metabolism, the responsible genes involved in these metabolic pathways (red color) and the 
reaction exchanges (gray color) are shown. 
 
1.4.4 The PHA cycle 
 
The PHA metabolism in P. putida KT2440 is mediated through two PHA synthases, 
PhaC1 (PP_5003) and PhaC2 (PP_5005) and the PHA depolymerase, PhaZ (PP_5004) 
that synthesize and degrade the PHA, respectively. 
More than 60 genes coding for PHA synthases in 45 bacterial species have been 
cloned and have been characterized (Rehm, 2003). These enzymes can be divided into 
four classes according to the substrate specificity, the amino acid primary sequence and 
the subunits composition (Zou et al., 2017). In general, synthase of class I (e.g. 
Cupriavidus necator; formally known as Ralstonia eutropha), class III (e.g. 
Allochromatium vinosum) and class IV (e.g. Bacillus megaterium) preferentially use (R)-
HA-CoA thioesters comprising 3 to 5 carbon atoms. The class II PHA synthases (PhaC1 
and PhaC2) are mainly observed in pseudomonads and preferentially utilize CoA 
thioesters of various (R)-3-hydroxy acids comprising of 6 to 14 carbon atoms. Several 
studies in other Pseudomonas species confirmed that the phaC2 synthase is functional 




Regarding the enzymes responsible for the PHA depolymerization, there are two 
types: the extracellular depolymerases and the intracellular ones. Several, non-PHA 
producer microorganisms secrete extracellular depolymerase that allows them to obtain 
carbon and energy sources from the degradation of the exogenous PHA. Generally, the 
microorganisms that produce PHA, have an intracellular depolymerase. For instance, 
the intracellular degradation of the scl-PHA has been studied extensively in C. necator 
H16 and Rhodospirillum rubrum. Functional genomic analyses confirm the complexity of 
the PHB hydrolysis process (Handrick et al., 2004; Pohlmann et al., 2006). 
 
Figure 12. PHA cycle in P. putida. The key players are the PHA synthases (PhaC1, PhaC2), PHA 
depolymerase (PhaZ) and Acyl-CoA synthetase (FadD). The (R)-HA-CoA is substrate for PhaC synthases 
and for the enzymes responsible for the fatty acid metabolism. The responsible genes involved in this cycle 
and the reaction exchanges are shown in red and grey color, respectively.  
The first intracellular mcl-PHA depolymerase PhaZ was described in P. putida 
GPo1 and its enzymatic activity was confirmed in vivo on the defective phaZ mutant 
(GPo500). In fact, the mutant was able to accumulate efficiently, however, no polymer 
degradation occurred during the stationary phase (Huisman et al., 1991). Similar 
experiments and conclusions have been obtained from P. putida U and P. putida KT2442 
(De Eugenio et al., 2007; De Eugenio et al., 2010a). The first biochemical 
characterization of PhaZ from P. putida KT2442 was carried out in our laboratory (De 
Eugenio et al., 2007). The PhaZ preferentially hydrolyzes mcl-PHAs containing aliphatic 
and aromatic monomers. The enzyme behaves as a serine hydrolase that is inhibited by 
phenyl-methylsulfonyl fluoride. The three-dimensional structure of PhaZ was modeled, 
complexed with a 3-hydroxyoctanoate dimer. Using this model, the enzyme appears to 
be built up from a core of a/β hydrolase-type domain capped with a lid structure with an 
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active site containing a catalytic triad buried near the connection between domains 
(Figure 13, (De Eugenio et al., 2007)). 
 
 
Figure 13. Model of the three-dimensional structure of PhaZ using CumD hydrolase as template. A. 
ribbon diagram, depicting the core domain (magenta) and the lid domain (cyan). Residues Ser102 (blue), 
His248 (green), and Asp221 (orange), and a docked theoretical dimer of HO are depicted in wire frame 
representation; B. schematic representation of the catalytic triad around the substrate. Adapted from (De 
Eugenio et al., 2007) 
Key proteins of the PHA machinery are the phasins. They lack enzymatic activity 
but have been identified as the major GAPs in PHA granules (Prieto et al., 1999). P. 
putida KT2440 contains two phasins, PhaF (PP_5007) and PhaI (PP_5008), which are 
present in all known mcl-PHA-accumulating bacteria (Prieto et al., 2016). PhaF (26 kDa) 
has two different modules connected by a leucine zipper domain. The N-terminal domain 
consists of a long amphipathic α-helix that can bind to the PHA granule (Maestro et al., 
2013). The C-terminal module is predicted to contain a superhelical structure that can 
interact with the nucleoid and is related to pha cluster transcriptional regulation (1.4.5 
section). The N-terminal and leucine zipper domains share sequence similarity with PhaI 
phasin (15 kDa) (Moldes et al., 2004). Recently, the formation of PhaF and PhaI 
complexes was confirmed and the involvement of leucine zipper domain for these 
interactions was established (Tarazona et al., 2019a).  
These modular proteins have multiple functions. The crucial role of PhaF/PhaI for 
granule formation and segregation between daughter cells during division has been 
described (Galán et al., 2011). Recently, PhaF has been demonstrated to function as a 
surfactant protein stabilizing PHA granules in the hydrophilic environments, as occurs in 




activity of PhaF domain confirmed the potential of these proteins to interact and stabilize 
the surface of very different hydrophobic materials (Mato et al., 2019). 
 
1.4.5 PHA metabolism regulation  
 
The pha gene cluster is well conserved among the mcl-PHA producer strains and 
contains 2 operons, phaC1ZC2D and phaFI, that are transcribed in opposite directions 
(Figure 14) (Prieto et al., 2007). The PhaD (PP_5006) is a TetR family transcriptional 
regulator and so far, PhaD was not found in the granule surface, between the GAPs. The 
intergenic regions of the pha cluster vary depending the species (as observed in P. 
corrugata, P. mediterranea, P. aeruginosa) suggesting that the transcription control 
differs between the strains (Prieto et al., 2007). 
 
Figure 14. Genetic organization of pha cluster in P. putida KT2440. The complex PHA global regulators 
such as GacS/GacA, PsrA, RpoS, Crc are demonstrated. Both operons, phaC1ZC2D and phaIF, are under 
the control of the regulator PhaD. 
PHA are widely investigated concerning its structure versatility, physicochemical 
properties, biodegradability, sustainable and optimization production possibilities (Chen, 
2009; Rehm, 2010; Gao et al., 2011; Li et al., 2016). However, the molecular 
mechanisms behind the PHA metabolism regulation are not yet clear, due to the 
complexity of this regulation system at different levels (genetic, post-trascriptional, 
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enzymatic and global regulators). Furthermore, the PHA accumulation could depend on 
the carbon source(s), the specificity of the PHA synthase and the metabolic pathways 
involved. The PhaC synthase substrates derive from the β-oxidation and de novo fatty 
acid synthesis. Thus, we can assume that regulating factors affecting the enzymes 
involved in these pathways could be involved in the PHA synthesis regulation, too.  
PhaF regulates the expression of the entire transcriptomic profile of pha genes, 
due to its DNA binding abilities and putative histone-like functionality (Galán et al., 2011; 
Dinjaski and Prieto, 2013). The co-existence of polycistronic transcription units by the 
identification of five functional promoters upstream of the phaC1, phaZ, phaC2, phaF 
and phaI genes has been proposed by using lacZ translational fusions (De Eugenio et 
al., 2010b). However, by RT-qPCR experiments, the PC1 and PI have been demonstrated 
to be the most active (De Eugenio et al., 2010b). 
PhaD transcriptionally activates the pha genes by binding to 25 and 29 bp target 
regions of the PC1 and PI promoters, respectively (De Eugenio et al., 2010b). In different 
Pseudomonas strains, variable transcription levels of phaF, phaFI have been observed, 
related to the PhaD role (Sandoval et al., 2007). The effector of PhaD remains unknown, 
however, CoA intermediates of fatty acid β-oxidation or TCA cycle have been proposed 
to be possible PhaD effectors. A clear carbon source dependence has been also 
demonstrated (De Eugenio et al., 2010a).  
Finally, the PHA production is modulated by the presence of global regulators 
(Figure 14) including Crc (catabolite repression response), PsrA, RpoS/RpoN and 
GacS/GacA (Prieto et al., 2016). In brief, Crc is a global regulator facilitating the 
hierarchical and sequential use of carbon sources when the growth medium contains 
several at non-growth-limiting concentrations/conditions (Rojo, 2010). Crc is influenced 
by the carbon source used and the culture C/N ratio. In fact, low ratios, (balanced 
medium conditions) which are not optimal for PHA accumulation, provoke Crc-
dependent repression response. However, high ratios, such as nitrogen limitation that 
favors PHA accumulation, suppress this response (La Rosa et al., 2014). Crc is 
associated with Hfq protein and controls gene expression post-transcriptionally, 
promoting an inhibition in the translation of RNAs containing an AAnAAnAA motif (where 
n represents any nucleotide), known as Catabolite Activity (CA) motif, located close to 
the translation start site. Crc regulation motifs, resembling the canonical CA were 
predicted close to the translation initiation sites of phaC1, phaF and phaI mRNAs. Only 
that of phaC1 appeared to be functional (La Rosa et al., 2014).  
PsrA is a TetR family transcription regulator that negatively regulates genes related 
to β-oxidation fatty acid metabolism by binding to the promoter region of fadBA, inhibiting 




active β-oxidation pathway, resulting in an increase of scl-monomers and in all the 
conditions tested demonstrated less PHA content than the wild type strain. Finally, the 
PsrA affect global gene expression including activation of stationary phase sigma factor 
rpoS in P. aeruginosa (Kang et al., 2008) and P. putida (Kojic and Venturi, 2001).  
 
1.5 PHA-related features influencing bacterial fitness and 
stress resistance 
 
Apart from their primary storage function, PHA play a variety of roles such as 
balanced the use of available energy and carbon sources and survival under 
environmental stresses (Figure 15). The PHA related functions are for example 
maintaining anoxic photosynthesis and the sulfur cycle in photosynthetic microorganisms 
(Rothermich et al., 2000), acting as carbon and energy source triggering spore formation 
and germination  in Bacilli  (Slepecky and Law,1961), encystment in Azotobacter 
vinelandii (Segura et al., 2003),  allowing energy production and NADH oxidation of 
nitrogen-fixing bacteria such as Rhizobium etli (Encarnacion et al., 2002), controlling the 
exopolysaccharide production in Azospirrilum brasilense (Kadouri et al., 2003a; Kadouri 
et al., 2005) and microbial biofilm formation in P. aeruginosa (Castro-Sowinski et al., 
2010). Furthermore, PHA play an important role in syntrophic interactions between 
consortia of organisms in different ecosystems such as Azospirillum and other 
rhizosphere bacteria by keeping plant and microorganism symbiosis (Kadouri et al., 
2005). Finally, PHA were reported to contribute to fitness of non PHA producer bacteria 
such as the obligate predator Bdellovibrio bacteriovorus (Martínez et al., 2013) by 
providing energy source.  
In the recent years, there is much interest on the involvement of PHA in bacterial 
stress resistance, reviewed by (Singh Saharan et al., 2014; Obruca et al., 2018). 
However, there are controversial studies on a variety of bacteria on whether just the 
presence of PHA granule (Goh et al., 2014), or the ability to accumulate and/or mobilize 
the PHA could attribute to stress resistance. For example, PHA accumulation has been 
related to resistance to a variety of environmental stresses such as high and low 
temperatures, desiccation, ultraviolet radiation, osmotic pressure and oxidative stress as 
observed by Azospirillum brasilense (Kadouri et al., 2002; Kadouri et al., 2003a; Kadouri 
et al., 2003b), Aeromonas hydrophila (Zhao et al., 2007) and E. coli (Wang et al., 2009). 
Additionally, ethanol and acid-pH value resistance were observed in A. hydrophila (Zhao 
et al., 2007) and E. coli (Wang et al., 2009), respectively. According to these, it could be 
concluded that PHA related roles towards stress resistance are regardless of the 
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microorganisms and the specific stressor. However, the particular protective mechanism 
of PHA is still unknown and it is likely that not just one single mechanism is responsible 
to these physiological PHA functions (Obruca et al., 2018).  
 
 
Figure 15. Physiological functions of PHA. With the goal of surviving in nutrient-poor ecosystems, 
bacteria use PHA metabolism to increase their ability to endure physical and chemical stresses. PHA can 
be used as a carbon source under nutrient deficiency conditions, and function as a source of energy 






1.6 PHA cycle as a robustness cycle 
 
Futile cycles occur in microorganisms inducing a considerable energy burden for 
the cell, operating when the reactions act in an antagonistic fashion, promoting the 
dissipation of energy. Such cycles fall into two main categories, those involving 
simultaneous phosphorylation and dephosphorylation reactions, and those involving 
transport reactions in the opposite direction.  
PHA metabolism is not an unidirectional metabolic process, where the PHA are 
either polymerized or depolymerized but an “ongoing” cycle, where there is a 
simultaneous polymerization and degradation of PHA polymer in order to facilitate the 
turnover of the polymer (Ren et al., 2009; De Eugenio et al., 2010a). PhaZ is active even 
under conditions where it would appear not to be required (Ren et al., 2009). Cells facing 
carbon excess and nutrient limitation direct the PHA metabolism to store the extra carbon 
in the form of polyesters by PHA synthases. Under balanced C/N ratio, PHA metabolism 
is directed to the hydrolysis pathway releasing (R)-HAs monomers to the extracellular 
medium by the action of the PhaZ depolymerase. The released monomers are then 
activated to HA-CoAs by a granule-associated acyl-CoA synthetase (FadD) via ATP-
dependent reaction (Figure 12). This metabolite is a substrate for PhaC as well as for 
the fatty acid metabolism. Depending on the metabolic state of the cell, (R)-HA-CoA is 
either incorporated into nascent PHA polymer chains or used by the fatty acid 
metabolism to make the stored carbon available to the central metabolism. 
Robustness is understood as the inherent property that allows systems to maintain 
their functions despite external and internal perturbations. It is a systems-level 
phenomenon ubiquitously observed in nature (Kitano, 2004, 2007). Recent work from 
our group, identified metabolic robustness cycles in P. putida KT2440 using the in silico 
genome-scale metabolic model iJN1411 (Nogales et al., 2017). Such cycles are more 
than conventional futile cycles and act as metabolic capacitors responsible for 
connecting catabolism and anabolism with central metabolism (Figure 16, cycles shown 
in green). These metabolic capacitors provide a pre-processed source of energy and 
anabolic building blocks while balancing and optimizing the redox state. Thus, such 
buffering cycles provide metabolic robustness and fitness under changing environmental 
conditions.  
PHA cycle has been traditionally considered as a futile cycle (Ren et al., 2009; De 
Eugenio et al., 2010a). However, based on the canonical definition of futile cycles, PHA 
cannot be considered as a such. In any case, it was not clear which was the metabolic 
advantage of the PHA cycle, as a great amount of energy was wasted (Ren et al., 2009; 
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De Eugenio et al., 2010a; Escapa et al., 2012). PHA cycle was identified among these 
robustness cycles. It has been proposed to be highly expressed under exponential 
growth phase irrespectively of the nutritional scenario (Nogales et al., 2017). This means 
that during nutrient imbalance conditions, the cells can adapt rapidly without the need to 
induce complex cascades of gene expression (Ren et al., 2009). Additionally, PHA cycle 
has been proposed to regulate the fatty acid flux towards the fatty acid oxidation pathway 
(Ren et al., 2009). Similarly, work from our group demonstrated that an active PHA cycle 
has a great impact on a variety of physiological processes such as cell size and number 
of individuals as function of carbon/nitrogen availability and biomass formation (De 
Eugenio et al., 2010a; Escapa et al., 2012).  
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  Objectives 




The objectives proposed for this Doctoral Thesis are listed: 
 
1. Validation of PHA cycle as robustness cycle in P. putida KT2440 
i. Physiological analysis of mutant strains in pha genes by high throughput phenotyping 
and gene expression studies 
ii. Study the impact of the PHA cycle on the overall metabolism of P. putida KT2440 
 
2. Study of the functional redundancy of isocitrate dehydrogenase in P. putida as a 
mechanism of robustness 
 
3.  Model-driven design and optimization of PHA production through system and 
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3 MATERIALS AND METHODS 
 
3.1 Bacterial strains 
 
The bacterial strains used in this Doctoral Thesis are listed in the Table 2. Their 
genotype and most relevant characteristics are mentioned.  
Strains Genotype/ Relevant characteristics Reference 
P. putida 
KT2440 Rfr, TOL plasmid-cured, spontaneous restriction 
deficient derivative of P. putida mt-2 
(Bagdasarian et al., 
1981) 
KT40Z KT2440 derivative strain, ΔphaZ deletion mutant This work 





M0 Gmr, P. putida KT40Z, with genomic insertion via 
Tn7 using pMM5 
This work 
M1 Gmr, P. putida KT40Z, with genomic insertion via 
Tn7 using pMM8 
This work 
M2 Gmr, P. putida KT40Z, with genomic insertion via 
Tn7 using pMM14 
This work 
M3 Gmr, P. putida KT40Z, with genomic insertion via 
Tn7 using pMM11 
This work 
M4 Gmr, P. putida KT2440, with genomic insertion via 
Tn7 using pMM12 
This work 
MM3 KT2440 derivative strain, ΔmmgF This work 
MM4 KT2440 derivative strain, Δ(mmgF scpC) This work 
MM6 KT2440 derivative strain, Δ(mmgF scpC sucC 
sucD) 
This work 
MM8 KT2440 derivative strain, Δ(mmgF scpC sucC 
sucD aceA) 
This work 
MM9 KT2440 derivative strain, Δ(mmgF scpC sucC 
sucD aceA glcB) 
This work 
MM11 KT2440 derivative strain, Δ(mmgF scpC sucC 
sucD aceA glcB icd) 
This work 
MM12 KT2440 derivative strain, Δ(mmgF scpC sucC 
sucD aceA glcB icd phaZ) 
This work 
MM13 KT2440 derivative strain, Δ(mmgF scpC sucC 
sucD aceA glcB icd phaZ PP_3190) 
This work 
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MM14 KT2440 derivative strain, Δ(mmgF scpC sucC 
sucD aceA glcB icd phaZ PP_3190 ocd) 
This work 
MM15 KT2440 derivative strain, Δ(mmgF scpC sucC 
sucD aceA glcB icd phaZ PP_3190 ocd hutF) 
This work 
MM16 KT2440 derivative strain, Δ(mmgF scpC sucC 
sucD aceA glcB icd phaZ PP_3190 ocd hutF 
PP_3533) 
This work 
MM18 KT2440 derivative strain, Δicd This work 
MM19 KT2440 derivative strain, Δ(mmgF scpC sucC 
sucD aceA glcB icd phaZ PP_3190 ocd hutF 
PP_3533 pha cluster) 
This work 
MT1 Kmr, MM19 strain with pMM55 This work 
MT2 Kmr, KT2440 Δpha strain with pMM55 This work 
MT9 Kmr Gmr, MM19 strain with pMM55 and pMM66 This work 
MT10 Kmr Gmr, KT2440 Δpha strain with pMM55 and 
pMM66 
This work 
MT11 Gmr, KT2440 with pMM66 This work 
 
E. coli 
DH5α Cloning host; F– λ– endA1 glnX44(AS) thiE1 recA1 
relA1 spoT1 gyrA96(NalR) rfbC1 deoR nupG 
purB20 Φ80(lacZΔM15) Δ(lacZYA-argF)U169, 
hsdR17(rK–mK+), 
(Grant et al., 1990) 
DH10B Cloning host; F-, mcrA Δ(mrr hsdRMS-mcrBC) 
Φ80dlacΔM15 ΔlacX74 deoR recA1 araD139 
Δ(ara-leu)7697 
Invitrogen, Thermo 
Fisher Scientific, USA 
CC118λpir Rfr,Spr Cloning host; Δ(ara-leu), araD, ΔlacX74, 
galE, galK, phoA20, thi-1, rpsE, rpoB, argE (Am), 
recA1, lysogenized with λpir phage 
(Herrero et al., 1990) 
HB101 Helper strain; F- λ- hsdS20(rB- mB-) recA13 
leuB6(Am) araC14 Δ(gpt-proA)62 lacY1 galK2(Oc) 
xyl-5 mtl-1 rpsL20(SmR) glnX44(AS) 
(Boyer and Roulland-
Dussoix, 1969) 
PIR2 Cloning host; F- Δlac169 rpoS(am) robA1 creC510 
hsdR514 endA recA1 uidA(ΔMlu I)::pir 
(Zobel et al., 2015) 
DH5αλpir Cloning host; DH5α lysogenized with λpir phage (Zobel et al., 2015) 
BL21 (λDE3) B F– ompT gal dcm lon hsdSB(rB–mB–) λ(DE3 [lacI 
lacUV5-T7p07 ind1 sam7 nin5]) [malB+]K-12(λS) 
Novagen, Merck 
KGaA, Germany 
Table 2. Strains used in this study 
 
  Materials and Methods 




The plasmids used in this Doctoral Thesis are listed in the Table 3. The most 
relevant characteristics are mentioned.  
Plasmids Relevant characteristics Reference 
pRK600 Cmr, ColE1 oriV RK2 Mob+ Tra+ donor of transfer 
functions 
(Kessler et al., 
1992) 
pK18mobsacB derivative vectors  
pK18mobsacB Kmr, pMB1, oriV, Mob+, lacZa, sacB; vector for allelic 
exchange homologous recombination mutagenesis 
(Schäfer et al., 
1994) 
pMM4 Kmr, pK18mobsacB derivative vector used for phaZ 
deletion 
This work 
pMM15 Kmr, pK18mobsacB derivative vector used for aceA 
deletion 
This work 
pMM16 Kmr, pK18mobsacB derivative vector used for glcB 
deletion 
This work 
pMM19 Kmr, pK18mobsacB derivative vector used for icd 
deletion 
This work 
pMM22 Kmr, pK18mobsacB derivative vector used for PP_3190 
deletion 
This work 
pMM24 Kmr, pK18mobsacB derivative vector used for hutF 
deletion 
This work 
pMM25 Kmr, pK18mobsacB derivative vector used for ocd 
deletion 
This work 
pMM26 Kmr, pK18mobsacB derivative vector used for PP_3533 
deletion 
This work 
pMM51 Kmr, pK18mobsacB derivative vector used for PP_4012 
inactivation with Ser133Ala, Asn136Ala, Arg140Ala 
This work 
pEMG deletion strategy vectors 
pEMG Kmr, plasmid used for deletions; ori R6K oriV, lacZα 
fragment with two flanking I-SceI recognition sites 
(Martínez-
García and de 
Lorenzo, 2011) 
pEMGTS1-TS2 Kmr, pEMG derivative vector used for pha cluster 
deletion 
Arantxa Mato 
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pET29a (+) derivative vectors  
pET29a (+) Kmr, Expression vector. F1 ori, T7 promoter/lac 
operator, N-terminal S•Tag™/thrombin 




pMM27 Kmr, pET29a (+) derivative vector for production  of 
PP_4011-His6 tag sequence 
This work 
pMM28 Kmr, pET29a (+) derivative vector for production  of 
PP_4012-His6 tag sequence 
This work 
pMM42 Kmr, pET29(+) derivative vector for production of 
PP_4012 mut-His6 tag sequence, with point 
mutations to Ser133Ala, Asn136Ala, Arg140Ala 
This work 
sucrose degradation vectors 
pSEVA23cscAcscB Kmr, J23106-BCD12-cscA-B0015; J23116-B0033m-
cscB-B0015; for sucrose degradation 
Juan Nogales 
lab 
pSEVA621 Gmr, ori RK2 used  for  the cloning of cscAcscB 
genes for sucrose degradation 
SEVA collection 
pMM66 Gmr, pSEVA621 derivative vector; J23106-BCD12-
cscA-B0015; J23116-B0033m-cscB-B0015; for 
sucrose degradation 
This work 
pBG derivative vectors and those used in PhaZ library construction 
pTnS-1 Ampr, ori R6K, TnSABC+D operon (Choi et al., 
2005) 
pTn7-M Kmr Gmr, ori R6K, Tn7L and Tn7R extremes, 
standard multiple cloning site 
(Zobel et al., 
2015) 
pBG Kmr Gmr, ori R6K, Tn7L and Tn7R extremes, BCD2-
msfgfp fusion 
(Zobel et al., 
2015) 
pBG28 Kmr Gmr, ori R6K, pBG derivative vector with 14a 
synthetic promoter 
(Zobel et al., 
2015) 
pBG37 Kmr Gmr, ori R6K, pBG-derivative vector with 14c 
synthetic promoter 
(Zobel et al., 
2015) 
pBG42 Kmr Gmr, ori R6K, pBG-derivative vector with 14g 
synthetic promoter 
(Zobel et al., 
2015) 
pBG51 Kmr Gmr, ori R6K, pBG-derivative vector with 14d 
synthetic promoter 
(Zobel et al., 
2015) 




pMM3 Ampr, pGEM-Teasy derivative vector, BCD2-phaZ 
fusion 
This work 
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pMM5 Kmr Gmr, ori R6K, pBG-derivative vector with BCD2-
phaZ fusion 
This work 
pMM8 Kmr Gmr, ori R6K, pBG28-derivative vector with 
BCD2-phaZ fusion 
This work 
pMM11 Kmr Gmr, ori R6K, pBG37-derivative vector with 
BCD2-phaZ fusion 
This work 
pMM12 Kmr Gmr, ori R6K, pBG42-derivative vector with 
BCD2-phaZ fusion 
This work 
pMM14 Kmr Gmr, ori R6K, pBG51-derivative vector with 
BCD2-phaZ fusion 
This work 
Golden Gate cloning vectors level 0 
pICH41295 Smr, ori pMB1/ColE1, golden gate cloning vector 
level 0_ promoter region  
Addgene, USA 
pICH41308 Smr, ori pMB1/ColE1, golden gate cloning vector 
level 0_ coding sequence region 
Addgene, USA 
pICH41276 Smr, ori pMB1/ColE1, golden gate cloning vector 
level 0_ terminator region 
Addgene, USA 
pRK154 Smr, pICH41295 derivative vector, λT0-SynPro16 
promoter 
This work 
pSS14 Smr, pICH41276 derivative vector, λT1 terminator This work 
pRK106 Smr, pICH41276 derivative vector, rnpB-T1 
terminator 
This work 
pRK107 Smr, pICH41276 derivative vector, rpoCterm 
terminator 
This work 
pSS68 Smr, pICH41308 derivative vector phaF gene This work 
pSS70 Smr, pICH41308 derivative vector, phaC1 gene This work 
pMM32 Smr, pICH41308 derivative vector, phaG gene This work 
pMM33 Smr, pICH41308 derivative vector, PP_0763 This work 
Golden Gate cloning vectors level 1 
pICH47732 Ampr, ori pUC/RK2, golden gate cloning vector level 
1 position 1 
Addgene, USA 
pICH47742 Ampr, ori pUC/RK2, golden gate cloning vector level 
1 position 2 
Addgene, USA 
pICH47751 Ampr, ori pUC/RK2, golden gate cloning vector level 
1 position 3 
Addgene, USA 
pICH47761 Ampr, ori pUC/RK2, golden gate cloning vector level 
1 position 4 
Addgene, USA 
pICH47772 Ampr, ori pUC/RK2, golden gate cloning vector level 
1 position 5 
Addgene, USA 
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pICH54033 Ampr, ori pUC/RK2, golden gate cloning vector level 
1 position 3; dummy 
Addgene, USA 
pMM34 Ampr, pICH47732 derivative vector level 1 position 
1; T0-SynPro16-phaC1-λT1 
This work 
pMM35 Ampr, pICH47742 derivative vector level 1 position 
2; T0-SynPro16-phaF-rnpB-T1 
This work 
pMM37 Ampr, pICH47772 derivative vector level 1 position 
5; T0-SynPro16-PP_0763-λT1 
This work 
pMM38 Ampr, pICH47761 derivative vector level 1 position 
4; T0-SynPro16-phaG-rnpB-T1 
This work 
Golden Gate cloning vectors level 2 
pAGM4723 Kmr, ori ColE1/pVS1, golden gate cloning vector 
level 2 
Addgene, USA 
pICH49299 Ampr, ori pUC/RK2, golden gate vector level 2 end-
linker (open construct), position 5 
Addgene, USA 
pMM55 Kmr, pAGM4723 derivative vector level 2; phaC1; 
phaF; dummy 3; phaG; PP_0763 
This work 
Table 3. Plasmids used in this study. 
 
3.3 Media and growth conditions 
 
E. coli and P. putida strains were grown routinely for DNA manipulations and for 
pre-cultures in lysogeny broth (LB) medium (Sambrook and Russell, 2001) at 37°C and 
30°C, respectively. The appropriate selection antibiotics, gentamicin (10 µg/ml), 
chloramphenicol (34 µg/ml), ampicillin (100 µg/ml), kanamycin (50 µg/ml), streptomycin 
(75 µg/ml) were added when needed. Additionally, IPTG (0.5-1 mM) and Xgal (40 µg/ml) 
were added when needed.  
Standard growth experiments of P. putida in defined medium were performed in 
M63 minimal medium (13.6 g of KH2PO4/L, 2 g (NH4)2SO4/L, 0.5 mg FeSO4 •7H2O/L, 
adjusted to pH 7.0 with KOH) (Miller, 1972), plus the carbon source needed in each case. 
For PHA accumulation, P. putida strains were grown in M63 0.1 N nitrogen-limited 
minimal medium (13.6 g of KH2PO4/L, 0.2 g (NH4)2SO4/L, 0.5 mg FeSO4•7 H2O/L, 
adjusted to pH 7.0 with KOH), supplemented with the needed carbon source for 24 h at 
30°C under vigorous shaking at 200 rpm, as previously described (De Eugenio et al., 
2010a). In both cases, the medium was supplemented with 1 mM MgSO4 and 1 X 
solution of trace elements (Goodies) (composition 1000 X dissolved in 1N HCl: 2.78 g/L 
  Materials and Methods 
                                                                             59 
 
of FeSO4•7H2O, 1.98 g/L of MnCl2•4H2O, 2.81 g/L of CoSO4•7H2O, 1.47 g/L CaCl2•2H2O, 
0.17 g/L of CuCl2•2H2O, 0.29 g/L of ZnSO4•7H2O). 
For P. putida growth experiments, fresh LB pre-cultures cells were washed twice 
with 0.85% saline solution (NaCl), adjusted to an optical density at 600 nm of 0.3 in the 
corresponding medium either M63 0.1 N or M63 plus the needed carbon source. Culture 
growth (50 ml) was monitored in shaking Erlenmeyer flasks (at 200 rpm) of 250 ml using 
a portable spectrophotometer (Fischer Scientific, Pennsylvania, USA) at 600 nm for 24-
48 h. In all the experimental approaches described, the cultures occupied no more than 
20% of the volume of the flask and special care was taken to control the C/N ratio, in 
order to compare between different growth conditions when different carbon sources 
were applied. For PHA mobilization experiments, the C/N ratio was varied between 1-3 
mol/mol, whereas for PHA accumulation experiments, the C/N ratio was maintained at 
40 mol/mol (Table 4).  
For the cultivation in 96-microwell plates, 200 μl aliquots were distributed in the 
microwells. The plates were incubated at 30°C for 24-48 h, with 20 seconds of heavy 
orbital shaking every 15 min using a Multiskan Ascent Incubator (Thermo Scientific, 
Waltham, MA, USA) that monitors optical density at 630 nm every 15 min. 
Substrate Nº 
carbons 




Octanoate 8 7.5  No 2 
15 Yes 40 
Glucose 6 10 No 2 
20 Yes 40 
4-Hydroxybenzoic acid 
(4HBz) 
7 5 No 1.12 
10 Yes 23.33 
p-Coumaric acid 9 3.9 No + EDTA 1.12 
Vanillic acid 8 4.4 No + EDTA 1.12 
Ferulic acid 10 3.5 No + EDTA 1.12 
Phenylacetatic acid 8 4.4 No + EDTA 1.12 
4HBz + octanoate 7 / 8 5 / 3 No 2 
4HBz + 10 undecenoic 
acid 
7 / 11 5 / 3 No 2.26 
Glycerol + octanoate 3 / 8 20 / 1 No 2.26 
Glycerol + glucose 3 / 6  20 / 1.3 No 2.26 
Sucrose 12 5 No 2 
Succinate 4 15 No 2 
Table 4. Carbon sources used in this work. The concentration, the medium and the C/N ratio are listed.  
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3.4 Synthetic biology DNA techniques 
 
The revisited KT2440 genome complete nucleotide sequence is accessible in the 
data bank ((Belda et al., 2016); https://www.ncbi.nlm.nih.gov/nuccore/NC_002947.4). 
Standard molecular biology techniques were performed as previously described 
(Sambrook and Russell, 2001). All oligonucleotides used for PCR amplification are listed 
in Table S 7. Plasmid DNA isolation was made using the High Pure Plasmid Isolation Kit 
(Roche, Mannheim, Germany) following the manufacturer’s protocol. Genomic 
extractions of P. putida KT2440 were performed with the illustraTM bacteria 
genomicPrep Mini Spin Kit (GE Healthcare, Buckinghamshire, UK) or PureLink® 
Genomic DNA kit (Invitrogen). DNA agarose gel bands, PCR products and digestion 
products were purified with illustraTM GFX PCR DNA and Gel Band Purification Kit (GE 
Healthcare, Buckinghamshire, UK) or QIAquick Gel Extraction Kit (Quiagen) and 
QIAquick PCR Purification Kit (Quiagen). DNA concentrations were measured with Nano 
Drop® 2000 Spectrophotometer (Thermo Scientifc, Massachusetts, USA). The enzymes 
Phusion DNA polymerase, T4 DNA ligase, EcoRI-HF, BamHI-HF, XbaI, HindIII-HF, NotI-
HF, NcoI-HF, DraIII-HF, PacI, SpeI and CutSmart buffer were acquired from New 
England Biolabs (NEB, Ipswich, Massachusetts). For cloning confirmation, the DNA Taq 
polymerase (Biotools, Madrid, Spain) was used. The GoldenGate-MoClo enzymes, BpiI 
and BsaI, and Buffer G were acquired from Thermo Scientific (Massachusetts, USA). 
The GoldenGate-MoClo Toolkit (Kit 1000000044) was purchased from Addgene 
(Massachusetts, USA).  
 
3.4.1 Preparation and transformation of competent strains 
 
Preparation of chemically competent E. coli cells was carried out using the RbCl 
method and their transformation was followed as described previously (Sambrook and 
Russell, 2001). P. putida strains were transformed following the Choi et al. protocol with 
some modifications (Choi et al., 2006). P. putida KT2440 strains were grown overnight 
in 20 ml of LB at 30°C. These cultures were pelleted at 3000 xg for 20 minutes at 4°C, 
washed five times with 300 mM sucrose and resuspended in 500 μl of 300 mM sucrose. 
100 μl of cell suspension was mixed with 100 ng of desired plasmid and transferred to a 
2 mm gap electroporation cuvette. After a pulse of 25 μF, 2.5 kV and 200 Ω (Gene 
Pulser/Pulse Controller (Bio-Rad)), 900 μl of fresh room temperature LB was added and 
transferred to a 100 x 16 mm round-bottom polypropylene tube and incubated for 1 hour 
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at 30°C and 200 rpm. Different dilutions were plated on LB 1.5% agar medium with 
corresponding antibiotic selection and grown at 30°C for 18 hours. 
 
3.4.2 Plasmid transfer by conjugation 
 
To perform a conjugation transfer, we need to bring together the donor cell that 
bears the plasmid of interest, the recipient strain, which is the target bacterium, and a 
helper bacterial strain to assist and catalyze the mating process. The mating helper is an 
E. coli strain that provides the conjugation machinery, which is normally derived from a 
RK2 or RP1 plasmid that involves the mobilization (mob) and transfer (tra) functions 
supplied in trans. There are two basic types of helper strains, which express the above 
mentioned functions either on a plasmid (such as HB101 carrying pRK600) or genome 
integrated (such as S17λpir). In this Doctoral Thesis, the former type of helper strain was 
used, and three bacterial strains in the mating process need to be included, offering the 
possibility of changing the donor E. coli strain. The donor strain should contain the pir 
gene as λpir lysogen such as CC118λpir or DH5αλpir in order to favor counter selection 
of transconjugants as needed (Martínez-García et al., 2017).  
Triparental mating was performed following the protocol described by Herrero and 
collaborators (Herrero et al., 1990), using E. coli DH10B with pMM series plasmids as 
donor strain, E. coli HB101 pRK600 as helper strain and P. putida KT2440 as recipient 
strain. The LB pre-inoculum strains were washed twice using 0.85% saline solution and 
then 100 µl of each strain were mixed in an eppendorf. As a negative control, the mixed 
strains without the recipient one was used. Then, on nonselective LB agar plate, we 
placed filters of 0.22 µm pores (Merck) and 100 µl of the mixture of the strains were 
placed on top of the filters. The plate was incubated for 10 hours in 30°C. Placing the 
conjugation mixture on a solid support facilitates oriT-mediated conjugation by 
immobilizing cells in close proximity to one another. The filter was used to facilitate the 
recovery of cells, and nonselective medium was required to avoid killing nontransformed 
recipient cells (Choi and Schweizer, 2006). The counterselection against E. coli was 
achieved by using Pseudomonas-selective rich media such as cetrimide-containing agar 
or minimal M63 medium supplemented with 0.2% citrate or 5 mM benzoate (E. coli donor 
cells cannot use citrate or benzoate as sole carbon and energy source). In all the cases, 
the corresponding antibiotic was added in order to inactivate any nontransformed P. 
putida cells.  
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3.4.3 Plasmid insertion via Tn7 transposon system 
 
Broad host range mini-Tn7 vectors facilitate integration of single-copy genes into 
bacterial chromosome at a neutral and naturally evolved site. The TnsABCD transposase 
components of Tn7 catalyze site and orientation-specific insertion with high frequency 
into bacterial chromosomes at Tn7 attachment (attTn7) sites. With very few exceptions 
these sites are located downstream of a highly conserved glmS gene coding essential 
glucosamine-6-phosphate synthetase (Choi et al., 2005; Choi and Schweizer, 2006).  
This method was carried out by four-parental mating. 4 ml of overnight LB 
precultures of E. coli CC18λpir bearing pMM series of plasmids (Table 3) strain (donor 
strain), E. coli HB101 pRK600 (helper strain), E. coli DH5αλpir pTnS-1 (leading 
transposase strain) and P. putida (recipient strain) were washed twice with 0.85% of 
saline solution and then 100 μl of each strain were mixed in an eppendorf. The same 
mating protocol was used as described previously. The transconjugants were selected 
on cetrimide agar containing 10 µg/ml gentamicin plates and incubated at 30°C for 18 
hours. A negative control of the E. coli parental strains without the recipient P. putida 
strain was also plated. The next day, few colonies were picked on LB kanamycin (to 
verify the loss of the plasmid) and LB gentamicin and incubated at 30°C for 18 hours 
(having Tn7 transposon chromosomically integrated). Few LB gentamicin resistant and 
LB kanamycin sensitive clones were selected in order to verify the correct insertion of 
the transposon into the att Tn7 site and checked via colony PCR and sequencing 
(primers 5-Pput-glmSUP and 3-Tn7L, Supplementary Table S7).  
 
3.4.4 Construction of P. putida deletion mutants 
 
During this Thesis, two deletion strategies based on the pK18mobsacB and pEMG 
were used. 
The gene of interest was inactivated by allelic exchange homologous 
recombination using the mobilizable plasmid pK18mobsacB (Schäfer et al., 1994). The 
PCR primer pairs used for these constructions are listed in the Supplementary Table S7. 
The PCR primer pairs were designed in order to amplify approximately 500-800 bps 
regions upstream (Z1) and downstream (Z3) of the gene that will be deleted to serve as 
recombination arms of homology. We added proper restriction enzyme sites upstream 
of Z1 and downstream of Z3, in order to clone the fragment Z1Z3 into pK18mobsacB. 
The two purified fragments Z1, Z3 were used in order to obtain a Z1Z3 fusion fragment 
(overlapping PCR). The obtained Z1Z3 fragment and the plasmid pK18mobsacB were 
digested with the appropriate restriction enzymes and further gel purified. Finally, the 
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purified fragment and plasmid were ligated using T4 DNA ligase (New England Biolabs) 
overnight at 16°C. These deleted genes were cloned into the corresponding unique sites 
of pK18mobsacB plasmid and transformed into chemically competent E. coli DH10B. 
The transformants were plated on LB plates with kanamycin (50 µg/ml), 0.5 mM IPTG 
and 40 µg/ml Xgal for selection and blue/white screening. Colony PCR was used to verify 
selected white colonies using the F24, R24 primer pair. From selected candidates we 
performed plasmid isolation and the correct sequence of the cloned inserts was 
confirmed by DNA sequencing.  
The resultant plasmid was used to delete the target gene to the host chromosome 
via homologous recombination. Triparental mating was performed following protocol 
described before, using E. coli DH10B with pMM series of plasmids (Table 3) as donor 
strain, E. coli HB101 pRK600 as helper strain and P. putida KT2440 as recipient strain. 
For the first recombination selection process, the cells were plated on cetrimide agar 
containing 50 µg/ml kanamycin, that permitted only the selection of P. putida strains 
(Zobel et al., 2015). The resulted recombinant strains were confirmed by PCR and the 
selected colonies were grown in LB during 6 hours and then plated on M63 10 mM citrate 
selective plates supplemented with 5% sucrose. The sacB counterselection marker from 
Bacillus subtilis confers sucrose sensitivity to Gram negative bacteria. Almost all 
sucrose-resistant colonies will have been cured from pK18mobsacB plasmid (Schäfer et 
al., 1994). Transconjugants sucrose resistant and kanamycin sensitive were isolated and 
the second crossover event was confirmed by PCR, using external primers of the arms 
of homology region (for example Z1-For, Z3-Rev) and DNA sequencing. A schematic 
representation of the process is represented in Figure 17. 




Figure 17. A schematic representation of pK18mobsacB strategy. The two possibilities of recombination 
events are represented. Z1 (green color), Z3 (blue color) upstream and downstream arms of homology 
regions.   With dot lines the different options of having restored wilt type phenotype (45% possibility; shown 
as wt) and gene knock out (55% possibility; shown as KO) are shown.  
For the pha cluster deletion, the pEMG knockout system was used, with some 
modifications (Martínez-García and de Lorenzo, 2011).  The pEMG system is based on 
similar principles of markerless gene replacements by a double-strand break in the 
chromosome, than the pK18mobsacB strategy. As far as it concerns the design of the 
homology regions (called as TS1 and TS2 regions, upstream and downstream of to be 
deleted gene (s), respectively), the delivery vector (pEMG) and the first recombination 
event transconjugants are the same as in the case of pK18mobsacB strategy.  
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The key event in the procedure is the generation of a single break in target genome 
through conditional expression of the I-Sce-I endonuclease. The site recognized by this 
enzyme is an 18 bp sequence (5´-TAGGGATAACAGGGTAAT-3´) that is not present in 
any of the >1700 microbial genomes known thus far. The I-Sce-I sites are entered in the 
chromosome of the bacterium upon co-integration of the recombinogenic vector. Under 
these conditions, surviving cells must have recombined the sequences that flank the I-
Sce-I site to restore chromosomal integrity. The constructing vector pEMG incorporates 
two I-Sce-I sites flanking a lacZa poly-linker. This vector functions in concert with the I-
Sce-I producing pSW(I-SceI) plasmid that allows the accumulative edition of the genome 
of P. putida (Martínez-García and de Lorenzo, 2011).  
Thus, P. putida transconjugants of the first recombination event were transformed 
with pSW-I via electroporation. The selection plates were LB + 500 μg/ml Amp and 15 
mM 3-methylbenzoate (3MB) and incubated on 30ºC for 16 h. We should note here, that 
KT2440 is naturally resistant to ampicillin but such concentration allows plasmid 
selection. Additionally, the I-Sce-I endonuclease expression is dependent on a 3MB 
inducible promoter system. Single colonies were picked on LB + 500 μg/ml Amp and LB 
+ Km to screen for kanamycin sensitive clones. Similar to pK18mobsaB strategy, several 
kanamycin sensitive clones were checked for the knockout phenotypes, using external 
primers to the homology region (FdPHA and RdPHA, Supplementary Table S7). To 
confirm, the integrity of the homology region, DNA sequencing of the PCR product was 
also performed. Under non-selective cultivation Pseudomonas loses the pSW-I plasmid 
quite fast. For this purpose, several single colonies were checked for 500 μg/ml Amp 
sensitivity to verify pSW-I plasmid loss.  
 
3.4.5 GoldenGate-MoClo protocol  
 
Golden Gate cloning method is based on the use of type IIS restriction enzymes 
combined with restriction-ligation. Extremely high cloning efficiency is obtained using a 
simple one-pot incubation of multiple undigested entry constructs and a destination 
vector in the presence of restriction enzyme and ligase. MoClo (modular cloning system) 
allows any multigene construct of choice to be made by using a defined set of pre-made 
vectors and a defined assembly strategy. Basic genetic elements like promoters, coding 
sequences and terminators are cloned at level 0 modules. Each module is flanked by 
two BsaI restriction sites specific for each modules type, with cleavage sites designed to 
allow sets of compatible modules to be assembled in one step in a level 1 destination 
vector (using BsaI enzyme). The resulting level 1 constructs contain transcriptional units, 
which are then assembled six at a time in level 2 constructs using a second type IIS 
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enzyme, BpiI. The cloning process can then be repeated to add more transcription units 
to the resulting construct by alternating the type IIS enzyme (s) for cloning.   
GoldenGate-MoClo plasmids were constructed following the Weber et al. protocol 
with some modifications (Weber et al., 2011). For Level 0 plasmid construction, every 
part was PCR amplified with oligonucleotides designed with the Benchling platform 
(www.benchling.com) with the following characteristics: a tail containing the BpiI 
recognition site followed by the corresponding 4-nt fusion site, 21 bp of minimal length 
for target complementarity, 50°C of minimal Tm for that region and a maximal Tm 
difference of ± 1.5°C between both oligonucleotides. If a part contained a BpiI/BsaI 
recognition site, it would be eliminated introducing by PCR amplification silent 
samesense point mutations in the restriction site sequences. PCR products were purified 
using gel purification kit following manufacturer instructions. Digestion-ligation reaction 
was set up by pipetting in one tube 100 ng of destination vector and the corresponding 
DNA amount of PCR product to maintain 2:1 insert-vector molar ratio, 10 U of BpiI, 400 
U of T4 DNA ligase and 1 mM ATP in commercial Buffer G in a final reaction volume of 
20 μl. The reaction was incubated in a thermocycler for four cycles of restriction-ligation 
at 37°C for 10 minutes and 16°C for 10 minutes and then heat inactivation at 65°C for 
20 minutes. The final step is of great importance, thus, omitting this inactivation would 
lead to re-ligation of some of the insert and plasmid backbone fragments when the 
reaction vessel is taken out of the thermal cycler and would lead to a higher proportion 
of colonies containing incorrect constructs 100 μl of chemically competent E. coli DH5α 
were transformed with 5 μl of reaction mix. Transformed cells were grown overnight at 
37°C in LB 1.5% agar supplemented with 75 μg/ml streptomycin, 0.5 mM IPTG and 40 
μl/ml X-gal. Blue-white selection was carried out and four white colonies were transferred 
to 4 mL of liquid LB medium with 75 μg/ml streptomycin for plasmid purification. The 
extracted plasmids were digested for one hour at 37°C with BsaI to check the presence 
of the correct insert in an agarose 0.7% gel. Two plasmids with the correct insert size 
were sequenced with RK81-RK82 (Supplementary Table S7) to verify sequence 
integrity.  
The position and orientation of each gene in a final construct determines which 
level 1 destination vector has to be chosen for assembly of a transcription unit. A total of 
14 vectors are available (pL1F1-7, pL1R1-7) for cloning of genes either forward or 
reverse orientation at each of seven possible positions. These level 1 vectors differ only 
by the sequence of the fusion sites. The two external fusion sites (BpiI cleavage sites) of 
each vector are designed to be compatible with the fusion sites of the vectors from the 
position before and after. The downstream fusion site of the vector at position 7 is 
compatible to the upstream fusion site of vector at position 1 (TGCC). Thus, multigene 
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constructs with more than seven genes can be assembled without the need for additional 
cloning vectors. In practice, a gene that is planned to be cloned at position 8 in a 
multigene construct is simply cloned in a position 1 destination vector etc. For Level 1 
plasmid construction of transcription units, the reaction mix was composed by 100 ng of 
destination vector (pL1F-1 to pL1F-7 depending on the CDS position), a promoter 
plasmid part, a CDS plasmid part and a terminator plasmid part in a 2:1 donor vector-
destination vector molar ratio. 10 U of BsaI, 400 U of T4 DNA ligase and 1 mM ATP in 
Buffer G in a final reaction volume of 20 μl. The reaction was incubated in a thermocycler 
for four cycles at 40°C for 10 minutes and 16°C for 10 minutes, then at 50°C for 10 
minutes and heat inactivation at 80°C for 20 minutes. 100 μl of chemically competent E. 
coli DH10B were transformed with 5 μl of the reaction. Transformed cells were grown 
overnight at 37°C in LB 1.5% agar supplemented with 100 μg/ml ampicillin, 0.5 mM IPTG 
and 40 μl/ml X-gal. Blue-white selection was carried out and four white colonies were 
transferred to 4 mL of liquid LB medium with 100 μg/ml ampicillin to do a plasmid 
purification. The extracted plasmids were digested for one hour at 37°C with BpiI to check 
the presence of the correct insert in a 0.7% agarose gel. Two plasmids with the correct 
insert size were sequenced with RK155-RK156 to verify sequence integrity (Table S7).  
Level 2 vectors contain two inverted BpiI recognition sites for insertion of level 1 
modules. The upstream fusion site (TGCC) is compatible to a gene cloned in a level 1 
vector, whereas the downstream fusion site consists of a universal sequence (GGGA). 
This design allows cloning of two to six genes in the same vector. Using more genes in 
this step would lead to incorrect clones because the same fusion sites would be present 
in different modules. The last gene is fused to the vector by using a compatible linker. 
There are two types of linkers, the “closed” construct, where no further genes can be 
added (pELE-1-7) and the “opened” construct for cloning of further genes (pELB1-7 and 
pELP1-7).  Level 2 reactions were carried out with 100 ng of destination vector (pL2), 
the corresponding end-linker vector (depending on the number of transcriptions units 
and if the construct was “opened” or “closed”), the vector/s with each transcription unit in 
a 2:1 donor vector-destination vector molar ratio. 10 U of BpiI, 400 U of T4 DNA ligase 
and 1 mM ATP in Buffer G in a final reaction volume of 20 μl. The reaction was incubated 
in a thermocycler for four cycles at 37°C for 10 minutes and 16°C for 10 minutes and 
then heat inactivation at 65°C for 20 minutes. 100 μl of chemically competent E. coli 
DH10B were transformed with 5 μl of the reaction. Transformed cells were grown 
overnight at 37°C in LB 1.5% agar supplemented with 50 μg/ml kanamycin. Red-white 
selection was carried out and four white colonies were transferred to 4 mL of liquid LB 
medium with 50 μg/ml kanamycin to do a plasmid purification. The extracted plasmids 
were digested for one hour at 37°C with DraIII-HF and other control enzymes in order to 
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check the presence of the correct inserts in an agarose 0.7% gel. During each step of 
the part construction, apart from the control digestion process, sequencing (with the 
listed oligonucleotides in Supplementary Table S7) of all the included parts was realized. 
An example of the hierarchical cloning levels of GoldenGate-MoClo used in this 
work is shown in Figure 18. In all the cases, the SynPro16 promoter was used with an 
upstream λT0 terminator which was introduced into the Golden Gate-MoClo pL0-PU 
plasmid (Tiso et al., 2016). Genes encoding PhaC1, PhaF, PhaG and PP_0763 enzymes 
from P. putida KT2440 were cloned into the pL0-SC plasmid from the Golden Gate-
MoClo kit. The terminator λT1, rnpB-T1 and rpoC-term were cloned into the pL0-T 
plasmid from the Golden Gate-MoClo kit.  
 
Figure 18. The hierarchical cloning levels of GoldenGate-MoClo. Representation of different possible 
combinations that can be carried out from Level 0 parts to form Level 1 transcription units and the subsequent 
assembly of three Level 1 transcription units to form a Level 2 multigene assembly plasmid.  
 
3.5 Molecular biology RNA techniques 
 
3.5.1 RNA extraction 
 
For the RNA extraction process, standard molecular biology techniques were 
followed (Escapa et al., 2012). The RNA samples were obtained from at least three 
independent cultures, grown under PHA mobilization and PHA accumulation conditions 
(more details in each Results chapter). After 6 h of growth (mid-exponential phase), 7 ml 
were harvested by centrifugation at 3000 xg for 10 min at 4°C. The cell pellets were 
rapidly frozen in dry ice and stored at -80°C until further use.  Pellets were resuspended 
in TE buffer (10 mM Tris-HCl pH 7.5, 1 mM EDTA) containing 5 mg/ml of lysozyme. RNA 
was extracted using the High Pure RNA Isolation kit (Roche) following the manufacturer’s 
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instructions. Extracted RNA was treated with DNase (Ambion) following the 
manufacturer´s instructions. RNA integrity was checked by agarose gel electrophoresis 
and was quantified with NanoDrop 2000® Spectrophotometer (Thermo Scientific, 
Massachusetts, USA). For further verification of DNA absence, a control PCR verifying 
the absence of amplification was performed. 
 
3.5.2 Real time quantitative reverse transcription PCR assay 
 
cDNA synthesis was proceeded by using Transcriptor First Strand cDNA Synthesis 
kit (Roche), following the manufacture´s recommendations. cDNA was synthesized from 
1 μg of purified RNA using random hexamer-primed reactions. For the qRT-PCR assay, 
the protocol described by Revelles and collaborators was followed with some 
modifications (Revelles et al., 2016). For the RT-PCR reaction, 1 μg of transcribed cDNA 
was used and a standard curve of differential dilutions (from 10-1 to 10-5) of P. putida 
genomic DNA was realized. The sequence of the primers used for this study are listed 
in Table S7. Finally, the absolute quantification was chosen for our data analysis, 
showing the expression levels in nM concentration of DNA. This analysis was performed 
in three technical replicates from three independent biological samples and the size of 
each amplified gene was taken into account. 
 
3.6 Physiological parameters quantification 
 
3.6.1 Total biomass calculation 
 
For total biomass calculation, 40 ml of culture medium were centrifuged, in 
previously tared 50 ml Falcon tubes, for 45 min at 3000 xg at 4°C. Cell pellets were 
rapidly frozen at -80°C and were freeze-dried for 24 h in a lyophilizer. Finally, the tubes 
were weighted and the cell densities were expressed in grams of cell dry weight (CDW) 
per liter. By residual biomass, it is referred to the total biomass free of PHA.  
 
3.6.2 Cell viability calculation 
 
Bacterial serial dilutions from 10-1 to 10-7 were made in salt solution (0.85% NaCl), 
in order to calculate the cell viability. Three different spots of each dilution from 10-3 to 
10-7 were plated on LB solid medium. After the spot was dried off, the plates were 
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incubated O/N at 30°C and then the colony-forming units (cfu) were counted. For each 
strain and condition, at least three independent experiments were carried out.  
 
3.6.3 Growth rate calculation 
 
It is worth to notice that PHA content disturbs cells turbidimetry, thus, the optical 
density gives mixed information about cell growth plus PHA accumulation. Optical 
density can only be used to determine the growth rates in absence of PHA (from the 
linear part of the growth curve). Growth rates have been calculated based on the log10 
of residual biomass (biomass free of PHA) data in different time points versus time. The 
curve slope was multiplied by a conversion factor (2.303) between Napierian logarithms. 
 
3.7 Analytical procedures 
 
3.7.1 Methanolysis process and GC-MS analysis for PHA determination 
 
For composition and cellular PHA content, standard GC-MS techniques of the 
methanolysed polyester, previously described from our lab with some modifications were 
used (De Eugenio et al., 2010a). 2-5 mg of lyophilized samples (culture pellets) were 
resuspended in 2 ml of methanol containing 15% sulfuric acid (Sigma-Aldrich, Merck, 
Germany) and 2 ml of chloroform containing 0.5 mg/ml 3-methylbenzoic acid (internal 
standard; Sigma-Aldrich, Merck, Germany) and then incubated using screw-capped tube 
at 100°C for 5-6 h. After cooling, 1 ml of distilled water was added to the mixture, to 
extract most cell debris and the sulfuric acid left. A two-phase extraction process was 
performed by removing completely the water phase to prevent fouling of the GC column. 
Finally, a small amount of Na2SO4 powder was added to dry the chloroform phase and 
to remove any water remains. The absence of sulfuric acid residues to the samples was 
verified by checking that the pH was 5. Then, the organic phase containing the resulting 
methyl esters of monomers was analyzed by GC-MS. 
An Agilent (Waldbronn, Germany) series 7890A coupled with a 5975C MS detector 
(EI, 70 eV) and a split–splitless injector were used for analysis. An aliquot (1 µl) of organic 
phase was injected into the gas chromatograph at a split ratio of 1:50. During this work 
the DB-5HTDB-5HT  column (400°C: 30 m x 0.25 mm x 0.1 µm film thickness) was used. 
Helium was used as carrier gas at a flow rate of 0.9 ml min-1. The injector and transfer 
line temperature were set at 275°C and 300°C respectively. The oven temperature 
program was initial temperature 80°C for 2 min, then from 80°C up to 175°C at a rate of 
  Materials and Methods 
                                                                             71 
 
5°C min-1, for efficient separation of peaks. EI mass spectra were recorded in full scan 
mode (m/z 40–550). With this program, monomers from C4 to C14 were detected. The 
retention time for each monomer is 1.9 min (C4), 2.4 min (C5), 3.5 min (C6), 4.8 min 
(C7:1), 7.2 min (C8), 9.3 min (C9:1), 12.0 min (C10), 14.1 min (C11:1), 16.2 min (C12:1), 
16.6 min (C12), 20.9 min (C14) and 6.1 (3MB, internal standard). 
 
3.7.2 GC-MS and octanoate consumption quantification 
 
For the quantification of extracellular octanoate using GC-MS, the lyophilized 
supernatants of the strains growing under PHA accumulation conditions were 
derivatized. Approximately 5 mg of lyophilized sample were weighted and 100 μl of 
pyridine (Sigma-Aldrich, Merck, Germany) and 50 μl of N´N´BSTFA 
(Bis(trimethylsilyl)trifluoroacetamide, Sigma-Aldrich, Merck, Germany)  were added. The 
mixture was incubated for 45 min in sand bath at 70°C with agitation. Then, 50 μl of 10 
mM n-decane (Sigma-Aldrich, Merck, Germany) dissolved in pyridine was added in the 
mixture, as an internal standard. A standard curve of sodium octanoate (Sigma-Aldrich, 
Merck, Germany) was performed with the same procedure.  The used column was HP-
5MS  5% Phenyl Methyl Silox (400°C: 30 m × 0.25 mm × 0.1 µm film thickness). The 
transfer line temperature was set at 280°C. The oven temperature program was initial 
temperature 80°C for 0 min, and then from 20°C min-1 up to 200°C for 0 min, the duration 
of the run was 6 min, for efficient separation of peaks. The retention time was 2.4 min 
and 4 min for the internal standard (decane) and sodium octanoate, respectively. 
 
3.7.3 HPLC-MS and extracellular (R)-HAs quantification 
 
P. putida strains were cultivated under PHA mobilization and accumulation 
conditions. After different time points, 40 ml of culture medium were centrifuged, in 
previously tared 50 ml Falcon tubes, for 45 min at 3000 xg at 4°C. Supernatants were 
rapidly frozen at -80°C and were freeze-dried for 24 h in a lyophilizer. Finally, the tubes 
were weighted for further calculations. The lyophilized supernatant was homogenized 
and was resuspended in solution methanol-water (50% v/v) at 10 mg/ml. Then, 25 μl 
were injected into the chromatographic system, for the determination of (R)-
Hydroxyalkanoic acids ((R)-HAs; free monomers) content by using a Finnigan Surveyor 
pump coupled to a Finnigan LXQ TM ion trap mass spectrometer (Thermo Electron) 
(HPLC-MS).  
The separation was performed on a 2.1×150 mm (3.5 μm particle size) XTerra MS 
C18 column (Waters) at a flow rate of 100 μL min–1 and an injection volume of 25 μL. 
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The mobile phase was 0.1% ammonium hydroxide in water (A), 0.1% ammonium 
hydroxide in methanol (B) and 0.1% ammonium hydroxide in acetonitrile (C). The 
following elution program was used as follows: at the start, 95% A and 5% B; after 3 min, 
the percentage of B was linearly increased to 95% in 20 min, then kept constant for 5 
min, and after that, percentage of C was increased from 0 to 45% in order to clean the 
column. Finally, it was ramped to the original composition in 5 min, and then equilibrated 
for 10 min. The samples were introduced to the electrospray ionization (ESI) source in 
negative mode by continuous infusion by means of the instrument syringe pump at a rate 
of 3 mL min–1. The source was operated at 4.5 kV and the capillary temperature was set 
to 200°C. All spectra were recorded in full scan mode (m/z 50-1500). 
 A standard curve of commercial 3-hydroxyoctanoic acid (HO; Sigma-Aldrich, 
Merck, Germany) was used, where we observed a deprotonated HO monomer (m/z 159) 
with retention time 15.4 min, a dimer adduct of HO-HO (m/z 603) with retention time 21.5 
min, a trimer adduct of HO-HO-HO (m/z 887) with retention time 29.7 min and a tetramer 
adduct HO-HO-HO-HO (m/z 1171) with retention time 35.6 min (Figure 19). The samples 
analysis revealed mainly two peaks a deprotonated HO monomer (m/z 159) and a dimer 
adduct of HO-HO (m/z 603).  
 
Figure 19. Identification of the P(HO-co-HX) hydrolysis products catalysed by PhaZ. LC-MS analysis 
of 2 mg/ml commercial 3-hydroxyoctanoic acid (HO). Four picks are identified the HO monomer, HO-HO 
dimer adduct, HO-HO-HO trimer adduct and HO-HO-HO-HO tetramer adduct.  
 
3.7.4  HPLC for the identification of extracellular metabolites 
 
Detection of metabolites using the method published by (Revelles et al., 2016). 
The reference compounds used: fructose, acetate, citrate, succinate, pyruvate, 
propionate, malate, formate, fumarate, oxoalacetate, ketoglutarate, butyrate, glucose 
and sucrose (Sigma-Aldrich, Merck, Germany). The different compounds were quantified 
by HPLC (Agilent Series 1260 Infinity II, Agilent, CA, USA), on an Aminex HPX-87H 
column (Biorad, Hercules, CA, USA) at 40°C with a flow rate of 0.5 mL min-1 and an 
injection volume of 25 μl. The mobile phase was 2.5 mM H2SO4 applied in an isocratic 
regime and detection was performed with a refractive index detector. 
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Sucrose (rt = 8.4 min), ketoglutarate ( rt =8.6 min), citrate (rt = 8.9 min), malate (rt= 
9.5 min), oxoalacetate (rt = 9.6 min), pyruvate (rt=9.9 min), glucose (rt= 9.9 min), fructose 
(rt= 10.9 min), succinate (rt = 13.4 min), formate (rt = 15.7 min), fumarate (rt= 15.8 min), 
acetate (rt = 17.3 min), propionate (rt = 20.4 min), butyrate (rt= 25.8 min). 
The presence of residual 4 Hydroxy benzoate (4HBz; Sigma-Aldrich, Merck, 
Germany) was quantified by HPLC (Agilent Series 1260 Infinity II, Agilent, CA, USA), on 
a ZORBAX Eclipse Plus C18 (Biorad, Hercules, CA, USA, Agilent, CA, USA) at room 
temperature with a flow rate of 0.51 mL min-1 and an injection volume of 25 μL. The 
mobile phase was 0.1% trifluoroacetic acid in water (A) and 0.1% trifluoroacetic acid in 
methanol (B). The following elution program was used as follows: at the start, 85% A and 
15% B; after 11 min, the percentage of B was linearly increased to 50%.  After that, it 
was ramped to the original composition in 2 min, and then equilibrated for 8 min. The 
mobile phase was 2.5 mM H2SO4 applied in an isocratic regime and detection was 
performed with a refractive index detector. The retention time of 4HBz was 13.5 min. A 
standard curve of 4HBz was done (1-5 mM). As a control, the medium without 4HBz was 
injected. 
 
3.8 Proteins production, purification and detection 
 
3.8.1 Analyses of PhaZ production 
 
LB pre-cultures of the strains were grown until OD 600 nm 0.6 in fresh LB medium. 
Whole cell extracts were used for these immunological techniques of PhaZ production.  
Western blot was performed as described before (De Eugenio et al., 2007). Briefly, 
12.5% polyacrylamide gels were prepared. The primary anti-PhaZ antibody, 1:5000 (De 
Eugenio et al., 2007) was used, previously washed O/N at 30°C with shaking 200 rpm 
with the sonicated KT40Z phaZ null strain. The secondary antibody was a commercially 
one, rabbit polyclonal antiserum against PhaZ, 1:10000 (GE Healthcare, England). 
Western blot analysis was performed with the ECL Western Blotting Detection Kit (GE 
Healthcare, England) according to the protocol described by the manufacturer. The 
expected PhaZ size is 31 kDa. The Western blot signal intensities were quantified using 
Image J software and the resulting intensities were normalized to the M4 strain and 
taking into account the OD 600nm equivalent load of each sample.  
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3.8.2 Overproduction and purification of recombinant isocitrate 
dehydrogenase 
 
In this work the dimeric icd (PP_4011) and monomeric idh (PP_4012) genes of P. 
putida KT2440 were cloned and enzymatically characterized. A mutated form of 
PP_4012, was obtained by site-directed mutagenesis on Ser133Ala, Asn136Ala, 
Arg140Ala. For kinetic properties characterization, they were heterologously 
overexpressed in E. coli using the traditional pET29a vectors and His-tagged protein 
versions were used in order to enable the protein purification. The PP_4011 fragment 
was obtained using MM152 and MM153 primers, while PP_4012 using MM154 and 
MM155 primers, and for PP_4012 mut MM223-MM224 primers were additionally used. 
The resulting PCR fragments were cloned in pET29a plasmid (Novagen) using BamHI-
HF and HindIII-HF. For maintaining the plasmid and its sequence validation (using T7 
prom and TT7 primers), hosts that do not contain the T7 RNA polymerase gene were 
initially used (DH10B), in order to avoid the production of proteins potentially toxic to the 
host cell. Once established the correct sequence of the inserts, plasmids were 
transferred into the expression hosts E. coli BL21(DE3). 
The E. coli BL21 (λDE3) (pET29a (empty plasmid as negative control), pET29a-
4011, pET29a-4012 and pET29a-4012 mut) strains pre-cultures were resuspended in 
fresh LB medium supplemented with kanamycin (50 μg/ml) with initial OD 600 nm of 0.05. 
When OD 600 nm reached 0.6, 1 mM of IPTG was added to induce recombinant protein 
synthesis under T7 promoter control, and growth was continued at 37°C for 2 hours. The 
cells were harvested from a 100 ml culture by centrifugation at 3000 x g at 4°C for 20 
min and washed twice with 0.85% saline solution and the pellets were frozen at -80°C 
until further use.  
Cells were resuspended in buffer A (50 mM NaH2PO4, 50 mM Na2HPO4, 300 mM 
NaCl, 20 mM imidazole at pH 7.4 and 1 tablet of Roche cOmpleteTM, EDTA free, protease 
inhibitor cocktail per 50 ml culture) and disrupted by two passages using French press 
at 1000 psi. The soluble extract was obtained by a 30 min centrifugation at 10.000 xg at 
4°C to remove cellular debris and was purified in small-scale using Ni-NTA, with 
macroporous silica support material, Spin columns (Quiagen; Catalog Number 31314).  
To previous equilibrated column (three passages with buffer A), the soluble extract was 
loaded (three passages) and several column washes were realized by increasing 
gradiently the imidazole concentration (20-500 mM (buffer B)). His-isocitrate 
dehydrogenase was eluted at 250 mM imidazole. The protein concentration was 
quantified by Bradford method using bovine serum albumin (BSA) as a standard 
(Bradford., 1976). Up to 250 mM imidazole does not interfere with the Bradford assay. 
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3.8.3 Isocitrate dehydrogenase enzymatic activity 
 
ICDH (Isocitrate dehydrogenase, both icd and idh) activity was assayed at 30°C 
by following NAD(P)H formation spectrophotometrically at 340 nm. The assay mixture 
contained 25 mM Tris-HCl (pH 7.3), 5 mM MgCl2, 0.6 mM NADP+, 0.6 mM isocitrate, 10 
mM succinate (to inhibit interfering of isocitrate lyase activity) and 0.05 mg of purified 
protein extract. For the calculations, we took into account the extinction coefficient of 
NADPH, 6.22 mM-1 cm-1, which can be used to directly quantify the product formation. 
Enzyme activity is expressed as U/mg, where a Unit is defined as a μmol of NAD(P)H 
formed per minute per milligram of protein. To measure the KM value for isocitrate we 
maintained a fixed concentration of NADP+ (0.2 mM) varying the isocitrate 
concentrations from 0-0.6 mM. Similarly, to measure the KM value for NADP+ we 
maintained a fixed concentration of isocitrate (0.2 mM) varying the NADP+ 
concentrations from 0-0.6 mM. The Km and Vmax values were obtained using Prism 6 




3.9.1 Optical microscopy 
 
Cultures were routinely visualized with a 100 X phase-contrast objective (Nikon 
microscope) and images were taken with a connected camera Leica DFC345 FX. For 
cell size quantification, 40 individual cells from at least three individual experiments were 
quantified at different time points during the bacteria growth curve, using image J 
software. 
 
3.9.2 Transmission electron microscopy 
 
P. putida cells previously grown under the conditions of interest for 24 h were 
harvested and washed twice in 1 X PBS. Afterwards, cells were suspended in 2.5% (w/v) 
OsO4 for 1 h, gradually dehydrated in ethanol (30, 50, 70, 90, and 100% (v/v); 30 min 
each) and propylene oxide (1 h), embedded in Epon 812 resin. Ultrathin sections 
(thickness 70 nm) were cut with a microtome using a Diatome diamond knife. The 
sections were picked up with 400 mesh cupper grids coated with a layer of carbon and 
subsequently observed in a Jeol‐1230 electron microscope (JeolLtd, Akishima, Japan). 
The analysis of the biological samples was performed by CIB services.  
Materials and Methods 
76 
 
3.10 Systems biology approaches  
 
3.10.1 Constraint-based flux analysis 
 
The iJN1411 model was exported from SimPHeny as an SBML file and analyzed 
with the COBRA Toolbox v2.0 within the MATLAB environment (The MathWorks Inc.) 
(Becker et al., 2007; Schellenberger et al., 2011). A recent update of this Toolbox is 
available (Heirendt et al., 2019). Tomlab CPLEX and the GNU Linear Programming kit 
were used for solving the linear programming problems. The constraint-based model 
consists of a 2087 x 2826 matrix containing all the stoichiometric coefficients in the model 
of 2087 metabolites and 2826 reactions (S).  
 
3.10.2 Flux balance analysis 
 
Flux balance analysis (known as FBA) is a widely used approach for studying 
biochemical networks, in particular GENREs (genome-scale metabolic networks 
reconstructions). FBA calculates the flow of metabolites through the given metabolic 
network (Figure 20). Thus, FBA makes possible to analyze the phenotypes and 
capabilities of organisms with different environmental or genetic perturbations, to predict 
the growth rate of an organism or the rate of production of a metabolite of interest.  
FBA is based on solving a linear optimization problem by maximizing or minimizing 
a given objective function Z subject to a set of constraints (Figure 20). The constraints 
S*v=0 correspond to a situation of steady-state mass conservation where the change in 
concentration of the metabolites as a function of time is zero. The vector v represents 
the individual flux values for each reaction. These fluxes are further constrained by 
defining lower and upper limits for flux values. For reversible reactions, an upper and 
lower bound of -1000 mmol.gDW-1.h-1 and 1000 mmol.gDW-1.h-1 were used respectively. 
A lower bound of 0 mmol.gDW-1.h-1 was used in case of irreversible reactions. For 
simulating condition-specific growth conditions, lower bounds of the corresponding 
exchange reactions were modified accordingly. 
In FBA the metabolic reactions equations are solved using computational linear 
programming algorithms such as those included in the COBRA (constraint-based 
reconstruction and analysis) Toolbox (is a freely available MATLAB toolbox). COBRA 
methods emphasize describing the constraints that a system must satisfy rather than 
computing an explicit solution, by leading to the definition of a “solution space”, which 
contains the set of feasible solutions that satisfy all imposed constraints. Some of the 
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limitations of FBA are the fact that cannot predict the metabolite concentrations since it 
does not use kinetic parameters and it is only suitable for determining fluxes at steady 
state (Orth et al., 2010). 
 
 
Figure 20. With no constraints, the flux distribution of a biological network may lie at any point in a 
solution space. When mass balance constraints imposed by the stoichiometric matrix S (labeled 1) and 
capacity constraints imposed by the lower and upper bounds (ai and bi) (labeled 2) are applied to a network, 
it defines an allowable solution space. The network may acquire any flux distribution within this space, but 
points outside this space are denied by the constraints. Through optimization of an objective function, FBA 
can identify a single optimal flux distribution that lies on the edge of the allowable solution space; adapted 
from (Orth et al., 2010). 
 
3.10.3 Construction of condition specific models 
 
For the in silico data contextualization, we used the experimental data collected 
under PHA accumulation conditions including the residual biomass, growth rate, 
octanoate uptake rate, extracellular (R)-HAs production, PHA production rate. Different 
condition-specific models were thus obtained and flux balance analysis (Orth et al., 2010) 
and random sampling of Monte Carlo (Schellenberger and Palsson, 2009) were used for 
analysis. In Monte Carlo analysis, sampling mixed fractions of 0.53-0.58 were obtained, 
indicating that the solution space for these models was uniformly sampled. Finally, the 
median value from the distribution was used as the most probable flux value. 
Randomized sampling of Monte Carlo has many advantages such as the ability to 
work with missing data, apply post-processing techniques, quantify uncertainty by 
knowing how limiting the imposed constraints are, and optimize experiments in order to 
reduce this uncertainty by shrinking the size of the solution space. This approach is 
based on that random set of points, which are chosen from the solution space to act as 
surrogate for the entire space. This means that many of the properties that can be 
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calculated for one candidate solution can then be calculated for point throughout the 
entire space. The obtained properties can be evaluated in statistical manner where we 
obtain the mean value of flux through each reaction. Summing up, Monte Carlo sampling 
allow us to analyze large-scale networks towards understanding the whole cell 
metabolism (Schellenberger and Palsson, 2009). 
 
3.10.4 Data clustering  
 
For the data clustering, experimental data, such as, growth rate, total biomass, 
residual biomass, PHA content, viable cells number, (R)-HAs free monomers content of 
the strains grown for 24h under PHA accumulation conditions were used. Each data was 
previously normalized to the corresponding wild type values.  With value of 1, refers to 
no differences observed, values less or higher than 1 to a decrease or an increase 
compared to the wild type, respectively.  
 
3.10.5 Growth-coupled overproducing strains 
 
For growth-coupled overproducing strain designs, the Genetic Design through 
Local Search (GDLS) algorithm was used (Lun et al., 2009). GDLS is a computational 
design tool for metabolic engineering that uses an efficient, low-complexity local search 
approach to identify favorable genetic designs using flux-balance metabolic models. 
GDLS was chosen over other strain design methods due to the complexity of our 
objective, e.g., to find growth-coupled designs of PHA overproducing strains from PHA-
unrelated substrates, which could anticipate a large number of gene knockouts needed, 
and would require a large computational runtime due to the size of our model. GDLS is 
a heuristic algorithm method capable of handling large metabolic models while allowing 
a much larger number of genetic manipulations in the final design than other methods. 
In addition, GDLS runtime scales linearly in contrast to other globally‐optimal search 
methods that scale exponentially. Moreover, GDLS employs a local search approach 
with multiple search paths to find a set of locally optimal strategies that allow for the 
analytical evaluation of the different paths. Similar to other strain design methods, GDLS 
implements reductions that simplify FBA models. Finally, GDLS was demonstrated to 
have as good performance as other globally optimal search methods such as OptFlux 
and Optknock with an order of magnitude of improvement in computational time for 
solutions that yield equal or comparable value. The function GDLS implemented in 
COBRA 2.0 was used (Schellenberger et al., 2011). 
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In order to achieve an optimal biomass-coupled product yield (BCPY), GDLS runs 
were computed using minimum growth rate values up to 60% of that predicted for the 
wild-type model. Due to computing time limitations, the number of simultaneous 
knockouts (neighborhood parameters) tested were 2 to 4, and 3 was the value that 
showed a significant increase in PHA production in all designs described in the results. 
The number of paths used was tested from 1 to 10 depending of the computing 
complexity for each neighborhood value. Generally, a single path was selected by default 
for each case described in the results. The maximum number of knockouts and iterations 
were set to 50 and 70, respectively, by default. Those paths with the greatest BCPY 
value in the final design for each case were selected.  
 
3.11 Statistical analysis and other software 
 
Data sets were analyzed using Prism 6 (GraphPad Software Inc., USA) and Excel 
software. Comparisons among multiple groups were made using one-way or two-way 
analyzes of variance (ANOVA) test, depending on whether one or two different variables 
were considered, respectively. In addition, Tukey's multiple comparisons test was used. 
In every statistical analysis performed, the confidence interval was 95%.   
For DNA processes (construct designs and DNA sequence alignments), Geneious 
and Benchling softwares were used and Prime 3 for the oligonucleotide design. For 
visualization of the DNA sequences chromatograms apart for the above-mentioned 
programs, Chromas software was used. For additional DNA sequence alignment, we 
based on Lalign Server (EMBnet- Expasy) and BLASTN in the NCBI server. For protein 
multiple sequences alignment CLUSTALW in the EMBL-EBI server was used. For 
identifying functional association networks, String web, part of the ELIXIR infrastructure, 
was used. For proteins crystal structure information the Protein Data Bank (PDB) was 
used. For isocitrate dehydrogenase available information, the comprehensive enzyme 
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4.1 Chapter 1: Systems analysis and synthetic tuning of the 
PHA cycle in P. putida KT2440 
 
PHA cycle is a continuous cycle, where polymerization and degradation of the 
polymer happens simultaneously. PHA are not only a source of carbon during carbon 
starvation but rather a key element in resource balancing that assures efficient growth.  
In this chapter, it was performed a thoroughly validation of PHA cycle as a robustness 
cycle in P. putida KT2440 (1.4.4 and 1.6 sections). A DBTL cycle was used by combining 
synthetic and systems biology advances (Figure 21). In order to study the impact of the 
PHA turnover and native pha regulation process on the central metabolism of P. putida, 
the phaZ depolymerase was deleted. Thus, the possibility to complete the PHA cycle 
was avoided by preventing the production of PHA degradation monomers. Then, a library 
of strains with tuned PhaZ production levels were constructed and further extensively 
phenotyped, in order to investigate the impact of the differential phaZ expression levels 
into P. putida physiology. To obtain an overall view of this impact on Pseudomonas 
metabolism, condition specific models were finally constructed allowing the in silico 
contextualization of the in vivo experimental data (Figure 21). 
 





4.1.1 Construction of a P. putida strain lacking the PHA cycle 
 
In order to study the impact of the PHA turnover process on the central metabolism 
of P. putida, the phaZ depolymerase was deleted using the pK18mobsacB strategy, 
resulting to KT40Z strain (Table 2 and 3.4.4 section). A schematic representation of the 
phaZ deletion process is shown in Figure 22A. The phenotype exhibited by the knockout 
strain was initially analyzed by electronic microscopy. As it could be expected, no effect 
on PHA production was observed and in the KT40Z background, cells were able to 
accumulate PHA as efficient as the wild type does after 24 h of growth under PHA 
accumulation conditions (Figure 22B).  
 
Figure 22. Construction of phaZ null depolymerase mutant. A. Schematic representation of the phaZ 
deletion mutant. The oligonucleotides used for the deletion process are shown with black arrows and detailed 
in the Supplementary Table S7. For this deletion the Z1-phaZ-For and Z1-phaZ-Rev primers were used to 
obtain the Z1 upstream homology region and the Z3-phaZ-For and Z3-phaZ-Rev resulting into the Z3 
downstream homology region. For the second recombination process verification, the external phaC1-For 
and phaC2-Rev primers were used.  The remaining nucleotide sequence after the deletion is shown. The 
stop codons and the start codons are shown with bold blue and bold underlined, respectively. The first stop 
codon corresponds to the phaC1 gene and the second one to the phaZ gene. The first start codon 
corresponds to the phaZ and the second one to the phaC2. The Ribosome binding site (RBS) is shown in 
red color. The phaZ remaining nucleotide sequence is shown in orange color. B. TEM microscopy picture of 
wild type and KT40Z strains after 24 h of growth under PHA accumulation conditions. The scale bar is 1 μm. 
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Since the phaZ is co-transcribed with the pha genes, its deletion could result in 
putative polar effects, impacting on the expression of downstream pha genes. 
Additionally, if the PhaD transcriptional activator is not properly transcribed, it could 
decrease the transcription levels of the whole pha cluster (Figure 14, for a scheme of the 
regulatory system). In order to analyze the putative polar effects, the transcription levels 
of some of the downstream pha genes were verified by means of qRT-PCR. Since the 
transcription levels of phasins phaFI, as major GAPS proteins,  were significantly higher 
than those of phaC2 synthase, the phasins were selected for these analyses. The wild 
type and KT40Z strains were harvested after 6 h of growth (mid-exponential phase) 
under PHA mobilization and PHA accumulation conditions and qRT-PCR experiments 
were performed using total RNA. 
It is worth to notice that, by PHA mobilization conditions, we refer to conditions 
where the PHA degradation is favored and no nutrient limitation is observed. However, 
under PHA accumulation conditions, the PHA storage is favored due to carbon excess 
and some nutrient limitation. In this chapter for simplicity, we refer as PHA mobilization 
conditions as cell growing on minimal M63 medium supplemented with 7.5 mM octanoate 
by maintaining the C/N ratio at 2 mol/mol. PHA accumulation conditions means growth 
on minimal M63 0.1N medium supplemented with 15 mM octanoate by maintaining the 
C/N ratio at 40 mol/mol.  
As it could be expected, significantly higher phasin expression was found under 
PHA accumulation than in PHA mobilization conditions (Figure 23). Under this scenario, 
PHA is being synthetized and the requirement of phasins increase accordingly in order 
to allocate this PHA into the growing granules both in the wild type and phaZ strain. 
KT40Z strain showed 1.4 to 1.5 times higher phaF transcription levels compared to wild 
type under PHA mobilization and PHA accumulation conditions, respectively. 
Furthermore, KT40Z strain showed 1.4 and 1.2 times higher phaI transcription levels 
compared to wild type under PHA mobilization and PHA accumulation conditions, 
respectively (Figure 23). Thus, so far, it could be concluded that the KT40Z null mutant 
strain produced efiiciently PHA and there was no decrease in phasins transcription levels 






Figure 23. Phasins transcription levels by qRT-PCR experiments. Quantification of expression levels of 
KT2440 and KT40Z phasins phaF (A) and phaI (B). The expression levels of phasins under PHA mobilization 
conditions (blue bars) and PHA accumulation conditions (black bars) were monitored after 6 h of growth. 
One way ANOVA test analysis was performed and the significant differences compared to the wild type 
strain are shown (*, p<0.05). 
 
4.1.2 Construction and validation of a library of strains driving differential 
phaZ expression levels 
 
In an attempt to finely tune the flux through the PHA cycle, a library of P. putida 
strains was constructed harbouring differential PhaZ production levels. For this purpose, 
a collection of vectors was obtained, expressing the phaZ gene under the control of 
constitutive synthetic promoters with different strength. For this collection construction, 
we based on a promoter library collection previously tested for optimal expression in P. 
putida KT2440 (Zobel et al., 2015).  
The pBG derivated version plasmids contain three modules; the synthetic 
promoter, the translational coupler or bicistronic element BCD2 and the reported gene, 
msf::gfp. The only variable in this system is the promoters strength. Bicistronic couplers 
were used in order to fix the translational efficiency by limiting the interaction of mRNA 
secondary structures with the 5´-untranslated regions of the gene of interest (GOI). 
BCD2 add a downstream region to the promoter and contains two Shine-Dalgarno 
sequences where the SD2 is translationaly coupled to the GOI. In our case, the BCD2-
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msf-gfp was substituted by the BCD2-phaZ. The latter construct was obtained by a PCR 
amplification of P. putida genome with AvrII-BCD2-phaZ and phaZ-BamHI-Rev primers 
using phusion polymerase (Table S7). BCD2-phaZ construct was subcloned into the 
pBG-derived vectors using AvrII and BamHI-HF restriction enzymes, resulting to a panel 
of pBG-derived vectors expressing phaZ gene at different dosage (Table 3).  
E. coli constructs verification was checked via plasmid sequencing. Further, 
genome integration of these constructs into the P. putida KT40Z was performed by using 
the Tn7-strategy (Materials and Methods 3.4.3 section). The resulting strains, that should 
theoretically account for increasing level of phaZ expression were called as M0-M4. A 
detailed description of the structural organization of the resulting pBG-derived plasmids 
is schematically represented in the Figure 24 and the sequences of the integrated 
synthetic promoters used in this work are listed in the Table 5.   
 
Figure 24. Structural organization of pBG-derived library collection vectors. A. Functional elements of 
the plasmid include, a backbone vector bearing a Kmr marker, origin of replication oriR6K, the origin of 
transfer oriT and a Tn7 module cloned between AscI and SwaI sites that bears a Gmr marker. Two 
terminators (T1 and T0), a SEVA version of MCS, and two Tn7 sites recognized by transposase (which is 
provided in trans). Three modules were designed; a module carrying the synthetic promoter, BCD2 
translational coupler, and the gene of interest (GOI), phaZ. The sequence of the leader peptide is indicated 
between SD1 and SD2 (Shine-Dalgarno sequence, shown in red letters). The restriction enzymes between 
each module are shown in green letters. The initial codon of phaZ gene is shown with bold underlined letters.  
B. Schematic representation of pBG-derived vectors chromosome integration after the glmS gene, on KT40Z 
strain. The primers used for the genome integration confirmation are shown with arrows (Table S7). The 




 Table 5. Sequences of integrated synthetic promoters. Restriction sites (shown in green) for PacI 
(TTAATTAA) and AvrII (CCTAGG), the conserved -35 (TTGACA) and -10 (TATAAT) regions of sigma -70 
promoters (shown in red). 
The library of P. putida strains accounting for increasing levels of PhaZ was further 
validated by means of Western blot analysis (Figure 25 and materials and methods 3.8.1 
section). In these experiments, P. putida M0-M4 strains were grown overnight in LB 
medium at 30ºC under vigorous shaking (250 rpm). Then, the cells were inoculated in 
fresh LB medium at initial OD 600nm of 0.05. The cells were harvested at mid-exponential 
phase by reaching OD 600nm of 0.6. Different concentration of whole cell extracts were 
tested by Western blot experiments, shown as OD equivalent load (Figure 25A). The 
phaZ null strain, KT40Z was used as negative control. The expected size of PhaZ is 31 
kDa (De Eugenio et al., 2007).  
As it could be expected a positive correlation was found between the promoter 
strength and the PhaZ production levels, where M0; the lowest to M4; the highest 
promoter´s activity (Figure 25B). The wild type strain behaved similar to M0 strain, where 
no signal was observed in the Western blot experiments. Additionally, the KT2440, 
KT40Z and M4 strains, were tested under PHA mobilization and accumulation 
conditions. Only, the M4 strain was observed by Western blot experiments (data not 
shown). It can be concluded that M0-M4 strains can successfully produce differential 
PhaZ levels, higher than the native one.  
 




M0 pBG TTAATTAAGCGGATAACAATTTCACACAGGAGGCCGCCTAGG 
M1 pBG28/14a TTAATTAACTAGGTTGACATGGATATAATGTATGTACCTAGG 
M2 pBG51/14d TTAATTAATCTACTTGACATCCGACATTCGCGACTGTATAATAAGTTGGCCTAGG 
M3 pBG37/14c TTAATTAAGTGAATTGACATGTCAATTTTTATGTTGTATAATATAACTACCTAGG 
M4 pBG42/14g TTAATTAAGCCCATTGACAAGGCTCTCGCGGCCAGGTATAATTGCACGACCTAGG 
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Figure 25. Construction of P. putida strains with tuning PhaZ production levels. A. Anti-PhaZ Western 
blots. Whole cell extracts of cells collected in mid-exponential phase (O.D.600=0.6). The OD equivalent load 
in each case is shown.  B. relative PhaZ concentration in culture is indicated. The data where normalized to 
M4 strain. The library of strains named M0-M4, from the lowest (M0) promoter’s activity to highest (M4). 
KT40Z was used as negative control. The signal intensities of PhaZ production levels were quantified using 
ImageJ software. Then, the data were normalized to the M4 production levels and taking into account the 
OD equivalent load in each case. 
 
4.1.3 Increasing the level of flux through PHA cycle leads to significant 
physiological and phenotypical changes in P. putida 
 
To investigate the impact of the fine tuning expression of phaZ on P. putida 




mobilization and accumulation conditions were next carried out. The results were 
compared with a control strain, where the whole pha cluster was deleted KT2440 Δpha). 
Under PHA mobilization conditions, no major differences in cell size, growth and 
viable cell number were observed beween the analyzed strains (Figure 26). For instance, 
as it could be expected due to the lack of a functional pha cluster, the KT2440 Δpha 
strain did not accumulate PHA, either on 8 or 24 h of growth (Table 6 and Figure 26C). 
Interestingly, similar behaviour was found in M2-M4 strains, due to the high 
depolymerase activity present in these strains, that completely avoid the net 
accumulation of PHA (Figure 26). In contrast, the wild type strain was able to accumulate 
small amounts of PHA at 8 h, but not at longer times where the degradation of the 
polymer is favoured (Figure 26C). In fact, after 24 h only negligible amount of PHA was 
detected, reaching up to 4% of CDW. Similar behaviour to the wild type was observed 
by the M0-M1 strains, confirming the results obtained by the Western blot experiments 
(Figure 25). Finally, the absence of PhaZ in the KT40Z strain promoted the accumulation 
of up to 29% PHA of the CDW.  
Under PHA mobilization conditions, it would be expected to find (R)-HAs content 
in the supernatant of the strains, since the PHA degradation is favored. However, no 
significant amounts of (R)-HAs were detected in all the strains tested after 24 h of growth 
under these conditions, suggesting that the low C/N ratio favors the catabolism of the 
free acids.  
Table 6. Physiological data after 24 h of growth under PHA mobilization condition. Total biomass, 
PHA content, Residual biomass, viable cell number were listed. Residual biomass is referred to biomass 
free of PHA.  










KT2440 0.9 ± 0.1 4.0 ± 1.3 <0.1 0.8 ± 0.1 21.2 ± 3.9 
KT40Z 0.9 ± 0.1 29.3 ± 6.0 0.2 ± 0.0 0.6 ± 0.1 17.7 ± 5.0 
KT2440 Δpha 0.9 <0.5 <0.1 0.9 ± 0.0 27.0 ± 0.0 
M0 0.9 ± 0.0 7.6 ± 1.9 <0.1 0.8 ± 0.0 26.0 ± 8.5 
M1 1.0 ± 0.1 1.6 ± 0.7 <0.1 1.0 ± 0.0 21.5 ± 4.9 
M2 1.0 ± 0.2 <0.5 <0.1 1.0 ± 0.2 18.0 ± 0.0 
M3 0.9 ± 0.1 <0.5 <0.1 0.9 ± 0.0 17.0 ± 0.0 
M4 1.0 ± 0.0 <0.5 <0.1 0.9 ± 0.0 18.3 ± 3.8 
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Figure 26. Growth characteristics of selected strains under PHA mobilization conditions. A. growth 
curves B. viable cell number throughout time. C. Optical microscopy picture after 8 and 24 h. The strains 
tested were KT2440 (in green), KT40Z (in orange), M4 (in blue) and KT2440 Δpha (in black). The scale of 
the pictures corresponds to 2 μm. The PHA granules are indicated with arrows. 
Next, we studied the phenotype of the constructed strains on a variety of growth 
parameters under PHA accumulation conditions. Under these conditions, large 
differences were found regarding the PHA accumulation properties of the different cells 
(Figure 27). As it would be expected the KT2440, KT40Z and M1 strains reached up to 
72% PHA under 24 h of growth under these conditions (Table 7). On the contrary, it was 
found that in those P. putida strains harbouring high constitutive PhaZ levels (e.g., M2-
M4 strains), the trend was towards a decrease in cell density and smaller cell size. In 
fact, the M2-M4 strains after 8 h of growth were twice smaller than the wt strain (Figure 
27D). The lack of PHA production resulted in one log increase in viable cell number of 




strains (Figure 27B). As far as it concerns the residual biomass, no major differences 
were observed among the strains, reaching between 0.4 to 0.7 g/L. Furthermore, since 
the PHA content alters the cells turbidimetry, the residual biomass was used in order to 
calculate the cell growth rate (3.6.3 section). It can be concluded that M2-M4 strains had 
higher viable cell number, but the cells were smaller, with similar residual biomass. 
Therefore, the cell size is not due to the presence of PHA.  
In order to have a complete picture of the carbon cycle in the strains analyzed, we 
proceeded to monitor both, residual octanoate and secreted (R)-HAs after 24h of growth. 
Regarding the residual octanoate concentration, no significant amounts were detected 
in the culture supernatants of all the strains tested, after 24 h of growth under these 
conditions. With higher phaZ expression levels, more (R)-HAs content is expected in the 
supernatant of the strains (3.7.3 section), since the polymer degradation process is 
favored. In fact, M2-M4 strains produced up to 0.6 g/L of (R)-HAs compared to 0.2 g/L in 
the wild type strain (Table 7). As it would be expected, in absence of phaZ (in the KT40Z 
strain), no (R)-HAs production was observed.  
Table 7. Physiological data after 24 h of growth under PHA accumulation conditions. Sodium 





















KT2440 1.3 ± 0.1 71.7 ± 3.1 1.0 ± 0.1 0.4 ± 0.0  0.2 ± 0.0 1.8 ± 0.6 0.31 ± 0.02 
KT40Z 1.4 ± 0.0 72.3 ± 3.3  1.0 ± 0.1 0.4 ± 0.0 0.0 ± 0.0 1.2 ± 0.5 0.31 ± 0.01 
KT2440 Δpha 0.6 ± 0.1 0.0 ± 0.0 <0.01 0.6 ± 0.1 0.0 ± 0.0 22.3 ± 4.8 0.34 ± 0.00 
M1 1.3 ± 0.1 70.2 ± 3.7 0.9 ± 0.1 0.4 ± 0.0 0.3 ± 0.0 4.1 ± 0.3 0.30 ± 0.01 
M2 0.6 ± 0.0 0.3 ± 0.4 <0.01 0.6 ± 0.0  0.5 ± 0.1 16.5 ± 3.1 0.29 ± 0.00 
M3 0.7 ± 0.1 0.4 ± 0.4 <0.01 0.7 ± 0.1 0.6 ± 0.0 16.8 ± 3.1 0.31 ± 0.00 
M4 0.5 ± 0.0 0.7 ± 1.0 <0.01 0.5 ± 0.0 0.5 ± 0.0 15.4 ± 3.6 0.35 ± 0.02 
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Figure 27. Growth characteristics under PHA accumulation conditions. A. growth curves B. viable cell 
number throughout time. C. Optical microscopy pictures after 8 and 24 h. The strains tested were KT2440 
(in green), KT40Z (in orange), M4 (in blue) and KT2440 Δpha (in black). The scale of the pictures 




Taking into account that the residual biomass production shown in the Table 7, it 
is very likely that other metabolites are released and increment of CO2 production occurs. 
In order to investigate the accumulation of extracellular metabolites originated from an 
unbalanced carbon catabolism, the culture supernatants of all the strains after 24 h of 
growth under PHA accumulation conditions, were analyzed by HPLC (3.7.4 section). The 
presence of sucrose, citrate, pyruvate, glucose, fructose, malate, succinate, formate, 
acetate, propionate, butyrate, fumarate, oxaloacetate and ketoglutarate were checked. 
No significant amounts of these compounds were detected in the culture medium after 
24 h of growth. Similar observations have been obtained previously by pha mutant 
strains (Escapa et al., 2012). 
In order to comparatively integrate the overall behaviour of the analyzed strains 
after 24 h of growth under PHA accumulation conditions, the quantified phenotype 
including: i) total and residual biomass, ii) PHA and (R)-HAs (free monomers) content 
and iii) growth rate were used as input for systematic clustering (Table 7 and Figure 27).  
Accordingly, the strains can be classified into two main categories (Figure 28). On 
one hand, the strains that were able to produce PHA with no o low (R)-HAs production 
(like KT2440, M1, and KT40Z strains). On the other hand, those strains that did not 
produce PHA, since they had increased PhaZ production levels, which favored the 
increased depolymerization of PHA resulting on increased (R)-HAs production (like M2 
- M3 - M4 strains). No PHA accumulation (M2-M4 and KT2440 Δpha strains) led to one 
log increase in the viable cell number compared to the strains able to accumulate PHA 
(wild type and KT40Z). Due to PHA production, the strains had an increased total 
biomass, which led to a slight decrease in residual biomass compared to M2-M4 strains. 
No major differences were observed as far as it concerns the growth rate of all the strains 
tested. Furthermore, in the KT2440 Δpha strain neither PHA or (R)-HAs production was 
observed, but a similar total and residual biomass to M2-M4 strains was obtained. 
 
Figure 28. Data analysis. The data in each column were previously normalized to the corresponding wild 
type values. Comparison should be realized only among the data of each column. With value of 1 we refer 
to no differences observed when compared with the wild type (shown in grey color); values less than one to 
a decrease compared to the wild type (shown in red color); and with values higher to one an increase 
compared to the wild type (shown in green color).  
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4.1.4 Model-based phenotyping data contextualization highlights large 
metabolic changes in response to increasing flux through PHA cycle 
 
To further understand the effect of increasing the flux through the PHA cycle on 
the physiology of P. putida, the experimental data collected under PHA accumulation 
conditions (Tables 7-10) were contextualized, within the metabolic model (iJN1411) 
(Nogales et al., 2017). For this, a serie of condition-specific models were constructed by 
using a step-by-step procedure for the integration of experimental data in genome-scale 
metabolic models based on GIMME (Nogales and Agudo, 2015). Firstly, it was noticed, 
after the careful analysis of the time series datasets collected, that up to three different 
growth phases could be considered under PHA accumulation conditions, likely 
corresponding to three different steady states (Figure 29). The phase A (between 0-5 h 
of growth; early exponential phase), where the bacteria majorly grew and there was slight 
PHA accumulation and/or (R)-HAs production. The phase B (between 5-10 h of growth; 
late exponential phase), where the bacteria were majorly producing PHA or (R)-HAs 
content and there was slight growth. The phase C (between 10-24 h of growth; stationary 
phase), where there was no o slight growth and/or PHA/(R)-HAs free monomers 
production. Therefore, due to the presence of these three consecutive steady states, 
three independent growth-phase condition models were constructed mimicking the early 
exponential, late exponential and stationary phases, respectively. This way, it was 
possible to simulate the whole growth curve by overlapping these three consecutive 
steady states.  
To construct each growth-phase condition model, the experimental data were 
firstly transformed into flux rates (mmol.gdw-1.h-1), a compatible format for constraining 
the model. Subsequently, octanoate uptake rate, growth rate, initial residual biomass, 
PHA and (R)-HAs production rates for the three different phases (A, B, C) were applied 
as constraints into the iJN1411 model (material and methods section 3.10.3 and Figure 
30). All the experimental data used for the in silico contextualization and for the condition 
specific model construction are listed in Tables 7-10. At time 0 the residual biomass of 
all the strains was between 0.08-0.09 g/L with no PHA and (R)-HAs observed in the 
culture pellet and supernatant, respectively. The octanoate concentration at t0 in culture 






Figure 29. Growth phases representation. Experimental data of KT2440 growth under PHA accumulation 
conditions. The PHA content and Residual Biomass are shown in red and black color, respectively. The 
Phase A, B and C are shown in shaded pink, blue and green color, respectively.  
 
Figure 30. Schematic representation of the experimental data contextualization for the P. putida 
strains by using iJN1411 model. Condition specific models were constructed for the phase A (Early 
exponential phase; shown in pink), phase B (Late exponential phase; shown in blue) and phase C (Stationary 
phase; shown in green). In the resulted condition specific models, the metabolic states were analized by 
using Flux Balance Analysis (FBA) and Random sampling of  Monte Carlo.   
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KT2440 0.26 ± 0.02 13.25 ± 0.57 0.03 ± 0.00 0.22 ± 0.01 13.03 ± 1.21 
KT40Z 0.25 ± 0.02 14.48 ± 0.86 0.03 ± 0.01 0.22 ± 0.02 14.71 ± 0.59 
KT2440 Δpha 0.26 ± 0.01 N.D. N.D. 0.26 ± 0.01 15.05 ± 0.99 
M1 0.26 ± 0.03   9.83 ± 0.40 0.02 ± 0.00 0.23 ± 0.03 13.52 ± 0.74 
M2 0.23 ± 0.04 N.D. N.D. 0.23 ± 0.03 14.63 ± 0.28 
M3 0.23 ± 0.05 N.D. N.D. 0.23 ± 0.04 15.39 ± 0.18 
M4 0.25 ± 0.02 N.D. N.D. 0.25 ± 0.02 14.80 ± 0.47 
Table 8. Physiological data at t3 h used in the in silico contextualization process under PHA accumulation 
















KT2440 0.52 ± 0.06 23.32 ± 2.54 0.12 ± 0.01 0.40 ± 0.05 0.17 ± 0.02 11.80 ± 1.44 
KT40Z 0.51 ± 0.03 19.09 ± 1.95 0.10 ± 0.02 0.41 ± 0.02 0.00 ± 0.00 11.52 ± 1.34 
KT2440 
Δpha 
0.45 ± 0.01 N.D. N.D. 0.45 ± 0.01 0.13 ± 0.01 13.64 ± 1.24 
M1 0.52 ± 0.05 20.02 ± 2.16 0.11 ± 0.02 0.40 ± 0.03 0.21 ± 0.02   9.85 ± 1.10 
M2 0.42 ± 0.03 N.D. N.D. 0.42 ± 0.03 0.19 ± 0.00 12.35 ± 0.84 
M3 0.40 ± 0.00 N.D. N.D. 0.40 ± 0.00 0.16 ± 0.02 12.47 ± 0.08 
M4 0.45 ± 0.06 N.D. N.D. 0.45 ± 0.05 0.22 ± 0.01 11.88 ± 0.99 
Table 9. Physiological data at t5 h used in the in silico contextualization process under PHA accumulation 
















KT2440 1.22 ± 0.12 56.27 ± 2.75 0.67 ± 0.04 0.52 ± 0.08 0.21± 0.02 3.13 ± 0.64 
KT40Z 1.08 ± 0.05 44.91 ± 3.45 0.48 ± 0.03 0.59 ± 0.05 0.00 ± 0.00 3.03 ± 0.54 
KT2440 
Δpha 
0.61 ± 0.06 N.D. N.D. 0.61 ± 0.05 0.14 ± 0.01 7.16 ± 0.60 
M1 1.01 ± 0.08 40.26 ± 2.29 0.42 ± 0.03 0.62 ± 0.03 0.37 ± 0.04 2.01 ± 0.48 
M2 0.52 ± 0.01 N.D. N.D. 0.52 ± 0.01 0.43 ± 0.04 6.32 ± 0.30 
M3 0.51 ± 0.05 N.D. N.D. 0.51 ± 0.04 0.48 ± 0.02 5.43 ± 0.35 
M4 0.56 ± 0.05 N.D. N.D. 0.56 ± 0.04 0.48 ± 0.04 6.55 ± 0.43 
Table 10. Physiological data at t10 h used in the in silico contextualization process under PHA 





Figure 31.  Condition specific model validation for KT2440, KT40Z, M1-M4 and KT2440 Δpha  strains 
using FBA analysis. The in silico and in vivo data were shown with lines and dots, respectively. Residual 
biomass data shown in blue color; PHA data shown in red color; (R)-HAs shown in green color and residual 
octanoate consumption (mM) shown in black color. 
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Using the condition-specific models for each phase, the computation of the growth 
curve, the consumption and production profiles of octanoate and PHA/(R)-HAs of each 
strain was carried out (Figure 31). A high level of agreement was demonstrated by 
interpolling and comparing the in silico data with the experimental ones. Therefore, it can 
be concluded that the condition specific models predict accurately what happens in vivo. 
Thus, these models became in unprecedent tools in order to study the impact of phaZ 
on P. putida metabolism under these environmental conditions. For this purpose, the 
solution space for each condition-specific model  was further computed by Markov chain 
Monte Carlo sampling (Schellenberger and Palsson, 2009). 
 
4.1.5 Model-based identification of residual oxidative metabolism under 
stationary phase associated to PhaZ activity 
 
In order to analyze the impact of increasing the phaZ dosage on P. putida, the 
solution space in each growth phase model was sampled by using Monte Carlo approach 
(materials and methods 3.10.3 section). Thus, the probabilistic flux value for each 
reaction was computed for each model. Random set of points were chosen from the 
solution space to act as surrogate for the entire space. The impact of PhaZ flux on the 
distribution of central metabolites at each individual growth phases (A, B, C), for KT40Z 
and M4 strains compared with the wild type strain, is shown in Figures 32-34. The flux 
distribution predictions for the rest of the strains are listed in Supplementary Tables S8- 
S10. 
According to model prediction, depolymerase reaction deletion led to significant 
carbon flux distribution changes compared to wild type strain in phase A (early 
exponential). In fact, based on the flux analysis, KT40Z strain showed higher flux 
channeled through the TCA cycle (Figure 32A). Therefore, key reactions of TCA cycle, 
including citrate synthase (CS), aconitate dehydratase (ACONTa/b) and malate 
dehydrogenase (MDH) had between 1.8-2.2 times higher flux compared to the wild-type 
strain. Accordingly, in the KT40Z strain, this high activity of TCA cycle resulted in 1.7 
higher ATP production compared to wild type (Supplementary Table S8 and Figure 32, 
bottom left). Finally, as a consequence of this high oxidative metabolism, KT40Z 
produced 3.2 times higher CO2 and showed 2.2 fold higher respiration rate than the wild 
type strain (Table S8).  
Additionally, during this phase, KT40Z showed a 1.3 fold higher flux through the 
glyoxylate shunt reactions e.g., isocitrate lyase (ICL) and malate synthase (MALS), 
respectively, thus providing higher levels of C4 metabolites from Acetyl-CoA. According 




blocks and sugars via gluconeogenesis. In fact, 1.5-1.8 increased flux was predicted in 
this pathway when compared to the wild-type strain (glyceraldehyde-3-P-
dehydrogenase, GAPD; phosphoglycerate kinase, PGK; phosphoglycerate mutase, 
PGM and phosphopyruvate hydratase, ENO reactions).  
 Interestingly, the lack of PhaZ function not only led to PHA cycle blockage, but to 
a significant reduction of the flux through the PHA synthase (PHAP2C80). In addition, 
the (R)-HA-CoA, PHA synthase substrate, was not incorporated into nascent PHA, but 
instead it was funnelled to β-oxidation pathway through the reaction catalized by 3-
oxoacyl-ACP reductase, FabG (RHACOAR80) and subsequently transformed in Acetyl-
CoA, thus funnelling the TCA cycle and the oxidative metabolism described above.     
From the other hand, by increasing the PhaZ concentration in phase A, no major 
differences were observed in the carbon flux distribution around TCA cycle and glycolysis 
compared to the wild-type strain (Figure 32B). Interestingly, model based predictions 
suggested different pathway providing (R)-HA-CoA. Thus, while 3-oxoacyl-ACP 
reductase (RHACOAR80) was predicted providing (R)-HA-CoA in M4 strain, enoyl-CoA 
hydratase, PhaJ (RECOAH3), acted as major source of (R)-HA-CoA in the wild type 
strain. Since 3-oxoacyl-ACP reductase (RHACOAR80)-based pathway, closely assisted 
by enoyl-CoA dehydratase, FadB (ECOAH3) and 3-hydroxyacyl-CoA dehydrogenase, 
FadB (HACD3i), interchanges a mole of NADH by NADPH by a mole of (R)-HA-CoA 
produced, it is tempting to speculate that this alternative pathway in the M4 strain could 
be a consequence of a putative balancing of reducing equivalent. However, further 
experiments are needed in order to validate this exciting model-based hypothesis. On 
the other hand, this alternative pathway in the M4 strain could be simply a computational 
artfact due to the nature of FBA where multiple optimal solutions are allowed.  
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Figure 32. Impact of PhaZ depolymerase on the distribution of central metabolite fluxes, as 
determined by random samping of Monte Carlo in phase A (0-5 h). The diagrams summarize the 
reaction networks in cells growing under PHA accumulation conditions. Modifications in the carbon flux 
resulting from the deletion (A) or the overexpression (B) of the phaZ gene, are indicated by red arrows 
(reduced flux), thick green arrows (increased flux) and unaffected fluxes are shown in grey arrows. The 
numbers next to the arrows indicate the net flux (mmol.gCDW -1. h-1) in the mutant and wild-type strain 
(mutant/wild type). The model reactions are shown in grey color. Abbreviations in the figure: Gluc, glucose; 
Glucn, gluconate; 2K-Glucn, 2-keto-D-Gluconate; F6P, fructose-6-phosphate; G3P, glyceraldehyde-3-




phosphoenolpyruvate; OAA, oxaloacetate; CIT, citrate; ISC, isocitrate; KG, a-ketoglutarate; SCC, succinate; 
FUM, fumarate; MAL; malate; GLX, glyoxylate. For the model reaction nomenclature extra information can 
be found in the following link https://drive.google.com/file/d/1L-iVLsONX9qiReDmjVgRS_eDTL6sfJa9/view. 
As far as it concerns the carbon flux distribution during the phase B (late 
exponential), no major differences were observed among KT40Z and wild type strains. 
Again, differential production of (R)-HA-CoA was found, with KT40Z strain using mainly 
the enoyl-CoA hydratase (RECOAH3) reaction, in contrast to wild type strain that 
synthetized (R)-HA-CoA through 3-oxoacyl-ACP reductase (RHACOAR80) reaction 
(Figure 33A and Supplementary Table S9).  
However, M4 model saw significant differences with respect to the wild type model, 
in terms of flux distribution (Figure 33B and Table S9). Overall, the model predicts an 
important metabolism deceleration fuelled by a decrease in the uptake of octanoate (2.2 
vs 3.8, respectively). Subsequently, a significant decrease in the flux through the β-
oxidation pathway, PHA synthesis, TCA cycle, oxidative phosphorylation and 
gluconeogenesis was predicted (Figure 33B). As expected by the high depolymerase 
activity present in M4 strain, all the PHA synthetized was further hydrolysed and 
subsequently secreted to the medium. Interestingly, this observed metabolism 
deceleration does not impact on the growth rate and similar values were found in both 
strains. These results strongly suggest that as greater is the PhaZ activity, lower is the 
carbon spilling.   
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Figure 33. Impact of PhaZ depolymerase on the distribution of central metabolite fluxes, as 
determined by random samping of Monte Carlo in phase B (5-10 h). The diagrams summarize the 
reaction networks in cells growing under PHA accumulation conditions. Modifications in the carbon flux 
resulting from the deletion (A) or the overexpression (B) of the phaZ gene, are indicated by red arrows 
(decreased flux), thick green arrows (increased flux) and unaffected fluxes are shown in grey arrows. The 
numbers next to the arrows indicate the net flux (mmol.gCDW-1. h-1) in the mutant and wild-type strain 
(mutant/wild type). The model reactions are shown in grey color. Abbreviations in the figure: Gluc, glucose; 
Glucn, gluconate; 2K-Glucn, 2-keto-D-Gluconate; F6P, fructose-6-phosphate; G3P, glyceraldehyde-3-




phosphoenolpyruvate; OAA, oxaloacetate; CIT, citrate; ISC, isocitrate; KG, α-ketoglutarate; SCC, succinate; 
FUM, fumarate; MAL; malate; GLX, glyoxylate. For the model reaction nomenclature extra information can 
be found in the following link https://drive.google.com/file/d/1L-iVLsONX9qiReDmjVgRS_eDTL6sfJa9/view. 
As observed during phase B, the wild type and KT40Z strains saw similar carbon 
flux distribution during phase C (stationary phase), indicating that the deletion of phaZ 
had little effect on the physiology of P. putida growing under PHA accumulation 
conditions (Figure 34A). In both strains, phase C was dominated by a basal metabolism 
driven by a reduced octanoate uptake and modest activity of β-oxidation and TCA cycle.   
Interestingly, M4 strain maintained a very active metabolism in this phase 
characterized by high flux through β-oxidation driving a significant oxidation of Acetyl-
CoA in the TCA cycle. As a direct consequence, M4 strain maintained a significant 
activity through oxidative phosphorylation resulting in high production of ATP levels in 
stationary phase (Figure 34B). In fact ATP production rate was 9.8 times higher in the 
M4 background strain than the wild type (Supplementary Table S10).   
A summarized view of the phaZ tuning in key reactions of metabolism during the 
three phases is shown in Figure 35. The reactions focusing on the TCA cycle (Citrate 
synthase), ATP synthesis and CO2 producion are shown for the different strains studied 
in this work. By increasing the PhaZ concentration, the trend was towards a decrease in 
the flux of these reactions during the phase A (early exponential phase) and no major 
differences compared to the other strains during the phase B (late exponential phase). 
These results are fully consistent with the metabolism deceleration observed in the M4 
strain during these growth phases. Interestingly, the strains with higher PhaZ expression 
levels maintained flux through these reactions compared to the wild type and null phaZ 
depolymerase strain, during the phase C (stationary phase).  
Summing up, based on the carbon flux distribution predictions (Figures 32-35 and 
Supplementary Tables S8-10), it could be concluded that the activity of PhaZ 
depolymerase has a great impact in the overall P. putida metabolism. In fact, in the 
absence of phaZ, significant carbon flux alterations were observed during the initial 
phases A and B. On the contrary, the increased doses of phaZ led to minor changes 
during the first two phases, but maintained significant higher oxidative metabolism during 
the phase C compared to wild type and KT40Z strains. These results demonstrate that 
by controlling the PHA cycle activity, the carbon metabolism of P. putida could be 
controlled to tailor potential biotechnological applications.  
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Figure 34. Impact of PhaZ depolymerase on the distribution of central metabolite fluxes, as 
determined by random samping of Monte Carlo in phase C (10-24 h). The diagrams summarize the 
reaction networks in cells growing under PHA accumulation conditions, Modifications in the carbon flux 
resulting from the deletion (A) or the overexpression (B) of the phaZ gene, are indicated by red arrows 
(decreased flux), thick green arrows (increased flux) and unaffected fluxes are shown in grey arrows. The 
numbers next to the arrows indicate the net flux (mmol.gCDW -1. h-1) in the mutant and wild-type strain 
(mutant/wild type). The model reactions are shown in grey color. Abbreviations in the figure: Gluc, glucose; 
Glucn, gluconate; 2K-Glucn, 2-keto-D-Gluconate; F6P, fructose-6-phosphate; G3P, glyceraldehyde-3-




phosphoenolpyruvate; OAA, oxaloacetate; CIT, citrate; ISC, isocitrate; KG, α-ketoglutarate; SCC, succinate; 
FUM, fumarate; MAL; malate; GLX, glyoxylate. For the model reaction nomenclature extra information can 
be found in the following link https://drive.google.com/file/d/1L-iVLsONX9qiReDmjVgRS_eDTL6sfJa9/view. 
 
Figure 35. Impact of PhaZ depolymerase on the distribution of key metabolite fluxes, as determined 
by random samping of Monte Carlo in phases A-C. The reactions of citrate synthase, ATP synthase and 
CO2 production are shown in red, purple and green color, respectively. Net flux: mmol.gCDW-1. h-1 
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4.2 Chapter 2: Study the role of enzyme duplication in the 




Functional redundancy can be defined as the existence of more than one similar 
or identical mechanisms that can replace each other when needed (e.g., response to 
environmental perturbations), thus assuring the integrity of the whole system. Gene 
functional redundancy, overlapping functions and diversity have been described as 
alternative mechanisms of robustness (Kitano, 2004; Nogales et al., 2017). 
Non-essential genes have been widely distributed along the subsystems present 
in the in silico genome-scale metabolic model, iJN1411. 75% of them provided 
robustness under genetic perturbations through the alternative and redundant 
mechanisms. Thereby, 59% of them had at least one isoenzymes, that could replace 
each other, such as isocitrate dehydrogenase (Nogales et al., 2017). 
Isocitrate dehydrogenase catalyzes the oxidative decarboxylation reaction of 2R, 
3S-isocitrate to yield 2-oxoglutarate and CO2 in the TCA cycle (Figure 36). It is a key 
enzyme in amino acid biosynthesis, fatty acids and steroid biosynthesis, vitamin 
production and energy metabolism (Sivaraman et al., 2003). Furthermore, isocitrate 
dehydrogenase is an ancient enzyme widely studied in diverse organisms, focusing on 
characterizing and understanding its biochemistry, structure and evolution 
(Supplementary Table S11) (Dean and Golding, 1997; Zhu et al., 2005).  
 
Figure 36. Isocitrate dehydrogenase reaction 
There are two isocitrate dehydrogenases in living organisms; the NAD+-
dependent-IDH (EC 1.1.1.41; NAD+-IDH) and the NADP+-dependent isocitrate 
dehydrogenase (EC 1.1.1.42; NADP+-IDH). The first type forms a heterooligomeric 
structure and it is majorly found in eukaryotic organisms, while the majority of prokaryotic 
organisms contain NADP+-IDH. NADP+-IDH could either form a dimeric structure 
composed of identical subunits of 40-50 kDa or a monomeric one with molecular weight 
of 80-100 kDa (Gálvez and Gadal, 1995; Wang et al., 2015). For simplification, both 




Regarding the presence of PIDH in bacteria, there are organisms that contain 
both monomeric and dimeric PIDH, such as in the case of the obligatory psychrophile 
Colwellia maris (Supplementary Table S11). Depending on the type of PIDH, different 
biochemical properties in response to cold, acetate, environmental stresses among 
others have been demonstrated. For instance, the monomeric PIDH was a cold inducible 
gene, an important feature for the survival of this bacterium at low temperatures, and 
contributing to the metabolic robustness of the cell (Ishii et al., 1993; Suzuki et al., 1995).  
Interestingly, P. putida KT2440 contains both PIDH too, characteristic that will be 
studied in depth in this chapter. Construction and phenotyping of PIDH deletion mutants 
was performed. The biochemical properties of the purified PIDH enzymes were 
characterized. Finally, the proposed catalytic sites responsible for isocitrate binding were 
confirmed by site-directed mutagenesis experiments. 
 
Results 
4.2.1 P. putida encodes two transcriptionally active PIDH that are 
expressed under a wide variety of growth conditions 
 
Several studies of PIDH are available in pseudomonads such as in P. nautica (Roy 
and Packard, 1998), P. psychrophila (Matsuo et al., 2010), P. fluorescens (Hampton and 
Hanson, 1969; Alhasawi et al., 2015) and P. aeruginosa (Crousilles et al., 2018). 
However, it still remains unclear why mesophilic pseudomonads have two PIDH, a 
characteristic mainly observed in psychophilic bacteria (Ochiai et al., 1979; Matsuo et 
al., 2010). In P. putida KT2440 genome, two PIDH, have been annotated; the dimeric 
ICD (PP_4011) and the monomeric IDH (PP_4012) (Nelson et al., 2002; Belda et al., 
2016). It is worth to mention that during this chapter, the dimeric and monomeric 
isocitrate dehydrogenase will be named as ICD and IDH, respectively.  
Icd and idh genes are chromosomically located in tandem in opposite direction 
from each other (Figure 37). The dimeric icd is followed by the monomeric idh. This 
chromosomic arrangement of P. putida PIDH isoenzymes is conserved among 
pseudomonads including a 300-450 bps conserved intergenic region (Figure 37). 
However, this arrangement is different in the psychrophilic organisms, Colwellia maris 
and Colwellia psychrerythraea NRC1004. In these organisms, the two PIDH genes are 
located in tandem in the same direction, with the dimeric type following the monomeric 
one by maintaining a 200-300 bp conserved intergenic region (Matsuo et al., 2010). 
Some differences were observed in Colwellia psychrerythraea 34H, where two 
monomeric and one dimeric type PIDH have been described (Suzuki and Takada, 2016). 
Furthermore, Mycobacterium tuberculosis has two PIDH located in different 
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chromosomic regions (Murima et al., 2016). Finally, the Azotobacter vinelandii has only 
a monomeric idh and E. coli a dimeric icd.  
Sequence alignment analyses revealed that the ICD from P. putida KT2440 
exhibited 89.1%, 91.6%, 75.4% and 75.9% of identity with the ICD of P. aeruginosa 
PAO1, P. psychrophila, C. maris and E. coli, respectively. On the other hand, the IDH 
from P. putida showed 66.3%, 82.1%, 66.6% and 77.9% of identity with the monomeric 
IDH of P. aeruginosa PAO1, P. psychrophila, C. maris and A. vinelandii, respectively.  
 
Figure 37. Example of location of isocitrate dehydrogenase on the chromosome DNA in several 
bacteria. The monomeric idh and the dimeric icd genes are shown in red and black color, respectively. The 
intergenic region is annotated. Locational data for PIDH coding genes from these bacteria have been 
reported previously (Maki et al., 2006; Matsuo et al., 2010).  
Since this is the first study realized in P. putida KT2440, we first checked whether 
both PIDH coding genes are transcriptionally active under several growth conditions. 
Thus, in order to get a glance towards the transcription levels of both PIDH, available 
transcriptomic data of P. putida KT2440, collected from the literature under different 
growth conditions, including minimal medium supplemented by succinate, glucose, 
glycerol or fructose as sole carbon sources were used (Frank et al., 2011; Kim et al., 
2013; La Rosa et al., 2015; Bojanovič et al., 2017). The careful analysis of these 
expression profiles revealed that in the majority of the conditions, the monomeric idh 




in the conditions were fructose or glycerol was applied as sole carbon source, icd 
demonstrated higher expression levels (Figure 38).  
 
Figure 38. Transcriptomic data available on P. putida KT2440. The expression levels (RPKM values: 
reads-per-kb-per million read) of the dimeric ICD (black bars) and IDH (red bars) are shown. Different growth 
conditions were tested with data obtained under mid exponential growth published by different groups (Frank 
et al., 2011; Kim et al., 2013; La Rosa et al., 2015; Bojanovič et al., 2017). Conditions tested: Control: growth 
under M9 27.5 mM glucose, NaCl_7: growth under control conditions supplemented by 3% NaCl 7 min 
exposure, NaCl_60: growth under control conditions supplemented by 3% NaCl 60 min exposure, IP_7: 
growth under control conditions supplemented by 0.1 μg/ml of imipenem (IP) 7 min exposure, IP_60: growth 
under control conditions supplemented by 0.1 μg/ml of imipenem (IP) 60 min exposure, H2O2_7: growth 
under control conditions supplemented by 0.5 mM H2O2 7 min exposure, H2O2_60: growth under control 
conditions supplemented by 0.5 mM H2O2 60 min exposure (Bojanovič et al., 2017); M9 20 mM glucose and 
20 mM succinate (La Rosa et al., 2015); M9 10 mM glucose, M9 10 mM fructose, M9 20 mM glycerol, M9 
15 mM succinate (Kim et al., 2013); M9 15 succinate grown on 30ºC, M9 15 mM succinate grown on 10ºC 
(Frank et al., 2011). 
 In order to validate some of the available transcriptomic data, the expression level 
of both PIDH were further checked under different nutritional scenarios by means of qRT-
PCR experiments. The expression levels of the icd and idh of P. putida growing on LB, 
citrate, succinate and glucose are shown in Figure 39. Overall, we found a carbon source 
dependent expression of both PIDH, where the monomeric idh showed higher 
expression levels compared to the dimeric icd in all the conditions tested. These results 
are in accordance to the observed behavior of these enzymes by transcriptomic data 
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(Figure 38). In fact, when growing on LB and glucose, the idh gene showed up to 35 and 
5 times more expression than the icd, respectively (Figure 39). However, no significant 
differences were found in the expression levels of both enzymes when citrate and 
succinate were used as sole carbon source. 
 
Figure 39. qRT-PCR experiments of KT2440 strain grown in different carbon sources. The absolute 
expression levels (nM) of dimeric ICD and monomeric IDH are shown in black and red colors, respectively. 
P. putida cells were grown in rich LB medium and minimal M63 medium supplemented with 10 mM citrate 
(cit), 15 mM succinate (succ) or 10 mM glucose (glc) and they were harvested when reached mid-exponential 
growth (OD 600 nm: 0.5-0.6). One-way ANOVA analysis was performed and the significant differences 
compared to ICD are shown (*, p<0.05; **, p<0.01; ***, p<0.001; ****, p<0.0001). 
Therefore, it can be confirmed that i) both genes were transcriptionally active in P. 
putida KT2440, ii) the expression of these genes is carbon-source-dependent and iii) it 
looks that there is a clear preference towards the expression of the monomeric idh gene.  
 
4.2.2 The construction and phenotyping of P. putida KT2440 isocitrate 
dehydrogenase deletion mutants 
 
In order to investigate the importance of having two PIDH in P. putida KT2440 and 
a probable divergent response towards stressors, single and double deletion mutants 
were designed. For deleting the icd gene (PP_4011), the pK18mobsacB system was 




different attempts to delete the monomeric idh gene (PP_4012), using different 
approaches, including pK18mob, pK18mobsacB and I-Sce-I systems failed and the 
deletion mutant could not be obtained. Similarly, attempts to construct the double 
knockout strain were fruitless.  
We decided to continue by phenotyping the MM18 strain using several carbon 
sources, in order to shed light in the role of these enzymes in P. putida. Therefore, MM18 
strain was grown under different carbon sources and the growth profile was monitored 
using a multiwell reader (Figure 40). Despite the expression of the two isoenzymes was 
carbon source dependent (Figures 38-39), no differences were observed as far as it 
concerns the growth performance between the wild type and the MM18 strain in all the 
conditions tested (Figure 40). These results were somewhat expected in the case of 
glucose, given idh gene is highly expressed but not in the case of succinate, where 
similar icd and idh expression levels were observed previously. These observations 
could be explained by the presence of alternative (redundant) mechanisms. In other 
words, the monomeric IDH could replace the role of the dimeric ICD, by avoiding the 
collapse of the whole system. Further experiments need to be realized in order to validate 
this exciting hypothesis.  
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Figure 40. Growth curves on different carbon sources. Phenotyping of wild type strain (in blue color) 
and MM18 (null icd) strain (in orange color). The conditions tested were M63 supplemented with 7.5 mM 
octanoate,10 mM glucose,15 mM succinate, 7.5 mM octanoate +15 mM succinate, 5 mM 4hydroxybenzoate, 






4.2.3 Analysis of primary structure of P. putida PIDH 
 
Since several deletion attempts of monomeric IDH of P. putida KT2440 were 
unsuccessful, we tried to get closer to the metabolic role of these enzymes through 
enzymatic approaches. As a first approach, we addressed the identification of the 
catalytic sites determinant for the enzymatic activities of P. putida PIDH. For this purpose 
alignments for the dimeric ICD and monomeric IDH were realized (Figures 41-42).  
 
-Dimeric ICD 
Based on the available crystal data on the dimeric ICD, the proposed binding sites 
for isocitrate, metal and NADP+-coenzyme specificity for the dimeric ICD are summarized 
in the Table 11 (Chen and Yang, 2000; Yasutake et al., 2002).  
Proposed binding sites Residues 
for isocitrate Ser113, Asn115, Arg119, Arg129, Arg153, Tyr160, Lys230´ 
for metal Asp283´, Asp307, Asp311 
for NADP+ specificity Arg292´, Lys344, Tyr345, Val351, Tyr391, Arg395 
for phosphorylation Ser113 
Table 11. A summary of the proposed binding sites for isocitrate, metal and NADP+-coenzyme 
specificity for the dimeric ICD. The prime sign indicates the second subunit.  
Aimed by the architecture of the dimeric ICD coenzyme binding pocket, it was 
confirmed that the Lys344 and Tyr345 residues were the major determinants of the 
coenzyme specificity (Chen et al., 1997; Chen and Yang, 2000). These residues are also 
conserved in ICD of P. putida KT2440.  
Furthermore, the ICD of E. coli is reversibly phosphorylated at Ser113 by the action 
of kinase/phosphatase AceK. The P-Ser113 electrostatically repulses the isocitrate and 
prevents substrate binding (Walsh and Koshland, 1985; Dean et al., 1989). Recently, it 
was found that ICD from P. aeruginosa is also inactivated by AceK but the monomeric 
IDH does not. This is due to the differently structured catalytic sites of IDH and the 
absence of AceK recognition segment from monomeric IDH, that are critical for the AceK 
recognition and binding (Crousilles et al., 2018). This mechanism seems to be functional 
in the case of ICD from P. putida KT2440. An aceK gene (PP_4565) coding for the 
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M. tuberculosis      -MSNAPKIKVSGPVVELDGDEMTRVIWKLIKDMLILPYLDIRL---D-------YYDLGI 49 
C. maris             -MTNKIIIPTTGDKITFI-DGKL-----SVPNNPIIPYIEGDGIGVDVTPPMLKVVNAAV 53 
C. psychrerythraea   -MTNQIIIPTTGDKITFV-DGKL-----SVPNNPIIPFIEGDGIGVDVTPPMLKVVNAAV 53 
E. coli K-12         -MESKVVVPAQGKKITLQ-NGKL-----NVPENPIIPYIEGDGIGVDVTPAMLKVVDAAV 53 
P. aeruginosa PAO1   MGYQKIQVPATGDKITVNADMSL-----SVPKNPIIPFIEGDGIGVDISPVMIKVVDAAV 55 
P. psychrophila      MGYNKIKVPAAGEKITVNADHSL-----NVPDNPIIPYIEGDGIGVDISPVMIKVVDAAV 55 
P. putida KT2440     MGYQKIKVPTDGTKITVNADHSL-----NVPDHPIIPYIEGDGIGVDVSPVMIKVVDAAV 55 
  .   : . *  : .  :         : .  *:*:::      *         : .: 
 
M. tuberculosis      EHRDATDDQVTIDAAYAIKKHGVGVKCATITPDEARVEEFNLKKMWLSPNGTIRNILGGT 109 
C. maris             AKAYGGDRKIEWLEVYAGEKATKMYDSETWLPEETL---NILQEYKVSIKGPLTTPVGGG 110 
C. psychrerythraea   AKAYAGEREIAWMEVYAGEKATKMYDSETWLPEETL---AILQEYKVSIKGPLTTPVGGG 110 
E. coli K-12         EKAYKGERKISWMEIYTGEKSTQVYGQDVWLPAETL---DLIREYRVAIKGPLTTPVGGG 110 
P. aeruginosa PAO1   EKAYKGERKIAWMEVYAGEKATQVYDQDTWLPQETL---DAVRDYVVSIKGPLTTPVGGG 112 
P. psychrophila      SKAYAGKRKISWMEVYAGEKATQVYDQDTWLPQETL---DAVKDYVVSIKGPLTTPVGGG 112 
P. putida KT2440     QKAYGGKRKIAWMEVYAGEKATQVYDQDTWLPQETL---DAVRDYVVSIKGPLTTPVGGG 112 
:    . ::     *: :*        .  * *:      ::.  :: :* : . :** 
 
M. tuberculosis      IFREPIVIS----------------NVPR--LVPGWTKPIVIGRHAFGDQYRATNFKVDQ 151 
C. maris             MSSLNVAIRQMLDLYVCQRPVQWFTGVPSPVKRPSE-VDMVIFRENTEDIYAGIEYKAGS 169 
C. psychrerythraea   MSSLNVAIRQMLDLYVCQRPVQWFTGVPSPVKRPSE-VDMVIFRENTEDIYAGIEYKAGS 169 
E. coli K-12         IRSLNVALRQELDLYICLRPVRYYQGTPSPVKHPEL-TDMVIFRENSEDIYAGIEWKADS 169 
P. aeruginosa PAO1   IRSLNVALRQQLDLYVCQRPVRWFEGVPSPVKKPGD-VDMVIFRENSEDIYAGVEWKAGS 171 
P. psychrophila      IRSLNVALRQQLDLYVCLRPVRWFEGVPSPVKKPGD-VDMTIFRENSEDIYAGIEWKAGS 171 
P. putida KT2440     IRSLNVALRQQLDLYVCLRPVLWFQGVPSPVKKPGD-VDMVIFRENSEDIYAGIEWKAGS 171 
      :    :.:                 ..*     *     :.* *.   * * . ::*... 
 
M. tuberculosis      PGTVTL-TFTPADGSAPIVHEMVSIPEDGGVVLGMYNFKESIRDFARASFSYGLN-AKWP 209 
C. maris             DKAKSVIKFLIEEM----GASNIRFTENCGIGIKPV-SKEGSQRLVRQAIQYAIDNNKDS 224 
C. psychrerythraea   DKAKAVIEFLTEEM----GASNIRFTDNCGIGIKPV-SKEGSQRLVRQAIQYAIDNDKDS 224 
E. coli K-12         ADAEKVIKFLREEM----GVKKIRFPEHCGIGIKPC-SEEGTKRLVRAAIEYAIANDRDS 224 
P. aeruginosa PAO1   PEAEKVIKFLTEEM----GVKKIRFTENCGIGIKPV-SQEGTKRLVRKALQYAVDNDRSS 226 
P. psychrophila      PEAIKVIKFLKEEM----GVTKIRFDQDCGIGVKPV-SKEGTQRLARKALQYVVDNDRES 226 
P. putida KT2440     PEANKVIKFLKEEM----GVTKIRFDQDCGIGVKPV-SKEGTKRLVRKALQYVVDNDRES 226 
        :  :  *   :         : : :. *: :     :*. : :.* ::.* :   : 
 
M. tuberculosis      VYLSTKNTILKAYDGMFKDEFERVYEEEFKAQFEAAGLTY-------------EHRLIDD 256 
C. maris             VTLVHKGNIMKFTEGAFKDWGYELAIEEFGASLLHGGPWCSLKNPNTGKEIIIKDVIADA 284 
C. psychrerythraea   VTLVHKGNIMKFTEGAFKDWGYELARDEFGASLIDGGPWSTLTNPNTGNEIIIKDVIADA 284 
E. coli K-12         VTLVHKGNIMKFTEGAFKDWGYQLAREEFGGELIDGGPWLKVKNPNTGKEIVIKDVIADA 284 
P. aeruginosa PAO1   VTLVHKGNIMKFTEGAFKDWGYEVARDEFGAELLDGGPWMQFKNPKTGKNVVVKDVIADA 286 
P. psychrophila      LTIVHKGNIMKFTEGAFKEWAYEVAAEEFGATLLDGGPWMQFKNPKTGRNVIVKDAIADA 286 
P. putida KT2440     LTLVHKGNIMKFTEGAFKDWGYEVARDEFGAELLDGGPWMKFKNPKTGREVIVKDAIADA 286 
      : :  *..*:*  :* **:   .:  :** . :  .*                :. : * 
 
M. tuberculosis      MVAACLKW-EGGYVWACKNYDGDVQSDTVAQGYGSLGLMTSVLMTADGKTVEAEAAHGTV 315 
C. maris             MLQQVLLRPAEYSVIATLNLNGDYLSDALAAQVGGIGIAPGANLGDEVA--VFEATHGTA 342 
C. psychrerythraea   MLQQILLRPAEYSVIATLNLNGDYLSDALAAQVGGIGIAPGANLGDEVA--VFEATHGTA 342 
E. coli K-12         FLQQILLRPAEYDVIACMNLNGDYISDALAAQVGGIGIAPGANIGDECA--LFEATHGTA 342 
P. aeruginosa PAO1   MLQQILLRPAEYDVIATLNLNGDYLSDALAAEVGGIGIAPGANLSDSVA--MFEATHGTA 344 
P. psychrophila      MLQQILLRPAEYDVIATLNLNGDYLSDALAAEVGGIGIAPGANLSDTIA--MFEATHGTA 344 
P. putida KT2440     MLQQILLRPAEYDVIATLNLNGDYLSDALAAEVGGIGIAPGANLSDTVA--MFEATHGTA 344 
      ::   *       * *  * :**  **::*   *.:*:  .. :         **:***. 
 
M. tuberculosis      TRHYRQYQAGKPTSTNPIASIFAWTRGLQHRGKLDGTPEVIDFAHKLESVVIATVESGKM 375 
C. maris             PKYAGKN------KVNPGSVILSAEMMLRHMGWLEA-DLLLKGMS-------GAIQAKTV 388 
C. psychrerythraea   PKYAGKN------KVNPGSVILSAEMMLRHMGWLEAADLLLKGMS-------GAIKAKTV 389 
E. coli K-12         PKYAGQD------KVNPGSIILSAEMMLRHMGWTEAADLIVKGME-------GAINAKTV 389 
P. aeruginosa PAO1   PKYAGQD------KVNPGSLILSAEMMLRHMGWTEAADLIIKGTN-------GAIAAKTV 391 
P. psychrophila      PKYAGKD------QVNPGSLILSAEMMLRHMGWVEAADLIIKGTN-------GAISAKTV 391 
P. putida KT2440     PKYAGQD------KVNPGSVILSAEMMLRHMGWTEAADLIIKGTN-------GAIAAKTV 391 
                      ::  :       ..** : *::    *:* *  :.   ::.          .:: : .: 
M. tuberculosis      TKDLAILIGPEQDWLNSEEFLDAIADNLEKELAN 409 
C. maris             TYDFERLM-DDATLVSCSAFGDCIIDHM------ 415 
C. psychrerythraea   TYDFERLM-DDATLVSCSAFGDCIIDHM------ 416 
E. coli K-12         TYDFERLM-DGAKLLKCSEFGDAIIENM------ 416 
P. aeruginosa PAO1   TYDFERLM-DGATLLSCSEFGDAMIAKM------ 418 
P. psychrophila      TYDFERLM-DGATLVSSSGFGDALIAHM------ 418 
P. putida KT2440     TYDFERLM-EGAKLVSSSGFGDEMIKHM------ 418 
      * *:  *:      :... * * :  :: 
 
Figure 41. Dimeric isocitrate dehydrogenase multiple alignment using ClustalW. The amino acids that 
confer NADP+- coenzyme specificity and are responsible for metal (Mg2+, Mn2+) and substrate binding are 




indicated in bold letters. * (asterisk) indicates positions, which have a single, fully conserved residue; : (colon) 
indicates conservation between groups of strongly similar properties - scoring > 0.5 in the Gonnet PAM 250 
matrix; . (period) indicates conservation between groups of weakly similar properties - scoring =< 0.5 in the 
Gonnet PAM 250 matrix. The database accession numbers are for C. maris (BAA03135), C. psychrerythraea 
34H (AAZ24108), P. psychrophila (BAH80316), P. aeruginosa PAO1 (AAG06011), P. putida KT2440 
(NP_746141), M. tuberculosis H37Rv (NP_217856) and E. coli K12 (BAA35958).  
 
-Monomeric IDH 
The proposed binding sites for isocitrate, metal and NADP+-specificity for the 
monomeric IDH are summarized in the Table 12 (Chen and Yang, 2000; Yasutake et al., 
2002). Furthermore, previous experimental studies on psychrophilic bacteria identified 
the key amino acids residues involved in the mesophilic properties of the P. psychrophila 
IDH compared to the cold induced C. maris and C. psychrerythraea shown in the Figure 
42 (Matsuo et al., 2010; Kobayashi and Takada, 2014). The residues responsible for the 
mesophilic properties of the IDH of the P. psychrophila are conserved in IDH of P. putida 
KT2440.  
Proposed binding sites Residues 
for isocitrate Ser132, Asn135, Arg139, Arg145, Arg547, Tyr420, Lys255 
for metal Asp350, Asp548 
for NADP+ specificity Arg358, Lys588, His589, Arg649 
Table 12. A summary of the proposed binding sites for isocitrate, metal and NADP+-coenzyme 
specificity for the monomeric IDH.  
C. maris         MSTDNSKIIYTITDEAPALATYSLLPIIQAYTASSGINVETRDISLAGRILANFPKYLTK 60 
34H              MSTDNSKIIYTITDEAPALATYSLLPIIQAYTASSGINVETRDISLAARILANFPKYLTK 60 
A.vinelandii     --MSTPKIIYTLTDEAPALATYSLLPIIKAFTGSSGIAVETRDISLAGRLIATFPEYLTD 58 
P. psychrophila  -MPNRSKIIYTFTDEAPALATYSLLPIIEAFTAPADIAVETRDISLAGRILASFPEQLGA 59 
P. putida KT2440 -MPTRSKIIYTFTDEAPALATYSLLPIIEAFTASADIAVETRDISLAGRILAAFPEQLGA 59 
P. aeruginosa    -MSIRSKITYTFTDEAPALATYSLLPIVKAFAASAGIDVETSDISLAGRILANFADRLEA 59 
34H_2            ---MSSKIIYTYTDEAPLLATCSLLPIIKTFAASADIDIELKDISLASRVLSAFSDILPA 57 
M. tuberculosis  MSAEQPTIIYTLTDEAPLLATYAFLPIVRAFAEPAGIKIEASDISVAARILAEFPDYLTE 60 
                       .* ** ***** *** ::***:.:::  :.* :*  ***:*.*::: * . *   
 
C. maris         EQRIDDALAELGELAQTPEANIIKLPNISASIPQLEAVIKELQAKGYDLPHYPAEPQNEA 120 
34H              EQRVDDALSELGKLAKTPEANIIKLPNISASIPQLELAIKELQAKGYDLPHYPAEPQNEA 120 
A.vinelandii     TQKISDDLAELGKLATTPDANIIKLPNISASVPQLKAAIKELQQQGYKLPDYPEEPKTDT 118 
P. psychrophila  K-AVADHLAELGALAVTPEANIIKLPNISASVPQLQAAIKELQAQGFDIPDYPETVTTDA 118 
P. putida KT2440 EKQVGDHLAELGQLATTPEANIIKLPNISASVPQLKAAIKELQGKGFNIPDYADEPATAE 119 
P. aeruginosa    DQRIEDDLARLAVLATSPDANIIKLPNISASVPQLKGAIAELQGLGYKVPDFPEDPQTDE 119 
34H_2            DQQVPDTLAELGALTHHPDTNIIKLPNISASIPQLKDVISELQAQGYAIPDYPESPKTDE 117 
M. tuberculosis  EQRVPDNLAELGRLTQLPDTNIIKLPNISASVPQLVAAIKELQDKGYAVPDYPADPKTDQ 120 
                    : * *:.*. *:  *::***********:***  .* ***  *: :*.:     .   
 
C. maris         EESIKLTYAKILGSAVNPVLREGNSDRRAPASVKQYARNNPHSMGAWSKESKSHVAHMAS 180 
34H              EESIKLTYAKVLGSAVNPVLREGNSDRRAPGSVKQYARNNPHSMGAWSPESKSHVAHMES 180 
A.vinelandii     EKDVKARYDKIKGSAVNPVLREGNSDRRAPLSVKNYARKHPHKMGAWSADSKSHVAHMDN 178 
P. psychrophila  DKEVKARYSKVMGSAVNPVLREGNSDRRAPLSVKNYARKHPHKMGAWAADSKSHVAHMSE 178 
P. putida KT2440 EKESRARYDRIKGSAVNPVLREGNSDRRAPLSVKNYARKHPHKMGAWAADSKSHVAHMTQ 179 
P. aeruginosa    EKEVRARYAKILGSAVNPVLREGNSDRRAPAAVKAYARKHPHSMGKWSMASRSHADYMRG 179 
34H_2            DRSNEAKYSKTLGSAVNPVLREGNSDRRAPPSVKAFARKNPHSMGKWSQASRTHVSHMHS 177 
M. tuberculosis  EKAIKERYARCLGSAVNPVLRQGNSDRRAPKAVKEYARKHPHSMGEWSMASRTHVAHMRH 180 
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C. maris         GDFYGSEKSVTIDGATSVNIEFVAKNG-DVTLLKSKLPLLDKEIIDASVMSKSALVEFFE 239 
34H              GDFYGSEKSVTIDGATSINIEFVAQNG-DVTLLKSKLPLLDKEIIDASVMSKSALIEFYE 239 
A.vinelandii     GDFYGSEKAALIGAPGSVKIELIAKDG-SSTVLKAKTSVQAGEIIDSSVMSKNALRNFIA 237 
P. psychrophila  GDFYASEKAALIEAPGSVKIELIAQDG-TTTVLKEKTAVQAGEIIDCSVMSKKALRQFVA 237 
P. putida KT2440 GDFYGSEKAALIEADDSLRIELVGKDG-STTVLKEKTAVKAAEVIDCATMSRKALKAFIA 238 
P. aeruginosa    GDFFSSEQSITMAKAGDVRIEFVGKDG-K-VEVKKQLSLQEGEVLDSMFMSCGKLRDFFE 237 
34H_2            GDFYASEKCMTMDKACDVKIEFVAKDDGAVTVLKEKTSLQAGEIIDSMFMSKKILCEFLE 237 
M. tuberculosis  GDFYAGEKSMTLDRARNVRMELLAKS-GKTIVLKPEVPLDDGDVIDSMFMSKKALCDFYE 239 
                 ***:..*:.  :    .:.:*::.:.      :* :  :   :::*.  **   *  *   
 
C. maris         TEINKAKEEDVLLSLHLKATMMKVSDPVMFGHAVRVFYKDVFAKHAATFEQLGVDADNGI 299 
34H              TEINKAKEEDVLLSLHLKATMMKVSDPIMFGHAVKVFYKDVFTKHEATFDQLGVDADNGI 299 
A.vinelandii     AEIEDAKKQGVLLSVHLKATMMKVSDPIMFGQIVSEFYKDALTKHAEVLKQIGFDVNNGI 297 
P. psychrophila  AEIEDAKKQGVLFSVHLKATMMKVSDPIMFGQIVAEFYKDALEKHADILKEIGFNLNNGI 297 
P. putida KT2440 EQIADAKAAGVLLSVHLKATMMKVSDPIMFGVIVEEFYNDVLTKHAAALAEVGFNANNGI 298 
P. aeruginosa    KTLQDCKETGVMWSLHVKATMMKISHPIVFGHAVSVYYKDVFDKWGQLFEELGVNPNNGI 297 
34H_2            QEMEDARETGVMFSFHVKATMMKVSHPIVFGHAVKVYYKDLFAKHAETFEKLGVNANDGV 297 
M. tuberculosis  EQMQDAFETGVMFSLHVKATMMKVSHPIVFGHAVRIFYKDAFAKHQELFDDLGVNVNNGL 299 
                   : ..   .*: *.*:******:*.*::**  *  :*:* : *    : .:*.: ::*: 
 
C. maris         GDVYAKIARLPAAQKEEIEADLQAVYATRPEMAMVDSDKGITNLHVPSDVIIDASMPAAL 359 
34H              GDVYAKIARLPAAQKAEIEADLQAVYATRPEMAMVDSDKGITNLHVPSDVIIDASMPAAL 359 
A.vinelandii     GDLYARIKTLPEAKQKEIEADIQAVYAQRPQLAMVNSDKGITNLHVPSDVIVDASMPAMI 357 
P. psychrophila  GDLYARIKALPAEKQAEIEADIQAVYANRPALAMVNSDKGITNLHVPSDVIVDASMPAMI 357 
P. putida KT2440 GDLYARIKDLPADKQAEIEADIQALYAERPALAMVNSDKGITNLHVPSDVIVDASMPAMI 358 
P. aeruginosa    SSVYDKIKSLPASQQEEILHDIHEVYSHRPEMAMVDSVKGITNLHIPSDVIVDASMPAMI 357 
34H_2            SSIYEKVKQLPESWREEILADLHACYEKRPELAMVDSAKGISNLHTPNEVIVDASMPAMI 357 
M. tuberculosis  SDLYSKIESLPASQRDEIIEDLHRCHEHRPELAMVDSARGISNFHSPSDVIVDASMPAMI 359 
                 ..:* ::  **   : **  *::  :  ** :***:* :**:*:* *.:**:****** : 
 
C. maris         RASGMMWGPDGKQKDTKFMIPDRNYAGVFSAVVDFCRENGAFNPATMGTVPNVGLMAQKA 419 
34H              RASGMMWAPDGSQKDTKFMIPDRNYAGVFSAVVDFCRENGAFNPTTMGTVPNVGLMAQKA 419 
A.vinelandii     RDSGKMWGPDGKLHDTKAVIPDRCYAGVYQVVIEDCKQHGAFDPTTMGSVPNVGLMAQKA 417 
P. psychrophila  RDSGKMWNTEGQLQDTKAVIPDRCYATIYQATIEDCQKHGAFDPTTMGSVPNVGLMAQKA 417 
P. putida KT2440 RDSGKMWNAAGELQDAKAVIPDRCYAGIYQATIEDCKVNGAFDPTTMGSVPNVGLMAQKA 418 
P. aeruginosa    RNSGQMWGKDGKQKDTKAVMPESTYARIYQEMINFCKTNGAFDPTTMGSVPNVGLMAQKA 417 
34H_2            RAGGKMWGPDGKLKDTKAVMPESTFARIYQEIINFCKTHGAFDPTTMGTVPNVGLMAQKA 417 
M. tuberculosis  RAGGKMYGADGKLKDTKAVNPESTFSRIYQEIINFCKTNGQFDPTTMGTVPNVGLMAQQA 419 
                 * .* *:   *. :*:* : *:  :: ::.  :: *: :* *:*:***:*********:* 
 
 
C. maris         EEYGSHDKTFTMKAAGTVRVVN-SQGERLIEQEVAQGDIYRMCQVKDAPIQDWVKLAVTR 478 
34H              EEYGSHDKTFTMSATGVVRVVN-DNGDILIEQNVAQGDIFRMCQVKDAPIQDWVKLAVTR 478 
A.vinelandii     EEYGSHDKTFQIPADGVVRVTD-ESGKLLLEQSVEAGDIWRMCQAKDAPIQDWVKLAVNR 476 
P. psychrophila  EEYGSHDKTFQIKTPGVVRVTD-SNGNVLMEQNVEEGDIWRMCQAKDAPIRDWVKLAVNR 476 
P. putida KT2440 EEYGSHDKTFQIKADGVVRVVD-GKGNVVLEQNVEAGDIFRMCQTKDAPIQDWVKLAVNR 477 
P. aeruginosa    EEYGSHDKTFEMTADGTMRVVL-ADGSVLMQHKVETGDIWRACQTKDAPIRDWVKLAVTR 476 
34H_2            EEYGSHDKTFEVQGDGCIRIVDD-EGKTLLTMDVEEGDIWRMCQVKDAPIQDWVKLAVAR 476 
M. tuberculosis  EEYGSHDKTFEIPEDGVANIVDVATGEVLLTENVEAGDIWRMCIVKDAPIRDWVKLAVTR 479 
                 ********** :   *  .:.    *. ::  .*  ***:* * .*****:******* * 
 
C. maris         ARATGTPTVFWLDENRGHDEQMIKKVNTYLADHDTTGLDIQILEPVKACEFTLARVAKGE 538 
34H              AKATGTPTVFWLDENRGHDAEMIKKVNTYLADHDTNGLDIQILEPVKACEYTLARVAKGE 538 
A.vinelandii     ARATNTPAVFWLDPARAHDAQVIAKVERYLKDYDTSGLDIRILSPVEATRFSLARIREGK 536 
P. psychrophila  ARASNTPAVFWLDPKRSHDAEMIKKVETYLKDHDTSGLDIRIMAPVDAMKFTLERTRAGL 536 
P. putida KT2440 ARLSNTPAVFWLDPARAHDGVMIEKVQKYLKDHDTTGLDIRILAPVDAIKFSLARIREGK 537 
P. aeruginosa    ARQSDTPAIFWLDPERAHDRELRKKVELYLKDHDLTGLDISIMGYNEAIRVSMERLIRGK 536 
34H_2            AKLSDTPAVFWLDEYRPHEAELIKKVKLYLKDHDLTGLDIQIMSQTRAMRYTLERILRGG 536 
M. tuberculosis  ARISGMPVLFWLDPYRPHENELIKKVKTYLKDHDTEGLDIQIMSQVRSMRYTCERLVRGL 539 
                 *: :. *.:****  * *:  :  **: ** *:*  **** *:    : . :  *   *  
 
C. maris         DAISVTGNVLRDYLTDLFPILELGTSAKMLSIVPLMNGGGLFETGAGGSAPKHVQQFEKE 598 
34H              DAISVTGNVLRDYLTDLFPILELGTSAKMLSIVPLMNGGGLFETGAGGSAPKHVQQFEKE 598 
A.vinelandii     DTISVTGNVLRDYLTDLFPIMELGTSAKMLSIVPLMSGGGLFETGAGGSAPKHVQQFLEE 596 
P. psychrophila  DTISVTGNVLRDYLTDLFPIMELGTSAKMLSIVPLMNGGGLFETGAGGSAPKHVQQLLEE 596 
P. putida KT2440 DTISVTGNVLRDYLTDLFPIMELGTSAKMLSIVPLMNGGGLFETGAGGSAPKHVQQLVEE 597 
P. aeruginosa    DTISVTGNVLRDYLTDLFPIMELGTSAKMLSIVPLMAGGGMYETGAGGSAPKHVQQLVEE 596 
34H_2            DTISVTGNILRDYLTDLFPILELGTSAKMLSIVPLMAGGGLFETGAGGSAPKHVKQLIEE 596 
M. tuberculosis  DTIAATGNILRDYLTDLFPILELGTSAKMLSVVPLMAGGGMYETGAGGSAPKHVKQLVEE 599 






C. maris         NHLRWDSLGEFLALAASLEHVAVTTGNARAQILADTLDAATGKFLDTNKSPSRKVGELDN 658 
34H              NHLRWDSLGEFLALAASLEHVAISTGNAKAQVLADTLDSATGKFLDTNKSPSRRVGELDN 658 
A.vinelandii     GYLRWDSLGEFLALAASLEHLGNAYKNPKALVLASTLDQATGKILDNNKSPARKVGEIDN 656 
P. psychrophila  NFLRWDSLGEFLALAASLEHLGTTYNNPKALVLAKTLDQATGQFLDNNKSPSRKVGNIDN 656 
P. putida KT2440 NFLRWDSLGEFLALAASLEHLGNTYDNPRAKVLANTLDQATGKFLDTNKSPSRKVGGIDN 657 
P. aeruginosa    NYLRWDSLGEFLALAVSLEETGIKTGNAKAKLLGKALDEATGKLLDNNKSPSRKVGDIDN 656 
34H_2            NHLRWDSLGEFLAISASLEDLGIKQDSAKAKLLAKTLDQATAELLENGKSPSRKTGELDN 656 
M. tuberculosis  NHLRWDSLGEFLALGAGFEDIGIKTGNERAKLLGKTLDAAIGKLLDNDKSPSRKTGELDN 659 
                 ..***********:...:*. .    . :* :*..:** * .::*:..***:*:.* :** 
 
C. maris         RGSHFYLAMYWAQALAAQTTDTELQASFSSVAQALTKQEEKIVAELNAAQGPAIDLNGYY 718 
34H              RGSHFYLAMYWAQAIAEQTTDTDLKESFTGVAQALTKQEEKIVAELNAAQGPAIDVNGYY 718 
A.vinelandii     RGSHFYLALYWAQALAAQTEDKELQAQFTGIAKALTDNETKIVGELAAAQGKPVDIAGYY 716 
P. psychrophila  RGSHFYLALYWAQALAAQTEDKELQAQFAPVAKAMAENEAKIVAELNAVQGKPVDIGGYY 716 
P. putida KT2440 RGSHFYLTLYWAEALAAQTDDAALQARFAPLAKTLAENEATIVAELNAVQGKPADIGGYY 717 
P. aeruginosa    RGSHFYLAMYWAQALAAQNEDAELKAHFAPLAKALTEQEATIVAELNAVQGKPAEIGGYY 716 
34H_2            RGSHFYLALYWAKALAEQTEDTELQHHFAPLAQSLTENEAAIVSDLTTDQWHSVDIGGYY 716 
M. tuberculosis  RGSQFYLAMYWAQELAAQTDDQQLAEHFASLADVLTKNEDVIVRELTEVQGEPVDIGGYY 719 
                 ***:***::***: :* *. *  *   *: :*. ::.:*  ** :*   *    :: *** 
 
C. maris         FADTKLAEKAMRPSETFNTILSALL- 743 
34H              FADTQLTEKAMRPSETLNTILSALL- 743 
A.vinelandii     HPNTDLTSKAIRPSATFNAALAPLA- 741 
P. psychrophila  HADADKLSKVMRPSATLNAIIASLV- 741 
P. putida KT2440 APDAELTAKVMRPSQTLNSAIAAL-- 741 
P. aeruginosa    RSNPELTSKVMRPSATFNAAIDSLA- 741 
34H_2            KADAKKIIEIMRPSKCFNEVLAAFK- 741 
M. tuberculosis  APDSDMTTAVMRPSKTFNAALEAVQG 745 
                   : .     :***  :*  :  .   
Figure 42. Monomeric isocitrate dehydrogenase multiple alignment using Clustal W. The amino acids 
that confer NADP+-coenzyme specificity and are responsible for metal (Mg2+, Mn2+) and substrate binding 
are indicated in shaded pink, light green and blue colors, respectively. The amino acid residues involved in 
the mesophilic properties of the P. psychrophila monomeric IDH are indicated in bold green letters. The 
amino acid residues that are different from C. maris/C. psychrerythrea and P. psychrophila are shown in 
bold blue letters (Matsuo et al., 2010). The proposed amino acids responsible for the thermal properties are 
shown in shaded dark green color (Kobayashi and Takada, 2014). The point mutations realized in this study 
(pET29-PP_4012mut) are indicated in shaded yellow color. * (asterisk) indicates positions, which have a 
single, fully conserved residue; : (colon) indicates conservation between groups of strongly similar properties 
- scoring > 0.5 in the Gonnet PAM 250 matrix; . (period) indicates conservation between groups of weakly 
similar properties - scoring =< 0.5 in the Gonnet PAM 250 matrix. The database accession numbers are for 
C. maris (BAA03134), C. psychrerythraea 34H (AAZ27772/AAZ27953), P. psychrophila (BAH80317), P. 
aeruginosa PAO1 (AAG06012), P. putida KT2440 (NP_746142), M. tuberculosis H37Rv (NP_214580) and 
A. vinelandii (D73443/BAA11169). 
 
4.2.4 Kinetic properties of the purified isocitrate dehydrogenase isozymes 
 
Since several deletion attempts of the monomeric IDH were fruitless, we decided 
to inactivate its enzymatic activity by site-directed mutagenesis of some of the proposed 
catalytic sites for the substrate binding (Table 12 and Figures 42-43). Thus, the 
corresponding conserved residues in P. putida KT2440, Ser133, Asn136 and Arg140 
were substituted by Ala, resulting in a mutated monomeric idh (PP_4012 mut, Figure 43).  
To study the properties of the two native isocitrate dehydrogenase isoenzymes 
of P. putida KT2440 and the idh mutated version, these enzymes were heterologously 
overexpressed in E. coli using the traditional pET29a vectors (Materials and Methods 
3.8.2 section). His-tagged protein versions were used in order to facilitate the proteins 
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purification process. Four different strains were obtained, a negative control with an 
empty pET29a plasmid, a pET29a-PP_4011 (that overexpresses the dimeric icd), a 
pET29a-PP_4012 (that overexpresses the monomeric idh) and a pET29a-PP_4012mut 
(that overexpresses the mutated monomeric idh).  
 
Figure 43. close-up view of the conserved active site residues of monomeric IDH in P. putida KT2440 are 
shown. The residues mutated in this study are shown in green color, the isocitrate in red color and the 
magnesium in pink color. For rendering and animating 3D structures the pyMol software was used.  
The PIDH were successfully purified using the Quiagen Ni-NTA spin columns 
(Materials and Methods 3.8.2 section and Figure 44). The kinetic parameters for both 
PIDH were summarized in the Tables 13-14. Under standard assay conditions, the 
monomeric idh had higher specific activity than the dimeric icd. This observation is in 
accordance with previous work in Pseudomonas psychrophila (Matsuo et al., 2010). The 
PP_4012mut (Ser133Ala, Asn136Ala, Arg140Ala) lost completely its enzymatic activity 
(Table 13). Furthermore, the monomeric idh had higher Km values for the isocitrate (56.5 
µM) than the dimeric icd (34.7 µM). However, the influence of the construction in the 
monomeric idh cannot be discarded as responsible for the higher Km values for 
isocitrate. No major differences were observed as far as it concerns the Km values for 
the NADP+ on both IDHs (39.7 µM for dimeric versus 22.9 µM for the monomeric IDH). 




standard enzymatic assays with NAD+, resulted in no detectable activity. Furthermore, 
the turnover values and catalytic activities for both isocitrate and NADP+ were higher for 
the monomeric IDH than the dimeric ICD (Tables 13-14).  
 
Figure 44. A 12.5% polyacrylamide gel of the purified PIDH using His-trap columns. 1. MW ladder, 2. 
empty pET29a (negative control), 3. pET29a-PP_4011 (dimeric icd), 4. pET29a-PP_4012 (monomeric idh), 
5. pE29a-PP_4012 mut (monomeric idh mut). 
Enzyme 





















PP_4011 22.4 ± 0.7 34.7 ± 3.0 0.05 ± 0.01 14.5 ± 2.4 0.4 ± 0.1 
PP_4012 50.8 ± 6.3 56.5 ± 16.0 0.30 ± 0.04 94.7 ± 19.1 1.7 ± 0.2 
PP_4012 mut N.D. N.A. N.A. N.A. N.A. 
Table 13. Kinetic parameters for isocitrate at 30°C. The specific activity, the Km, Vmax, kcat and kcat/Km 

















PP_4011 39.7 ± 6.4 0.06 ± 0.01 19.9± 1.6 0.5 ± 0.0 
PP_4012 22.9 ± 10.9 0.24 ± 0.05 73.4 ± 8.7 3.9 ± 1.5 
PP_4012 mut N.A. N.A. N.A. N.A. 
Table 14. Kinetic parameters for NADP+ at 30°C. The specific activity, the Km, Vmax, kcat and kcat/Km 
are listed. N.A.: not determined. 
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The unsuccessful attempts to delete the monomeric IDH, could indicate that the 
activity of this enzyme is essential for growth in P. putida KT2440. However, this 
hypothesis is controversial because the dimeric isoenzymes is actively expressed and it 
is functional in P. putida. Thus, ICD could replace at least in part, the absence of the 
monomeric enzyme. In order to test whether the reason of the observed essentiality of 
IDH is other than its enzymatic activity, we tried to inactivate the monomeric IDH in P. 
putida by replacing the native gene by PP_4012mut by using pK18mobsacB second 
recombination process. However, various attempts to substitute the wild type PP_4012 
by the mutated PP_4012mut failed and in all the cases the wild type phenotype was 
rescued. These results thus confirmed the essentiality of the IDH activity in P. putida, 
despite the presence of a functional ICD.   
Summing up, in this chapter, we confirmed that both PIDH genes are 
transcriptionally active in P. putida KT2440, with a clear preference towards monomeric 
idh gene. Even though the expression of these enzymes is carbon source dependent, 
there is no apparent growth effect on the icdΔ deletion mutant (MM18). Additionally, by 
the kinetic properties characterization of the two enzymes, no major differences were 
observed. However, the results suggested that the monomeric IDH is more active than 
the dimeric ICD in P. putida KT2440. As far as it concerns the catalytic sites for isocitrate 
binding, Ser133Ala, Asn136Ala and Arg140Ala monomeric IDH mutant lost completely 
its enzymatic activity. Finally, since various deletions attempts of monomeric idh gene 
have been fruitless, it could be suggested that the monomeric idh could be an essential 
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4.3 Chapter 3: Model-driven design and synthetic biology-
assisted construction of growth-coupled P. putida KT2440 
strains overproducing PHA 
 
Introduction 
Nowadays, there is an increasing interest in the revalorization of complex and 
recalcitrant polymers including lignin and oil-based plastics, such as polyethylene 
terephthalate (PET) and polyurethane (PU) (Danso et al., 2019). Many of these 
heterogeneous substrates are degraded via the central intermediate protocatechuic acid 
(PCA) through the β-ketoadipate pathway (Figures 9 and 45). Monomers derived from 
the hydrolysis of these polymers have an intrinsic value, however the complete 
revalorization of these compounds require complex and expensive purification steps 
(Beckham et al., 2016). Therefore, an ideal scenario is the conversion of this complex 
mix of monomers into a single high-value product such as PHA. These monomers  as 
non-PHA related compounds render low PHA yields by using de novo fatty acid synthesis 
pathway for PHA synthesis (section 1.4.3). Another aspect to consider in the 
revalorization of these compounds is that these aromatic groups are highly toxic for the 
cell at high concentrations, thus hampering the traditional PHA production approaches 
based on unbalanced C/N ratio provoked by nitrogen limitation and carbon excess. 
Therefore, a new strategy is required in order to revalorize monomers derived from lignin 
and aromatic-based plastic into PHA.  
 
Figure 45. Schematic representation of the approach used in this study. The main aromatic compounds 
derived from lignin and PET hydrolysis are shown. The protocatechuate is the key intermediate of these 




Often, metabolic engineering endeavors and synthetic biology designs suffer 
metabolic limitations due to the introduction of non-native biochemical transformations in 
the host metabolic network, requiring a holistic approach for the final design of the 
chassis. Genome-scale models (GEMs) and constraint-based reconstruction and 
analysis (COBRA) methods rely on knowledge of the metabolic network and mass 
balance during steady state growth to predict the optimal distribution of metabolic flux for 
growth. Among other applications, GEMs have been shown to be able to predict with 
high accuracy byproduct secretions, such as in E. coli and S. cerevisiae (Famili et al., 
2003; Hoek and Merks, 2017). In addition, several computational methods have been 
developed to facilitate the overproduction of a given metabolite. In the context of GEMs, 
metabolic designs in which the target product must be generated for optimal growth are 
called growth-coupled designs, and large number of algorithms have been recently 
developed to predict and engineer growth-coupled chemical production (King et al., 
2017). Growth-coupling is a highly desirable trait as it minimizes the effect of undesirable 
regulatory constraints, alleviates the genetic instability and selection problems that can 
result from classical metabolic engineering, and enables the use of adaptive laboratory 
evolution (ALE) to further increase the production rate (Conrad et al., 2011).  
In this Doctoral Thesis, we took the challenge to transform highly recalcitrant 
substrates derived from the hydrolysis of PET, lignin and PU into high-value added 
product, PHA. For this purpose, these monomeric constituents were checked using the 
in silico iJN1411 model, for PHA production. Then, the in silico designs were further 
implemented and phenotyped in vivo, resulting in P. putida KT2440 recombinant growth-
coupled PHA overproducing strains from unrelated complex aromatic carbon sources. 
For the purpose of this work, DBTL cycles were used. These are interactive designs 
combining the advances in systems and synthetic biology towards rational strain 
modification and testing (1.3.3 chapter). The details of the two round DBTL cycle used 
in this work are shown in the Figure 46.  
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Figure 46. PHA overproducing DBTL cycle. First and second DBTL (Design Build Test Learn) run is 
shown in black and green colors, respectively.  
 
Results 
4.3.1 Model setup and construction of carbon source-specific reduced 
metabolic models 
 
The first step of this cycle (Design) included the model-based design of PHA 
overproducing P. putida strains based on growth-coupling using PET and PU as carbon 
source. It is worth to mention that P. putida KT2440 is not able to grow on PET either its 
monomers derived from hydrolysis, e.g., terephthalic acid (TPHTA) and ethylene glycol 
(EG) as sole carbon source. During the realization of this work, engineered P. putida 
strains were constructed for efficient EG utilization, shading light on the complex EG 
processing in P. putida KT2440 (Franden et al., 2018). 
In order to perform this analysis, the most comprehensive metabolic model of P. 
putida available so far, iJN1411 was used (Nogales et al., 2017). iJN1411 
(https://drive.google.com/file/d/1L-iVLsONX9qiReDmjVgRS_eDTL6sfJa9/view) was 
updated with the metabolic pathways involved in the metabolism of PET via terephthalate 
(TPHTA) and ethylene glycol (EG); and PU, via methylene diphenyl diisocyanate (MDI), 




resulted in the addition of 32 new reactions and 25 new metabolites 
(https://drive.google.com/file/d/16RK0bcaD9T9Q3V7T4qgoz11SPxpGCCH9/view). The 
resulting model, named iMM1412, was used for the subsequent analysis  
 
Figure 47. Biochemical overview of PET and PU hydrolysis. PET and PU wastes are depolymerised by 
PET and PU hydrolases. The resulting hydrolysis products were studied in this work. PET: polyethylene 
terephthalate, PU: polyurethane, TPHTA: terephthalate, EG: ethylene glycol, ADIPATE: adipic acid, 14BDO: 
1,4-butanediol, MDI: 4,4-methylene diphenyl diisocyanate, PCA: protocatechuic acid. This figure was 
adapted from the P4SB European project (https://www.p4sb.eu/) 
Subsequently and in order to reduce the computational complexity of the process, 
we proceeded to construct a simplified version of iMM1412, following the workflow shown 
in the Figure 48 (see also 3.10.5 section). The reduced model (Figure 48, dark green 
box) was constructed by applying two consecutive simplification steps e.g., model 
simplification and model reduction. This simplified model version included a less complex 
biomass equation and reduced PHA and alginate metabolism, e.g., only the final 
production of medium-chain length aliphatic PHA containing 8 carbon atoms (C8) and a 
specific single alginate (alginate with 3 units of acetylated D-mannuronate and 2 units of 
L-guluronate) were considered. Lumped reactions corresponding to pyruvate 
dehydrogenase and 2-oxoglutarate dehydrogenase were also removed from the 
simplified model. TOL plasmid reactions were removed excepting for the case of PU and 
MDI analyzes, in which reactions involved in complete incorporation of MDI (2-oxopent-
4-enoate hydratase and 4-hydroxy-2-oxopentanoate aldolase) were maintained. In the 
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following step the blocked reactions in each condition were identified (defined as those 
with a minimum and maximum theoretical flux lower than 10-6 mmol·gDW-1·h-1) and 
removed from the simplified model.  
 
Figure 48. Workflow scheme for model reduction and KO reactions list generation. The reduced model 
(green box) was constructed by applying two consecutive simplification steps e.g., model simplification and 
model reduction. The content of these reduced models was dependent of the carbon source used for the 




In order to create a reduced list of target reactions to be deleted (KO reaction list), 
we applied four additional reduction steps including the removement of: i) reactions 
encoded by essential and/or nearly-essential genes, ii) all reactions without associated 
genes in the model, iii) peripheral and transport reactions, and iv) the sets of flux-coupled 
reactions were aggregated as a single reaction. These approaches allowed us to 
significantly reduce the number of reactions suitable to be deleted. A metabolic content 
of each carbon source-specific reduced model and the lists of suitable reactions for 
knockout in each carbon source are listed in the Table 15.  
Carbon source Reduced model 
(reactions/metabolites) 




PET 1394/1036 252 3.78 
TPHTA 1388/1032 256 4.73 
EG 1387/1031 283 13.6 
PU 1413/1052 252 1.40 
ADIPATE 1388/1032 244 6.30 
MDI 1396/1039 253 2.52 
PAC 1383/1028 238 4.73 
14BDO 1389/1033 244 9.45 
Table 15. Metabolic content, KO reaction list and uptake rate data for each carbon source-specific 
reduced model. All uptake values used were taken in order to be equivalent in number of carbons to the P. 
putida glucose uptake (6.3 mmol·gDW-1·h-1) (del Castillo et al., 2007). 
 
4.3.2 Model-driven design of PHA overproducing strains using PET and PU 
as carbon source 
 
We first addressed the identification of growth-coupled in silico overproducing PHA 
designs using PET as sole carbon source. Therefore, the GDLS algorithm was applied 
using an uptake rate of PET of 3.78 mmol·gDW-1·h-1 (Table 15) and the default 
parameters for GDLS (3.10.5 section). As corresponds with a local search algorithm, in 
each positive iteration (where target product is predicted to be produced), GDLS keeps 
those deleted reactions providing product secretion and initiates a new iteration in order 
to optimize the production. This way, individual paths with increasing number of 
knockouts are provided in each GDLS run. Following this procedure, several GDLS paths 
were identified and the most promising in terms of i) PHA yield, ii) Biomass-coupled 
product yield (BCPY), iii) number of knockouts and iv) physiological feasibility, was 
selected for further analysis as it is shown in the Figure 49 and Tables 16-17. 
 
  Results 
                                                                             129 
 
GDLS runs 
PET1 PET2 PET3 PET4 
RHACOAE80 RHACOAE80 RHACOAE80 RHACOAE80 
PHADPC80 PHADPC80 PHADPC80 PHADPC80 
CYSS CYSS CYSS CYSS 
NACODA NACODA NACODA NACODA 
ALDD2x ALDD2x ALDD2x ALDD2x 
ENO ENO ENO ICL 
GHMT2 GHMT2 GHMT2 ICDHyr 
HSK HSK HSK PPCSCT 
ICL ICL ICL SUCOAS 
 ICDHyr ICDHyr ORNCD 
 PPCSCT PPCSCT PDHbr 
 SUCOAS SUCOAS PDHcr 
 TKT2 TKT2 ABUTD 
  ORNCD ALAR 
  PDHbr UPPN 
  PDHcr RBK 
   ALATA_L 
   FORGLUIH2 
   MALS 
   MCITL2 
   OARGDC 
Table 16. Key reactions identified to be knocked out for PHA growth-coupled mutants using PET as 
carbon source.  A signle path with 4 consecutive iterations (PET1-4) is shown. Model reaction 
abbreviations: ABUTD, aminobutyraldehyde dehydrogenase; ALAR, alanine racemase; ALATA_L, L-alanine 
transaminase; ALDD2x, aldehyde dehydrogenase acetaldehyde CYSS, cysteine synthase; ENO, enolase; 
FORGLUIH2, N-formimino-L-glutamate inimohydrolase; ICDHyr, isocitrate dehydrogenase NADP; ICL, 
isocitrate lyase; MALS, malate synthase; MCITL2, methylisocitrate lyase; NACODA, N-acetylornithine 
deacetylase; OARGDC, oxoarginine decarboxylase; ORNCD, ornithine cyclodeaminase; PDH, pyruvate 
dehydrogenase; PHADPC80, poly-3-hydroxyalkanoate depolymerase C80; PPCSCT, propanoyl CoA -
succinate CoA-transferase; RBK, ribokinase; RHACOAE80, R-hydroxyacyl CoA-thioesterase C80; 
SUCOAS, succinyl-CoA synthetase ADP-forming; TKT2, transketolase; UPPN, b-ureidopropionase 
Subsequently, the production envelopes of the model-driven designs obtained 
using PET as carbon source were plotted. As it could be expected, the more the number 
of gene knockouts is increased (from iteration PET1 to PET4), the higher the production 
of PHA is. Finally, a dynamic simulation of the behaviour of PET4 model (which included 
up to 21 reaction knockouts) was performed by using FBA analysis (Figure 49B). This 
simulation provided us with interesting predictions, such as the theoretical growth curve, 




(BCPY), listed in the Table 17. Interestingly, these model-based predictions suggested 
that a potential P. putida strain constructed on PET4 model deletions could accumulate 
more than 50% of biomass as PHA, even in absence of nitrogen limitation.  
 
Figure 49. A. Production envelopes for wild-type and PET P. putida knockout strains belonging to more 
promising GDLS path. The production envelopes for each overproducer design are shown as a function of 
the biomass production rate of the wild-type P. putida network using PET as sole carbon source (black lines). 
PET1 (blue), PET2 (green), PET3 (magenta), PET4 (red). B. Production of biomass (blue), PET uptake rate 
(green) and PHA (grey) as a function of time of design PET4 as predicted with dynamic FBA are shown. 
Design PET1 PET2 PET3 PET4 
Uptake rate (mmol·gDW-1·h-1) 3.78 3.78 3.78 3.78 
Knockouts 9 13 17 21 
Growth rate (h-1) 0.35 0.21 0.16 0.14 
Production Rate (min-max) 0 - 0.32 0 - 0.83 1.07-1.07 1.22-1.22 
Residual Biomass (g/L) 1.64 0.56 0.44 0.40 
PHA  (mM) N.D. N.D. 2.82 3.23 
PHA Biomass (g/L) N.D. N.D. 0.45 0.51 
Yp/s (mmol/mmol) 0 - 0.08 0 - 0.22 0.28 0.32 
BCPY (mmol·gDW-1·h-1) 0 - 0.11 0 - 0.18 0.17 0.17 
Biomass PHA (% CDW) N.A. N.A. 50.49 56.38 
Table 17. Properties of the PHA growth-coupled overproducer designs using PET as substrate at 10 
mM (2.26 g/L). (N.A..: not determined, N.D.: not detected). Uptake rate (mmol·gDW-1·h-1); Growth rate (h-1); 
Production rate (mmol·gDW-1·h-1); Yp/s, Product yield (mmol product/mmol substrate); BCPY, Biomass 
coupled product yield (mmol·gDW-1·h-1). 
Following similar approach, a collection of growth-coupled PHA overproducer 
designs was obtained using PU and the different metabolites derived from PET and PU 
hydrolysis, e.g., TPHTA, EG, 14DBO, ADIPATE, and MDI (Figure 50). The production 
envelopes and the properties of the PHA growth-coupled designs using PET and PU 
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hydrolysis products are listed in the Supplementary Figures S1-7 and the Supplementary 
Tables S12-S18. The best growth-coupled designs for each carbon source are shown in 
the Table 18 and the Figure 50.  
Design PET4 TPHTA4 EG4 PU4 ADIPATE5 14BDO4 MDI5 PAC5 
Concentration 
(mM) 
10 10 10 10 10 10 10 10 
Knockouts 22 *14 26 *15 *16 *17 *21 *17 
Growth rate  
(h-1) 
0.14 0.20 0.17 0.34 0.30 0.31 0.25 0.27 
Production rate 
(mmol.gDW-1.h-1) 
1.22 1.22 0.53 1.07 1.64 1.63 1.16 1.35 
Residual 
Biomass (g/L) 
0.40 0.44 0.16 2.09 0.47 0.33 0.93 0.56 
PHA Biomass 
(g/L) 
0.51 0.32 0.06 1.22 0.43 0.27 0.73 0.46 
Yp/s (mol/mol) 0.32 0.26 0.04 0.76 0.26 0.17 0.46 0.28 
Yp/s (g/g) 0.23 0.20 0.10 0.25 0.30 0.30 0.29 0.34 
Biomass PHA  
(% CDW) 
56.38 42.16 27.50 36.80 47.46 45.01 44.07 44.87 
Table 18. a summarised analysis of growth–coupled designs using different non-sustainable plastic 
wastes and their monomers, as a sole carbon source. The best designs are represented; PET4 
(polyethylene terephtalate), TPHTA4 (terephthalate), EG4 (ethylene glycol), PU4 (polyurethane), ADIPATE5 
(adipic acid), 14BDO4 (1, 4-butanediol), MDI5 (4, 4´-methylene diphenyl diisocyanate), PAC5 (phenylacetic 
acid). In the table, the concentration of each substrate and the needed knockouts in order to be able to 
produce polyhydroxyalkanoates (PHA) were indicated. Additional physiological parameters are shown such 
as growth rate, production rate, residual biomass (biomass free of PHA), PHA (g/L or %), Y p/s. * Indicates 
additional flux constraints.  
Due to the heterogeneity of substrates used, the ambitiousness of the final goal 
and the completeness of our metabolic model, a large number of knockouts, ranging 
from 14 in the case of TPHTA to 26 for EG, were needed in order to achieve PHA growth-
coupled designs (Table 18 and Figure 50, shown in black squares). Similarly, a large 
diversity was found in terms of the final yields, BCPY and amount of PHA produced. On 
average, the growth-coupled designs accumulated more than 40% of their biomass in 
form of PHA with the highest PHA% reached by PET4 design (Table 18). Therefore, the 
PHA growth-coupled designs present here represent an encouraging starting point for 





Figure 50. Clustering of the reactions required to be deleted (knockouts) in order to achieve the 
growth-coupled production of PHA in P. putida KT2440 using PET, PU and their derived substrates 
as carbon sources. The reactions removed in each carbon source are shown in black, while the one 
maintained are shown in red color. Model reaction abbreviations: 34HPPOR, 4 
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hydroxyphenylpyruvateoxygen oxidoreductase; 3OADPCOAT, 3-oxoadipate CoA-transferase; ABTA, 4 
aminobutyrate transaminase; ABUTD, aminobutyraldehyde dehydrogenase; ACONTa, aconitase half 
reaction A citrate hydro lyase; AKGDa, oxoglutarate dehydrogenase lipoamide; ALAR, alanine racemase; 
ALATA_L, L-alanine transaminase; ALDD2x, aldehyde dehydrogenase acetaldehyde NAD; APSR, 
adenosine 5-phosphosulfate reductase; CAT, catalase; CPPPGO, coproporphyrinogen oxidase; CS, citrate 
synthase; CYSS, cysteine synthase; DLYSPYRAT, D-lysinepyruvate aminotransferase; ENO, enolase; 
FALDM, formaldehyde dismutase; FORGLUIH2, N-formimino-L-glutamate inimohydrolase; GAPD, 
glyceraldehyde 3-phosphate dehydrogenase; GHMT2, glycine hydroxymethyltransferase; GLUR, glutamate 
racemase; GLYCTO1, glycolate oxidase; GLYO, glycine oxidase; GND, phosphogluconate dehydrogenase; 
GTHOr, glutathione oxidoreductase; HSK, homoserine kinase; ICDHyr, isocitrate dehydrogenase NADP; 
ICL, isocitrate lyase; MALS, malate synthase; MCITL2, methylisocitrate lyase; METGL, methionine g-lyase; 
METSOXR2, L-methionine R-sulfoxide reductase; MMTSAO, S-methylmalonate semialdehydeNAD 
oxidoreductase CoA-propanoylating; NACODA, N-acetylornithine deacetylase; OARGDC, oxoarginine 
decarboxylase; ORNCD, ornithine cyclodeaminase; PC, pyruvate carboxylase; PDH, pyruvate 
dehydrogenase; PGI, glucose 6-phosphate isomerase; PHADPC80, poly-3-hydroxyalkanoate 
depolymerase C80; PPC, phosphoenolpyruvate carboxylase; PPCSCT, propanoyl CoA -succinate CoA-
transferase; PPND, prephenate dehydrogenase; RBK, ribokinase; RHACOAE80, R-hydroxyacyl CoA-
thioesterase C80; SGDS, succinylglutamate desuccinylase; SUCOAS, succinyl-CoA synthetase ADP-
forming; TALA, transaldolase; THRAr, threonine aldolase; TKT2, transketolase; TPI, triose phosphate 
isomerase; UPPN, b-ureidopropionase. 
Despite the diversification of the reactions deleted, in order to achieve the 
overproduction of PHA in each substrate, common patterns were found. For instance, 
the deletion of the reactions ALDD2x, RHACOAE80, PHADPC80, NACODA, ORNCD, 
PDH and CYSS was required in all cases, suggesting that the deletion of these reactions 
is needed to achieve the overproduction of PHA and that they would be the first reactions 
to be deleted in vivo. In addition, a set of deletions were specific of PET and its derived 
substrates such as MALS, ALATA_L, MCITL2 and ICL; while others were specific of PU 
and derived substrates e.g., TALA, AKGDa and GLUR. Therefore, these sets of 
reactions point the way for the in vivo implementation of PET- and PU-based PHA 
growth-coupled strains, respectively. For model reaction abbreviation see the footnote 
of the Figure 50.  
Taken together, it could be concluded that PET4 design was the best growth-
coupled design as far as it concerns the PHA (%) production (Table 18). Even though 
high PHA production was also obtained from PU and its monomers, PU´s composition 
variability would complicate its in vivo implementation. Furthermore, taking into account 
the feasibility of PET degradation and the advanced research on PET hydrolases, the 
PET4 is a promising design for further in vivo implementation (Wierckx et al., 2018; 
Belisário‐Ferrari et al., 2019; Danso et al., 2019; Salvador et al., 2019). Finally, the PET4 




from lignin and PET hydrolysis (Figure 51). Therefore, the PET4 design was chosen for 
further in vivo validation.  
Finally, in order to increase the scope of above growth-coupled designs to 
additional carbon sources, other than those already tested (PET, TPHTA, EG, 14DBO, 
ADIPATE, MDI and PAC), we tested the feasibility of the different designs for 
overproducing PHA by using the complete set of carbon sources supporting iJN1411 
growth.  
As an example, the carbon sources allowing growth of PET4 design when 
compared to the wild type model were shown (Figure 51). As it would be expected, the 
PET4 strain exhibited a reduced metabolic versatility. For instance, since glyoxylate 
shunt was deleted, PET4 strain was unable to grow on fatty acids as carbon sources. It 
was also observed that from the carbon sources supporting PET4 strain growth, only a 
few of them allowed growth-coupled PHA production (Figure 51, graph below). 
Interestingly, the most of the compounds allowing PHA production were aromatic 
compounds. The most promising were PU-derived metabolites, such as phenyl acetic 
acid related compounds (red), followed by the lignin-derived carbon source (in orange, 
such as ferulic acid) and the PET derived metabolites (in green, such as 4-
hydroxybenzoic acid, vanillic acid and protocatechuic acid).  
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Figure 51. The growth performance of the PET4 strain (light purple) versus the wild type (dark purple) 
strain after in silico comparison of almost 210 carbon sources is shown. The PHA produced was 
normalized to the number of carbons of each substrate used in this analysis. From the carbon sources 
supporting PET4 growth, only a few allow growth-coupled PHA production (graph below). From these, PU 
like compounds (in red) are the more promising carbon sources. The lignin derived (in orange), the PET 
derived (in green) and other derivatives (in blue) are shown. The uptake rate for all the carbon sources was 
5 mmol·gDW-1·h-1. For the PHA production normalization, the number of carbons of each substrate was 
taken into account. Model reaction abbreviations: ‘EX_pac(e)’, Phenylacetic acid exchange; ‘EX_pacald(e)’, 
Phenylacetaldehyde exchange; ‘EX_peamn(e)’, Phenethylamine exchange; ‘EX_pea(e)’, 
Phenylethylalcohol exchange; ’EX_T4hcinnm(e)’, trans 4 Hydroxycinnamate exchange; ‘EX_34dhcinm(e)’, 
3 4 Dihydroxy trans cinnamate exchange; ‘EX_fer(e)’, Ferulate exchange; ‘EX_confrl(e)’, Coniferol 
exchange; ‘EX_catechol(e)’, Catechol exchange; ‘EX_3oxoadp(e)’, 3 Oxoadipate exchange; ‘EX_ecto_L(e)’, 
L Ectoine exchange, ‘EX_4hbz(e)’, 4 Hydroxybenzoate exchange; ‘EX_bz(e)’, Benzoate exchange; 
‘EX_34dhbz(e)’, 3 4 Dihydroxybenzoate exchange; ‘EX_spmd(e)’, Spermidine exchange; ‘EX_quin_kt(e)’, 
Quinate exchange; ‘EX_skm(e)’, Shikimate exchange; ‘EX_tpha (e)’, Exchange terephthalate; ‘EX_vanlt(e)’, 
Vanillate exchange; ‘EX_vanln(e)’, Vanillin exchange; ‘EX_alaleu(e)’, L alaninylleucine exchange; 





4.3.3 Synthetic Biology implementation of in silico PET4 PHA 
overproducer design 
 
The complete PET4 design was based on the deletion of 21 reactions, making 
challenging its in vivo implementation due to the large number of genetic modifications 
required. As a first step, a manual curation of PET4 design was performed, in order to 
identify the minimal number of knockouts still resulting in an efficient growth-coupled 
design. By this effort, the importance of each reaction towards growth-coupled PHA 
production was evaluated (Table 19). Some reactions including RHACOAE80, 
PHADPC80 among others, showed a dispensable behaviour for PHA production. 
Furthermore, the deletion of UPPN and ALATA_L reactions resulted in slight decrease 
in the PHA content and the PDH reaction showed a moderate decrease in the PHA 
production. Overall, from the initial list of 21 reaction knockouts required, only 9 reactions 
deletion were identified as completely essential for growth-coupled PHA production. 
Based on this analysis, it was feasible the identification of three possible growth-coupled 
designs accounting for an increasing number of knockouts, minimal, medium and 
complete (Figure 52 and Table 19). We proceeded to plot the production envelopes of 
each design in order to visualize the phenotype of these different in silico knockout 
strains (Figure 52). The production envelope of the wild type model is shown in black, 
while the minimal, medium and complete designs are shown in red, blue and green color, 
including 9, 12 and 21 knockouts, respectively. Despite the significant lower number of 
knockouts of the minimal design, it keeps the ability to overproduce a significant amount 
of PHA, so close as the complete design does.  
Design 
Complete (function) medium minimal 
RHACOAE80 (dispensable) RHACOAE80 PHADPC80 
PHADPC80 (dispensable) PHADPC80 FORGLUIH2 
FORGLUIH2 (essential) FORGLUIH2 ICL 
ICL (essential) ICL ICDHyr 
ICDHyr (essential) ICDHyr MALS 
MALS (essential)  MALS MCITL2 
MCITL2 (essential) MCITL2 ORNCD 
ORNCD (essential) ORNCD PPCSCT 
PPCSCT (essential) PPCSCT SUCOAS 
SUCOAS (essential) SUCOAS  
CYSS (dispensable) CYSS  
NACODA (dispensable) NACODA  
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UPPN (slight pha reduction)   
RBK (dispensable)   
OARGDC (dispensable)   
ABUTD (dispensable)   
ALATA_L (slight pha reduction)   
ALDD2x (dispensable)   
PDH (moderate pha reduction)   
PDHbr (moderate pha reduction)   
PDHcr (moderate pha reduction)   
Table 19. Key reactions identified to be knocked out for PHA growth-coupled mutants using PET as 
carbon source.  The importance of each reaction to PHA production was validated by manual curation 
process and indicated in the complete model. Model reaction abbreviations: ABUTD, aminobutyraldehyde 
dehydrogenase; ALAR, alanine racemase; ALATA_L, L-alanine transaminase; ALDD2x, aldehyde 
dehydrogenase acetaldehyde CYSS, cysteine synthase; ENO, enolase; FORGLUIH2, N-formimino-L-
glutamate inimohydrolase; ICDHyr, isocitrate dehydrogenase NADP; ICL, isocitrate lyase; MALS, malate 
synthase; MCITL2, methylisocitrate lyase; NACODA, N-acetylornithine deacetylase; OARGDC, oxoarginine 
decarboxylase; ORNCD, ornithine cyclodeaminase; PDH, pyruvate dehydrogenase; PHADPC80, poly-3-
hydroxyalkanoate depolymerase C80; PPCSCT, propanoyl CoA-succinate CoA-transferase; RBK, 
ribokinase; RHACOAE80, R-hydroxyacyl CoA-thioesterase C80; SUCOAS, succinyl-CoA synthetase ADP-
forming; TKT2, transketolase; UPPN, b-ureidopropionase 
 
Figure 52. Manual curation of PET4 optimal design. Flux through PHA versus growth rate is represented. 




Therefore, the minimal´s PET4 design was used as a starting point for the in vivo 
implementation. These reactions were blocked sequentially by deleting the 
corresponding coding gene(s). We relied on a system for individual gene deletions 
(pK18mobsacB) and in order to accumulate all the necessary deletions in a single strain 
many successive rounds were performed (section 3.4.4). A logical order to delete the 
genes was planned based on the predicted weight of each deletion on PHA production 
(Table 20 and Figures 53-54). In order to facilitate the understanding, a workflow of the 




Reaction Pathway Annotation Gene 
name(s) 
1 2-methylisocitrate lyase Succinate PP_2334 mmgF 
2 Propionyl-CoA:succinate-
CoA transferase 
Succinate PP_0154 scpC 
3 Succinyl-CoA synthetase 





4 Isocitrate lyase Glyoxylate PP_4116 aceA 
5 Malate synthase G Glyoxylate PP_0356 glcB 
6 Isocitrate dehydrogenase TCA cycle PP_4011, 
PP_4012 
icd, idh 
7 PHA depolymerase PHA PP_5004 phaZ 











Table 20. Reactions and their corresponding genes deleted to achieve the PET growth-coupled design 
strain.  
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Figure 53. Workflow of the mutants’ strategy construction. The obtained deletion mutants in P. putida 
KT2440 background called as MMxxx were shown.  
In the in silico PET design strain, PET is degraded into TPHTA and EG with the 
action of PET hydrolases. TPHTA is catabolized via PCA and then into succinate and 
acetyl-CoA, while EG is assumed to be metabolized via acetyl-CoA (Figure 47). A 
detailed analysis of PET4 minimal design showed that PHA overproduction relies on 
blocking oxidation of succinate and acetyl-CoA at tricarboxylic acid cycle (TCA). 
According to model predictions, succinate was used as biomass building block and 
energy source via glycine oxidation, while acetyl-CoA was used mainly as a PHA 





Figure 54. Predicted Carbon Flux Distribution in PET-growth optimized minimal design. The deleted 
reactions (in gray), the increased flux reactions (in green), the reduced flux reactions (in red) and the 
unaffected fluxes (in blue) are shown. 
Therefore, the first three reactions deleted were those responsible of blocking in 
succinate metabolism, 2-methylisocitrate lyase, propionyl-CoA:succinate-CoA 
transferase and succinyl-CoA synthetase subunit alpha/beta (Figure 55). The next 
reactions knocked out were responsible of glyoxylate cycle, isocitrate lyase and malate 
synthase (Figure 56). Glyoxylate cycle is a variation on the TCA cycle in charge of the 
biosynthesis of 4-carbon metabolites from acetyl-CoA (Introduction 1.4.2.5 section). The 
subsequent deletion was the isocitrate dehydrogenase, that when taken together with 
the five previous deletions, it was expected to eliminate a substantial portion of the 
carbon flux through the TCA cycle (Figure 57). The seventh reaction that was 
sequentially deleted was the PHA depolymerase, PhaZ, which was expected to allow for 
increased PHA accumulation. However, the single phaZ mutant (KT40Z) was made and 
has already been under active phenotypic investigation in our lab (Results chapter 1 and 
Figure 23, for mutant construction details). The last deletions were required in order to 
avoid alternative metabolism of acetyl-CoA and acetate secretion via amino acid 
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metabolism (Figure 58-59). The deletion strategy for all the knockout mutants and the 
remaining nucleotide sequence after the deletion is shown (Figures 55-59).  
- Blocking Succinate Metabolism 
 
Figure 55. Succinate metabolism reactions deletion strategy. The deleted gene products at their 
corresponding locus are shown. The arms of homology used for recombinatorial deletion of each gene 
consist of the flanking upstream and downstream genes. Arrows above indicate the annealing location for 
primers used for colony PCR following the second recombination event to confirm the gene deletion. The 
remaining nucleotide sequence after the deletion is shown. The stop codons, the start codons are shown 
with bold blue and bold underlined, respectively. The remaining nucleotides of the deleted genes are shown 





- Blocking glyoxylate shunt  
Figure 56. Glyoxylate shunt reactions deletion strategy. The deleted gene products at their 
corresponding locus are shown. The arms of homology used for recombinatorial deletion of each gene 
consist of the flanking upstream and downstream genes. Arrows above indicate the annealing location for 
primers used for colony PCR following the second recombination event to confirm the gene deletion. The 
remaining nucleotide sequence after the deletion is shown. The stop codons, the start codons are shown 
with bold blue and bold underlined, respectively. The remaining nucleotides of  the deleted genes are shown 
in orange color. IR: intergenic region.  
- Blocking Isocitrate dehydrogenase  
 
Figure 57. isocitrate dehydrogenase reaction deletion strategy. A. deletion strategy for both PP_4011 
and PP_4012, B. deletion strategy for PP_4011 and C. deletion strategy for PP_4012. The deleted gene 
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products at their corresponding locus are shown. The arms of homology used for recombinatorial deletion 
of each gene consist of the flanking upstream and downstream genes. Arrows above indicate the annealing 
location for primers used for colony PCR following the second recombination event to confirm the gene 
deletion. The remaining nucleotide sequence after the deletion is shown. The stop codons are shown with 
bold blue color. IR: intergenic region. 
- Blocking Amino acids metabolism 
 
Figure 58. Ornithine cyclodeaminase reactions deletion strategy. The deleted gene products at their 
corresponding locus are shown. The arms of homology used for recombinatorial deletion of each gene 
consist of the flanking upstream and downstream genes. Arrows above indicate the annealing location for 
primers used for colony PCR following the second recombination event to confirm the gene deletion. The 
remaining nucleotide sequence after the deletion is shown. The stop codons, the start codons are shown 
with bold blue and bold underlined, respectively. The remaining nucleotides of PP_3190 are shown with 
orange color.  
 
Figure 59. Formiminoglutamate deiminase reaction deletion strategy. The deleted gene products at 




consist of the flanking upstream and downstream genes. Arrows above indicate the annealing location for 
primers used for colony PCR following the second recombination event to confirm the gene deletion. The 
remaining nucleotide sequence after the deletion is shown. The stop codons, the start codons are shown 
with bold blue and bold underlined, respectively. The remaining nucleotides of PP_5036 are shown with 
orange color. 
 
4.3.4 Phenotypic evaluation of PET growth-coupled design strains 
 
Once the strains were constructed, the ideal scenario was to phenotypically 
evaluate their growth and PHA production capabilities under similar conditions to those 
previously simulated (PET). However, as we mentioned previously, P. putida KT2440 is 
not able to grow on PET either its monomers derived from hydrolysis, e.g., terephthalic 
acid (TPHTA) and ethylene glycol (EG) as carbon source. Thus, as a potentially 
equivalent substrate to the simulated conditions, protocatechuic acid (PCA) was chosen. 
PCA is an intermediate of TPHTA or PET degradation process (Figures 47 and 54). 
Since PCA is a very unstable substrate, due to its rapid oxidation in working conditions, 
sodium 4-hydroxybenzoate (4HBz) was used instead, which is metabolized in P. putida 
via PCA (Figure 9). 
Phenotypic evaluation of MM16 strain was carried out by assessing growth on 
microtiter and batch growth experiments. The growth and PHA production capabilities of 
MM16 strain were monitored under both balanced and nitrogen limitation conditions. 
Some growth performance parameters were monitored such as the growth rate, lag 
phase and maximum optical density reached (Table 21). As a control, wild type and 
KT40Z strains were used. MM16 strain exhibited a significantly higher lag phase in both 
conditions of growth when compared with the wild type and KT40Z strains. Under 
balanced conditions, MM16 strain showed a decrease in growth rate.  
Using this strategy and under balanced conditions, the PHA polymer degradation 
is favored. It is noteworthy remark here that under balanced conditions, while the wild-
type strain is able to depolymerize the polymer, KT40Z or MM16 strains are not, due to 
the lack of phaZ, among others. Therefore, it is reasonable to assume that under these 
conditions, the PHA accumulation would be favored in the knockout strains. However, 
no PHA production was observed in all the strains tested in any condition. This 
discrepancy to the in silico predictions is due likely to insufficient acetyl-CoA levels. In 
fact, PET4 design accounts also for EG utilization, which is metabolized to acetyl-CoA in 
the model. Summing up, PET utilization would result to 2 acetyl-CoA and 1 succinate, 
while PCA or 4HBz to 1 acetyl-CoA and 1 succinate. Therefore, it was considered that 
an extra pulse of acetyl-CoA would aim the PHA production. 
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M63 5 mM 4HBz 1.12 
KT2440 1.75 0.30 0.34 
KT40Z 3.25 0.26 0.34 
MM16 4.75 0.18 0.31 
M63 0.1 N 10 mM 4HBz 23.33 
KT2440 2.58 0.15 0.54 
KT40Z 3.25 0.23 0.54 
MM16 6.50 0.15 0.48 
Table 21. Growth characteristics under balanced and nitrogen limitation conditions. The results 
correspond to microtiter experiments.  
We proceeded to add a pulse of octanoate as an acetyl-CoA precursor source, 
while 4HBz was used as carbon source in this new experiment. In this case, MM16 strain 
produced 33.7% of PHA/CDW compared to 7% of wild type and 25.2% of KT40Z strain 
(Figure 60 and Table 22). Even though, the single deletion of the depolymerase resulted 
in 25.2% PHA/CDW, the deletion of extra reactions in MM16 led to higher PHA 
production (33.7% vs 25.2%). Thus, it could be concluded that these growing conditions, 
which largely mimic the in silico PET metabolism used to design MM16 strain, can be 
used instead of PET as feasible culture conditions for phenotyping our knockout strains.  
The above culture conditions were used in order to screen the impact of each 
individual and sequential deletions on PHA production (Figure 60 and Table 22) and to 
in vivo verify which reactions were essential to drive the PHA production. Thus, key 
knockout reactions leading to higher PHA content were the succinyl-CoA synthase, 
sucC-sucD, (in purple) and the isocitrate lyase, aceA (in orange). The special importance 
was the deletion of sucCD that increased the PHA production from 5% in MM4 strain to 
22% in MM6 strain (Figure 60 and Table 22). The deletion of isocitrate lyase has been 
previously reported to improve the PHA production (Klinke et al., 2000). To be best of 
our knowledge, this is the first time that the deletion of sucCD genes is related with 
improved PHA capabilities. The rest of knockouts only increased slightly the PHA 
production found in MM8 strain.  
Overall, it could be concluded, that MM16 strain was able to efficiently produce 
PHA under balanced growth conditions (M63 3 mM octanoate 5 mM 4HBz), reaching up 
to 33.7% of PHA/CDW production, 4.8 times improvement when compared to the wild 
type strain. In fact, MM16 strain produced up to 0.2 g/L of PHA compared to 0.05 g/L of 






Figure 60. A. The PHA (% CDW) content after 24h of growth in M63 3 mM octanoate 5 mM 4- 
hydroxybenzoate (C/N ratio: 2 mol/mol) in the different deletion mutants background is demonstrated (see 
Figure 53 and Table 2 for the strains nomenclature). B. Electronic microscopy pictures of the KT2440 and 
MM16 strains after 24 h of growth under the above mentioned conditions are shown. The scale bar of the 
pictures is 1 μm. 
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KT2440 0.69 ± 0.05 7.09 ± 0.78 0.05 ± 0.01 0.63 ± 0.05 
KT40Z 0.74 ± 0.03 25.19 ± 1.97 0.19 ± 0.02 0.56 ± 0.03 
MM3 0.68 ± 0.05 4.90 ± 1.02 0.03 ± 0.01 0.64 ± 0.04 
MM4 0.63 ± 0.04 4.38 ± 204 0.03 ± 0.01 0.60 ± 0.04 
MM6 0.63 ± 0.02 22.56 ± 4.07 0.16 ± 0.03 0.47 ± 0.01 
MM8 0.59 ± 0.01 32.41 ± 2.71 0.19 ± 0.02 0.40 ± 0.02 
MM9 0.57 ± 0.02 31.10 ± 2.07 0.18 ± 0.02 0.39 ± 0.00 
MM11 0.55 ± 0.04 29.05 ± 2.49 0.16 ± 0.00 0.42 ± 0.01 
MM12 0.60 ± 0.03 33.79 ± 2.14 0.19 ± 0.01 0.41 ± 0.02 
MM13 0.57 ± 0.04 32.68 ± 1.15 0.20 ± 0.01 0.40 ± 0.01 
MM14 0.60 ± 0.02 33.53 ± 2.82 0.20 ± 0.02 0.40 ± 0.01 
MM15 0.57 ± 0.04 33.15 ± 3.54 0.20 ± 0.02 0.38 ± 0.01 
MM16 0.59 ± 0.03 33.70 ± 2.47 0.20 ± 0.02 0.39 ± 0.02 
Table 22. Physiological parameters after 24 h of growth under M63 3 mM octanoate 5 mM 4HBz (C/N ratio: 
2 mol/mol). 
 
4.3.5 PHA is produced via β-oxidation pathway in the MM16 strain 
 
PHA can be produced either via β-oxidation or de novo fatty acid synthesis 
(Introduction sections 1.4.1 and 1.4.3). Since 4HBz is a non-PHA related carbon sources, 
the growth-coupled strains obtained are expected to follow the de novo fatty acid 
synthesis for PHA production. In order to assert the metabolic pathway responsible for 
the PHA production observed in the MM16 strain, octanoate was replaced by an odd 
fatty acid and the PHA monomers pattern was subsequently analyzed. Thus, if odd chain 
monomers were obtained, this unequivocally indicate that they came from the β-
oxidation; however, if even chain monomers appear, this would suggest that they came 
from de novo fatty acid synthesis. Following this premise, the PHA content was quantified 
in KT2440, KT40Z and MM16 strains after 24 h of growth using 3 mM 10-undecenoic 
acid and 5 mM 4-hydroxybenzoate as carbon sources (Table 23). No significant 
differences were observed as far as it concerns the PHA monomeric pattern between 
the strains. Since only odd monomers were observed, it could be concluded that the 
pathway used for PHA synthesis in MM16 strain was the β-oxidation and not the de novo 





Strains KT2440 KT40Z MM16 
% OH-C6 (mM) N.D. N.D. N.D. 
% OH-C7:1 (mM) 3.23 ± 2.11 3.70 ± 1.75 2.46 ± 2.03 
% OH-C8 (mM) N.D. N.D. N.D. 
% OH-C9:1 (mM) 63.83 ± 2.46 55.87 ± 1.22 53.47 ± 1.22 
% OH-C10 (mM) N.D. N.D. N.D. 
% OH-C11:1 (mM) 32.94 ± 1.24 40.44 ± 0.82 44.07 ± 2.82 
Table 23. The pattern of PHA monomers for the wild type KT2440, null phaZ (KT40Z), MM16 strains after 
24 h of growth under M63 3mM 10-undecenoic acid and 5 mM 4-hydroxybenzoate was shown. N.D.: not 
detected. 
This result strongly argued in favor of potential regulatory constraints avoiding the 
synthesis of PHA via de novo fatty acid synthesis pathway. In order to check the 
feasibility of this hypothesis, the transcription levels of key genes of pha cluster (phaF 
and phaI) as well as the (R)-3-hydroxydecanoyl-ACP:CoA transacylase phaG were 
checked in the MM16 strain (Figure 61). The phaG gene is a key connector between the 
fatty acid synthesis and PHA production (Introduction section 1.4.3).  
Therefore, the expression levels of phaF, phaI and phaG were quantified by means 
of qRT-PCR experiments from total RNAs extracted of bacterial cultures of genes for the 
control strains (KT2440, KT40Z), and MM16, after 6 h of growth using 5 mM 4HBz (red 
bars) or 3 mM octanoate and 5 mM 4HBz (blue bars). Similar results were obtained for 
the phaI phasin. A standard balanced condition of growth was used as a positive control 
for the expression levels of the phasins for the control strains (M63 7.5 mM octanoate, 
shown in black bars). MM16 strain could not be analyzed under these conditions since it 
cannot grow on fatty acid as sole carbon source (Figure 50). 
As it would be expected, the expression levels of phaF, for wild type and KT40Z 
strains were higher in the control condition (black bars) compared to the experimental 
(red and blue bars), since the strains were grown under PHA-related carbon source (fatty 
acid). Under this condition, PHA are being synthetized and the requirement of phasins 
increase accordingly in order to allocate the PHA into the growing granules both in the 
wild type and KT40Z strain. However, growth under 5 mM 4HBz 3 mM octanoate (blue 
bars) resulted in 1.3 and 1.7 fold decrease in the phaF expression levels in wild type and 
KT40Z strains, respectively compared to the control condition (black bars). Accordingly, 
MM16 strain showed 1.7 times decreased phaF expression compared to the 
corresponding values of the wild type strain. Finally, growth under 5 mM 4HBz (red bars), 
led to 2.2 fold decrease in the phaF expression levels of wild type and KT40Z strains. 
However, 3 fold decrease in its expression was observed by MM16 strain compared to 
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the corresponding levels of wild type strain. Thus, in the case of MM16 strain, the phaF 
expression levels were affected compared to the wild type. In addition, the phaG was 
barely expressed in all the strains and conditions tested.  
 
Figure 61. qRT-PCR experiments under M63 5 mM 4-hydroxybenzoate (5mM 4HBz; in red) and M63 
5 mM 4-hydroxybenzoate 3 mM octanoate (5 mM 4HBz 3 mM octa; in blue) and M63 7.5 mM octanoate 
(7.5 mM octa; in black bars). The expression levels (DNA concentration) for the phasin phaF (A) and phaG 
genes (B) for the strains KT2440, KT40Z and MM16 strains are shown in the left and right graph, 
respectively.  
Taking together, these results could explain, to some extent, the observed 
phenotypes. A plausible hypothesis could be that by increasing the expression levels of 
these critical genes, such as phaC1 synthase, phaF phasin and the phaG, recombinant 
microorganisms capable of producing PHA from de novo fatty acid synthesis could be 
obtained.   
 
4.3.6 Construction of a second generation of PHA overproducer P. putida 
strains 
 
As depicted above, MM16 strain synthetizes PHA through the β-oxidation pathway 
(Table 23) and not through de novo fatty acid synthesis as it was designed, likely due to 
the lack of proper expression of both pha genes (phaC1, phaF), as well as phaG gene 
in our experimental conditions (Figure 61). Therefore, it was decided to completely avoid 




sequential genetic iterations. Figure 62 shows the strategy consisting in i) the deletion of 
the whole pha cluster (blue color) and ii) the expression of a synthetic PHA operon 
containing the minimal set of enzymes required for PHA production and those needed to 
reroute the carbon flux towards de novo fatty acid biosynthesis (pink color).  
 
Figure 62. Schematic representation of second generation PHA overproducer strain construction. 
The obtained mutants in P. putida KT2440 background with the different iterations are shown. The growth-
coupled construction MM16 (green), pha cluster deletion (blue), optimized pha synthetic operon (pink) and 
genes required for sucrose degradation (gray) are indicated. 
- pha  cluster deletion  
i) As mentioned in the introduction (section 1.4.5), the pha metabolism is subjected 
to a complex regulation including global and specific regulator. In order to avoid this 
native regulation, the whole pha cluster was deleted using pEMG deletion strategy 
(Materials and Methods section 3.4.4 and Figure 62). The KT2440 Δpha strain has been 
constructed previously and it  has already been under active phenotypic investigation in 
our lab (Results chapter 1). The pha deletion in MM16 strain resulted in MM19 strain 
(Figure 62, blue color).  
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Figure 63. PHA cycle deletion strategy. The deleted gene products at their corresponding locus are 
shown. The arms of homology used for recombinatorial deletion of each gene consist of the flanking 
upstream and downstream genes. Arrows above indicate the annealing location for primers used for colony 
PCR (sequencing) following the second recombination counterselection to confirm the gene deletion. The 
remaining nucleotide sequence after the deletion is shown. The stop and start codons are shown with bold 
blue and bold underlined, respectively.  
- Optimized pha synthetic operon 
ii) As a second approach and in order to increase the preference of MM19 strain 
towards the de novo fatty acid synthesis, it was decided to overexpress key genes 
related with PHA synthesis. First, the phaG and the medium chain-fatty acid CoA ligase 
encoded by the gene PP_0763, were overexpressed. Our strategy was based on the 
previous work from Wang and collaborators that found high expression levels of phaG 
and PP_0763 genes associated to biosynthesis of mcl-PHAs from unrelated carbon 
sources (Q. Wang et al., 2012). Second, based on the suboptimal expression of key pha 
genes (Figure 61), we proceeded to overexpress the key genes involved in the PHA 
production, e.g., the phaC1 synthase and the phasin encoded by the phaF gene using 





Figure 64. Golden Gate – MoClo Level 1 plasmid constructions. Level 0 parts, including promoter, gene 
and terminator, were mixed along with the Level 1 destination vector, BsaI and T4 DNA Ligase to form each 
Level 1 product vectors. This reaction takes place by complementation using fusion sites (sequences 
represented). The promoter part (and the corresponding fusion sites for this part), and the terminator part 
are demonstrated with blue and green color, respectively. The Golden Gate-MoClo vectors that were used 
as backbones and the resulting L1 Product vectors are shown.   
Four Golden Gate-MoClo Level 1 reactions were carried out to create transcription 
unit constructs for the phaC1, phaF, phaG and PP_0763 (Figure 64). Correct Level 1 
assemblies/plasmids were then mixed with the Level 2 plasmid and the appropriate Level 
2 end-linker (Figure 65). This Level 2 Product vector (pMM55) contained an end-linker 
with the LacZ that maintained the construct opened, allowing the addition of extra 
transcription units if needed. The pMM55 plasmid was then transformed into P. putida 
MM19 and KT2440 Δpha strains, generating MT1 and MT2 strains, respectively (Figure 
62). 
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Figure 65. Golden Gate-MoClo Level 2 plasmid constructions. Level 1 transcription unit vectors are 
mixed along with the appropriate end-linker vector, the Level 2 destination vector, BpiI enzyme and T4 DNA 
Ligase to form each Level 2 product vector. This reaction takes place by complementation of unique fusion 
sites (sequences represented). The Golden Gate-MoClo vectors that were used as backbones and the 
resulting L2 Product vector are shown. Dummies can be used to assemble a multigene construct lacking a 
transcription unit at an internal position. For example, three transcription units previously cloned in level 1 
vectors for positions 1,2 and 4, can be assembled in a multigene construct by using dummy 3 in the level 2 
cloning reaction. The multigene construct obtained will contain 15 bp of sequence at position 3. 
 
4.3.7 Phenotypic evaluation of second generation growth-coupled design 
strains using fatty acids and PHA-unrelated carbon sources 
 
The performance of these synthetic genes were tested on plasmid in the MT1, MT2 
strains compared to the wild type KT2440 and the corresponding parental, MM19 and 
KT2440 Δpha null strains, respectively. The phenotypic comparison and the 
physiological parameters of these strains after 24 h of growth under M63 minimal 
medium supplemented with 3 mM octanoate 5 mM 4-hydroxybenzoate (C/N= 2 mol/mol) 
are listed in the Table 24. As it would be expected, the MM19 strain, resulted in no PHA 
production, since the whole pha cluster has been deleted. The MT1 and MT2 strains, 
resulted in 46% and 26% PHA/CDW, respectively compared to 33.7% produced in MM16 
strain. Slight higher amounts of C10 monomer was also observed in MT1 and MT2 
background strains compared to the MM16 strain (Table 25). These results validate the 
functionality of the synthetic operon, since the overexpression of the phaG and PP_0763 
genes would lead to an increased flux through the de novo fatty acid synthesis. 
Therefore, it would be interesting to test MT1 and MT2 growth-coupled PHA production 




source. The PHA production in these strains was first analyzed by electronic microscopy 
pictures after 24 h of growth under the above-mentioned conditions (Figure 66).  








KT2440 0.69 ± 0.05 7.09 ± 0.78 0.05 ± 0.01 0.63 ± 0.05 
MM16 0.59 ± 0.03 33.70 ± 2.47 0.20 ± 0.02 0.39 ± 0.02 
MM19 0.43 ± 0.01 N.D. N.D. 0.43 ± 0.01 
MT1 0.49 ± 0.04 46.05 ± 2.96 0.22 ± 0.01 0.26 ± 0.03 
MT2 0.70 ± 0.03 26.14 ± 3.72 0.18 ± 0.03 0.51 ± 0.03 
Table 24. Physiological parameters after 24 h of growth under M63 3 mM octanoate 5 mM 4HBz (C/N ratio: 
2 mol/mol). N.D.: not detected.  










KT2440 5.82 ± 0.27 88.62 ± 0.63 4.01 ± 1.84 N.D. 1.55 ± 2.20 
MM16 6.71 ± 0.44 91.64 ± 0.77 1.42 ± 0.51 N.D. 0.24 ± 0.41 
MT1 5.96 ± 0.38 76.49 ± 2.42 15.40 ± 1.59 0.79 ± 0.34 1.36 ± 0.54 
MT2 6.25 ± 0.37 82.59 ± 1.52 9.79 ± 1.19 0.43 ± 0.24 0.94 ± 0.38  
Table 25. PHA monomeric pattern after 24 h of growth under M63 minimal medium supplemented with 3 
mM octanoate 5 mM 4HBz (C/N ratio: 2 mol/mol). N.D.: not detected.  
 
Figure 66. Designing the optimal chassis for in vivo PHA production. Electronic microscopy pictures of 
the cells grown after 24 h under M63 3 mM octanoate 5 mM 4HBz (C/N ratio: 2mol/mol) 
Interestingly and contrary to the traditionally PHA overproducer strains that require 
unbalanced C/N ratio for efficient PHA production, strains MM16, MT1 and MT2 
accumulate significant amounts of PHA under equilibrate nutrients conditions using 
octanoate plus 4-hydroxybenzoic acid (4HBz) (Table 24). Even more, strains MT1 and 
MT2 produced significant PHA using unrelated carbon sources in the absence of 
octanoate (Table 26 and Figure 67). For instance, while the wild type strain produced a 
  Results 
                                                                             155 
 
negligible amount of PHA using aromatic compounds derived of lignin and PET (such as 
p-coumaric, ferulic, vanillic or 4HBz), the strain MT2 accumulated PHA ranging 4-8% of 
total biomass and MT1 strain accumulated higher amounts (up to 19.68% using ferulic 
acid as carbon source). Validating in silico predictions that suggested phenyl acetic 
carbon source for PHA production (Figure 51), the MT1 strain was able to produce up to 
14.7% of PHA after 72 h of cultivation (Table 26). Since the lignin, PET and PU derived 
monomers are PHA unrelated carbon sources, the de novo fatty acid synthesis is 
expected to be used for PHA production, leading to major production of C10, followed 
by C8 monomers. The monomeric pattern of the strains grown for 24 h using 4HBz are 
















KT2440 0.32 N.D. N.D. 0.32 ± 0.00 
MT2 0.33 4.13 ± 0.20 0.01 ± 0.00 0.31 ± 0.00 
MT1 (72 h) 0.28 14.67 ± 0.10 0.04 ± 0.00 0.24 ± 0.00 
Ferulic acid 
(3.5 mM) 
KT2440 0.37 ± 0.01 N.D. N.D. 0.37 ± 0.01 
MT2 0.38 ± 0.00 7.78 ± 0.94 0.03 ± 0.00 0.35 ± 0.00 




KT2440 0.38 ± 0.00 N.D. N.D. 0.38 ± 0.00 
MT2 0.38 ± 0.01 6.15 ± 0.94 0.02 ± 0.00 0.36 ± 0.01 
MT1 0.24 ± 0.04 14.23 ± 1.88 0.04 ± 0.01 0.21 ± 0.03 
Vanillic acid 
(4.4 mM) 
KT2440 (48 h) 0.27 ± 0.06 N.D. N.D. 0.27 ± 0.05 
MT2 (48 h) 0.29 ± 0.03 7.68 ± 0.49 0.02 ± 0.00 0.27 ± 0.02 
MT1 (48 h) 0.26 ± 0.02 15.29 ± 0.33 0.04 ± 0.00 0.22 ± 0.01 
4-HBz 
(5 mM) 
KT2440 0.39 ± 0.02 N.D. N.D. 0.39  ± 0.01 
MT2 0.34 ± 0.03 5.73 ± 2.16 0.02 ± 0.01 0.32  ± 0.03 
MT1 0.31 ± 0.03 17.65 ± 3.30 0.05 ± 0.01 0.26  ± 0.03 
Table 26. PHA production of strains MT1 and MT2 using aromatic compounds compared with the 
wild type strain KT2440. In all the cases except where noted the PHA content was obtained after 24 h of 
growth. In all the cases the C/N ratio: 1.12 mol / mol was maintained. N.D.: not detected 










MT1 0.66 ± 0.19 7.66 ± 1.35 80.75 ± 4.56 3.48 ± 1.11 6.79 ± 1.54 
MT2 0.60 ± 0.11 5.69 ± 0.57 83.27 ± 2.15 2.85 ± 0.35 7.50 ± 1.28 
Table 27. PHA monomeric pattern after 24 h of growth under M63 minimal medium supplemented with 5 





Figure 67. Phase contrast microscopy pictures after 24 h of growth under the corresponding 
conditions. The C/N ratio was maintained at 2 mol/mol. With arrows the PHA granules are indicated. 
KT2440, MT1 and MT2 are shown in blue, green and purple colors respectively. The scale bar is 2 μm. 
 
4.3.8 Optimal chassis for in vivo PHA production from cheap carbon 
sources 
 
Lignin valorization and plastic degradation towards high-value added bioplastics, 
PHA is an interesting and promising biotechnological field. However, PHA production 
from these recalcitrant carbon sources is extremely challenging for scale-up processes. 
This is mainly due to the scarce accesibility of these aromatic compounds as industrial 
feedstock, since there are found in form of complex polymers, such as PET or lignin. 
Furthermore, since almost 50% of the PHA production costs are dependent on the 
applied carbon source, cheap and abundant substrates are desirable for industrial scale 
PHA production. For this purpose, we faced the challenge of expanding the PET4 design 
(MM16 strain) for PHA production from aromatics to inexpensive and abundant 
substrates, such as sugars. In order to test whether this was the case, a series of 
phenotypic assays were realized under balanced growth conditions supplemented with 
10 mM glucose or 20 mM glycerol.  
No PHA accumulation was observed under balanced medium conditions 
supplemented with 10 mM glucose, from the parental strains, KT2440 Δpha and MM19, 
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since these two strains lack of a functional pha cluster. Additionally, under these 
conditions the growth-coupled PHA MT1 strain, reached 27.5% PHA, being 17.5 fold 
higher than that produced by wt (Figure 68 and Table 28). Surprisingly, the KT2440 Δpha 
background mutant, MT2 exhibited 14% PHA, respectively, being 8.9 times increased 
compared to the wt. Since glucose is a PHA-unrelated carbon source, the de novo fatty 
acid synthesis is used for PHA production (Table 29). As it would be expected, MT1 and 
MT2 strains had higher flux through the de novo fatty acid synthesis, due to the presence 
of the optimized pha synthetic operon. In fact, almost 20% higher amounts of C10 
monomers were observed in the MT1 and MT2 strains compared to wild type strain 
(Table 29).  
 
Figure 68. Phase contrast microscopy pictures after 24 h of growth under M63 10 mM glucose. The 
C/N ratio was maintained at 2 mol/mol. With arrows the PHA granules are indicated. wt (KT2440), Δpha 









KT2440 0.91 ± 0.02 1.57 ± 0.89 0.01 ± 0.01 0.90 ± 0.01 
KT2440 Δpha 0.93 ± 0.01 N.D. N.D. 0.93 ± 0.00 
MM19 0.83 ± 0.04 N.D. N.D. 0.83 ± 0.03 
MT2 0.90 ± 0.02 14.04 ± 0.73 0.12 ± 0.01 0.76 ± 0.01 
MT1 0.57 ± 0.03 27.48 ± 2.45 0.15 ± 0.02 0.42 ± 0.02 
Table 28. Physiological data after 24h of growth under M63 10 mM glucose. The C/N ratio was maintained 
at 2 mol/mol. N.D.: not detected. 










KT2440 N.A. N.A. N.A. N.A.  N.A. 
MT1 0.67 ± 0.10 8.70 ± 0.56 77.99 ± 3.54 3.83 ± 0.95 7.62 ± 1.40  
MT2 0.67 ± 0.21 8.79 ± 2.17 79.11 ± 4.75 3.45 ± 1.70 7.33 ± 2.63 
Table 29. PHA monomeric pattern after 24 h of growth under M63 minimal medium supplemented with 5 
mM 4HBz (C/N ratio: 1.12 mol/mol). Traces of %OH-C14 (mM) were detected in MT1 and MT2 strains. Since 
the % PHA/CDW content of wild type strain is very low, in this case the PHA monomeric pattern 




No PHA production was observed from the wt strain under balanced medium 
conditions supplemented with 20 mM glycerol, in good agreement with previous 
observations from our group (Escapa et al., 2013). The addition of small amounts of 
glucose (1.33 mM, equivalent to octanoate concentration) or octanoate (1 mM) to the 
cultures of 20 mM glycerol, was necessary in order to avoid the long lag phase observed 
under glycerol growth conditions (Wang and Nomura, 2010; Escapa et al., 2013). 
Similarly, as it would be expected, wt, Δpha and MM19 strains did not show detectable 
amounts of PHA production under balanced medium conditions supplemented by 
glycerol (plus glucose or octanoate; Figures 69-70 and Tables 30-31). 
In addition, growth-coupled MT1 mutant and MT2 strain reached up to 30% and 
9.7% PHA, respectively, after 24 h of growth using glycerol and 1.33 mM glucose (Figure 
69 and Table 30). These PHA quantities correspond to significant and highly 
encouranging PHA production improvements under balanced medium conditions, 
compared to the wt strain.   
 
Figure 69. Phase contrast microscopy pictures after 24 h of growth under M63 1.33 mM glucose and 
20 mM glycerol. The C/N ratio was maintained at 2.26 mol/mol. With arrows the PHA granules are indicated. 
wt (KT2440), Δpha (KT2440 Δpha) strains. The scale bar is 2 μm. 








KT2440 1.02 ± 0.02 N.D. N.D. 1.02 ± 0.02 
MT2 0.96 ± 0.04 9.73 ± 1.11 0.09 ± 0.01 0.87 ± 0.02 
MT1 0.39 ± 0.05 29.98 ± 4.28 0.10 ± 0.03 0.28 ± 0.01 
Table 30. Physiological data after 24h of growth under M63 1.33 mM glucose and 20 mM glycerol. The C/N 
ratio was maintained at 2.26 mol/mol. N.D.: not detected. 
Moreover, high amounts of PHA were observed under balanced conditions using 
glycerol and 1 mM octanoate by MT2 strain reaching 14% PHA. Even higher amounts of 
PHA were observed by the growth-coupled MT1 strain, reaching up to 51.8% PHA after 
24 h of growth (Figure 70 and Table 31). Similarly, these PHA production properties 
were, by far, improved to the reported ones (Escapa et al., 2013). 
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Figure 70. Phase contrast microscopy pictures after 24 h of growth under M63 1 mM octanoate and 
20 mM glycerol. The C/N ratio was maintained at 2.26 mol/mol. With arrows the PHA granules are indicated. 









MM19 0.93 0.09 ± 0.12 <0.01 0.92  ± 0.00 
MT2 0.75 13.97 ± 4.07 0.11  ± 0.03 0.65  ± 0.03 
MT1 0.27 51.79 ± 3.06 0.14  ± 0.01 0.13  ± 0.01 
Table 31. Physiological data after 24h of growth under M63 1 mM octanoate and 20 mM glycerol. The C/N 
ratio was maintained at 2.26 mol/mol. 
Summing up, it can be concluded that MT1 and MT2 strains have the catabolic 
potential expanded, being able to use cheap PHA unrelated compounds as sole carbon 
source, while accumulating significant amounts of PHA under nutritional balanced 
conditions. However, from the observed PHA data, it could be suggested that the PHA 
productivity remained the same among MT1 and MT2 strains, since similar PHA (g/L) is 
obtained. Even though, higher %PHA/CDW is produced in MT1 strain compared to MT2 
and wild type strains, its low residual biomass is a disadvantage for further scale up 
processes.    
 
4.3.9 Expanding the growth-coupled designs to non-native carbon 
sources 
 
In order to expand the repertory of suitable substrates to produce PHA, to non-
native carbon sources such as sucrose, the genes needed for its degradation were 
additionally added to the previous recombinant strains.  
In brief, a subcloning of the cscAcscB genes to pSEVA621 was performed, 
resulting to pMM66 plasmid. MT1, MT2 and KT2440 strains were electroporated with the 
obtained pMM66 plasmid resulting to MT9, MT10 and MT11 strains, respectively 





Figure 71. Schematic representation of the pMM66 plasmid constructed for sucrose degradation. 
The genes needed for the sucrose degradation (cscA, cscB; in dark green colors) are based on previous 
work realized in E. coli W (Archer et al., 2011; Sabri et al., 2013). The J23106 and J23116 are the promoters 
used in this work, based on the available Anderson library http://parts.igem.org/Promoters/Catalog/Anderson 
(Iverson et al., 2016); BCD12 and B0033m are the RBS and B0015 the terminator used in this case (Mutalik 
et al., 2013).  
The cells were grown under balanced conditions supplemented with 5 mM 
sucrose. Similarly to glucose, the wild type strain, MT11 was not able to accumulate 
PHA, while the growth-coupled mutant, MT9 exhibited 34.5% PHA/CDW production after 
24 h of growth versus the 17.8% PHA/CDW produced by the MT10 strrain (Figure 72 
and Table 32). These PHA quantities obtained by MT9 and MT10 strains were highly 
improved to the wild type.  
 
Figure 72. Phase contrast microscopy picture after 24 h of growth under M63 5 mM sucrose. The C/N 
ratio was maintained at 2 mol/mol. With arrows the PHA granules are indicated. The scale bar is 2 μm. 








MT11 0.79 ± 0.00 N.D. N.D. 0.79 ± 0.00 
MT10 0.31 17.74 ± 1.12 0.05 ± 0.00 0.25 ± 0.00 
MT9 0.30 ± 0.04 34.47 ± 1.98 0.10 ± 0.01 0.20 ± 0.02 
Table 32. Physiological data after 24h of growth under M63 5 mM sucrose. N.D.: not detected 
In summary, MT1 not only can be considered as a great candidate for PHA 
production using several aromatic and cheap substrates under balanced growth 
conditions, but it is a nice example of how the application of a DBTL cycles can improve 
significantly biotechnological output. However, further DBTL runs targeted on strain 
optimization via additional genetic iterations and/or evolutionary engineering via 
Adaptive Laboratory Experiments (ALE) could be performed to ameliorate certain growth 
parameters such as growth rate, biomass yield and PHA production (Fong et al., 2005b; 
Conrad et al., 2011; Dragosits and Mattanovich, 2013). 
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5 INTEGRATED DISCUSSION 
 
PHA are biodegradable polymers with similar properties to the petrochemical 
derived polymers. There is an increasing interest over the years about their production 
and the molecular basis of the PHA metabolism regulation. PHA are reserve storage 
granules generally considered to play a role as sink for carbon and reducing equivalents 
when other nutrients are limited (De Eugenio et al., 2010a; Prieto et al., 2016). The 
buffering role of PHA cycle by maintaining active the recirculation of key metabolites of 
central metabolism has been proposed previously (Ren et al., 2009; De Eugenio et al., 
2010a; Nogales et al., 2017). As it will be discussed, this characteristic could provide 
stability in fitness and metabolic robustness under fluctuating environmental conditions.  
In this Doctoral Thesis, we checked the impact of tuning the flux through the PHA 
cycle in conferring metabolic robustness to P. putida KT2440 physiology (Results 
chapter 1). Among the mechanisms providing biological robustness, the redundant 
(alternative) mechanisms have been also proposed (Kitano, 2004). The presence of two 
isocitrate dehydrogenase isoenzymes in P. putida KT2440 was investigated (Results 
Chapter 2). In the final Results chapter, recombinant microorganisms have been 
obtained, able to reroute the carbon flux provided by recalcitrant and inexpensive 
abundant carbon sources towards high-value added product production, such as PHA.  
 
5.1 Chapter 1: PHA cycle tuning contributes to P. putida 
KT2440 metabolic robustness 
 
In this chapter, we focused on the effect of PHA cycle on the overall metabolism, 
as biological robustness in P. putida KT2440. For this purpose several mutant strains on 
key pha genes were obtained. First of all, in order to avoid the PHA cycle turnover in P. 
putida cells, the phaZ depolymerase null mutant strain (KT40Z) was constructed and the 
absence of polar effects on downstream pha genes was verified by qRT-PCR 
experiments (Figures 22-23). Higher phaF and phaI transcription levels were observed 
in KT40Z null background compared to wild type strain (Figure 23). Similar observation 
was reported previously by Cai and collaborators (Cai et al., 2009), where the phaC2 
transcription levels were higher in the phaZ null mutant compared to the parental KT2442 
strain under PHA accumulation conditions, probably due to the higher amounts of PHA 
in the phaZ null mutant strain. Additionally, in order to avoid the whole pha cluster 
complex native regulation, a null pha strain was obtained and used as a control strain in 




To increase the flux through the phaZ depolymerase reaction, a battery of strains, 
M0 to M4 driving differential phaZ depolymerase expression levels were constructed in 
a KT40Z background (Figure 24 and Table 5). The resulting strains were further validated 
by Western blot experiments (Figure 25) and, as it would be expected, the PhaZ 
production levels were correlated to the strength of the applied promoters (Zobel et al., 
2015).  
To investigate the impact of tuning the PhaZ production levels on the carbon 
metabolism of the cell, a battery of phenotyping analyses were performed under PHA 
mobilization and PHA accumulation conditions (Figures 26-28). Under the former 
conditions, where the PHA degradation is favored, no major differences were observed 
in all the strains tested, in terms of growth characteristics (growth rate, viable cell 
number, cell size) (Figure 26 and Table 6). For instance, as it could be expected, the 
only strain able to accumulate PHA content after 24 h of growth under these conditions 
was the KT40Z, since the phaZ depolymerase was not present to degrade the polymer, 
reaching up to 29% PHA (Figure 26 and Table 6).  
However, under PHA accumulation conditions large differences were found 
regarding the PHA accumulation properties of the different cells tested. In fact, with 
higher PhaZ production levels, the trend was towards no PHA accumulation, resulting to 
one log increase in viable cell number and twice smaller cell size (Figure 27). Similar 
observations have been described previously in pha mutant strains (De Eugenio et al., 
2010a). Furthermore, the strains with higher PhaZ production levels, favored the PHA 
degradation resulting in releasing free monomers ((R)-HAs; Tables 7-10) to the culture 
medium supernatant. These results are in accordance to previous observations from our 
laboratory with a phaZ overproduction strain in P. putida KT2442 (De Eugenio et al., 
2010a) and in P. putida U by (Sandoval et al., 2005). Interestingly, after 24 h of growth 
under PHA accumulation conditions, we were able to produce 2.5 times more (R)-HAs 
in the M2-M4 strains compared to the wild type. Additionally, the strains with higher PhaZ 
expression levels (M2-M4) had less total biomass due to no PHA production, that results 
in loss of carbon either in form of accumulation of extracellular metabolites or in an 
increased CO2 production. In order to  check the accumulation of metabolite originated 
from an unbalanced carbon metabolism, the culture supernatant of the strains after 24 h 
of growth under PHA accumulation conditions was analyzed by HPLC. However, no 
significant amounts of any of the metabolites tested were detected, as reported 
previously in other pha mutant strains (Escapa et al., 2012).  
To get a glance of the impact of PHA cycle tuning on the overall P. putida 
metabolism, the experimental data (Tables 7-10 and Figures 27-30) were contextualized 
in the in silico iJN1411 genome-scale model. In order to cover the whole range of growth 
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phases (A, B, C) observed, three condition-specific models for each strain were 
constructed (Figures 29 and 31). Based on the results observed in Figure 31, it can be 
concluded that the in silico model iJN1411 predicts accurately what is happening in vivo 
and it is a useful tool in order to study the metabolism. Previous metabolic flux analysis 
using stoichiometric model for a pseudo steady state period (4-8.5 hours of growth under 
PHA accumulation conditions) of KT2442 and KT42C1 strains has been performed in 
our group (Escapa et al., 2012). To be best of our knowledge, this is the first study where 
a detailed in silico modeling of PHA metabolism was performed throughout the whole 
growth curves including different growth phases. 
 By flux analyses such as random sampling of Monte Carlo (Schellenberger and 
Palsson, 2009), we studied how PHA cycle tuning affects P. putida metabolism. 
Modifying the PHA cycle leads to significant metabolic changes (Figure 31), which are 
reflected on the differential strains response throughout the growth phases A, B and C 
(Figures 32-35 and Supplementary Tables S8-S10). Interestingly, the null phaZ (KT40Z) 
and M1 (strain with low PhaZ levels) strains have higher flux through key reactions 
affecting the TCA cycle, the energy conservation and the CO2 production compared to 
wild type strain, during the growth phase A (Figure 32 and Table S8). Thus, these strains 
could be a promising tool for metabolic engineering processes affecting the TCA cycle 
such as, TCA metabolite production, e.g., succinate or proteinogenic amino acids 
(Molina-Henares et al., 2010) 
Furthermore, the strains with higher PhaZ levels maintained higher flux distribution 
through key reactions involved in gluconeogenesis, β-oxidation, TCA cycle, energy 
generation and CO2 production compared to wild type strain during phase C (Figure 34 
and Table S10). Thus, these P. putida recombinant cells were still metabolically active 
even during stationary phase, an interesting and promising quality that it could be useful 
for maintaining the cells alive for longer periods. Maintenance of viability is a desirable 
feature for prokaryotic cell array assays, as tools in toxicity testing (Elad et al., 2008). 
Additionally, these strains could demonstrate higher resistance to environmental 
stresses and they could be a valuable tool in experiments using resting cells. Finally, this 
library of strains with tuning PhaZ production levels exhibited higher (R)-HAs monomers 
production compared to wild type strain and they could be promising biotechnological 
candidates for scaling up process to produce these enantiopure products.  
The (R)-HAs monomers have been considered really valuable substrates, since 
they can be used as building blocks for a variety of biotechnological applications such 
as, for the synthesis of antibiotics, polyesters, vitamins, flavors and pheromones (Ruth 
et al., 2007; De Eugenio et al., 2010a).  It was also reported that some (R)-HAs could 




De Eugenio et al., 2010a; Koskimäki et al., 2016). Furthermore, It was reported that 
intracellular concentration of 3HB monomer in C. necator was 16.5 times higher than in 
mutant incapable of PHA biosynthesis, serving as a potent chemical chaperone 
protecting proteins and other molecules from denaturation during low and high 
temperatures, heavy metals and oxidative stress. It was also proposed to be an efficient 
cryo-protectant (Obruca et al., 2016a; Obruca et al., 2016c). To test if (R)-HAs could 
protect against oxidative stress in P. putida KT2440, the sensitivity to oxidative stress 
was checked in plate assays. In fact, in both growth conditions, these preliminary results 
showed that the M4 strain resulted in 1.3 to 1.5 more tolerance to oxidative stress 
compared to the other strains tested (data not shown).  
Key interrelated aspects to be considered for a competitive (R)-HA production at 
large scale are substrate cost, product purification and strain fitness. Previous studies in 
our laboratory characterized a KTZ1 strain able to produce 10 fold higher amounts of 
(R)-HAs than the wild type strain, in a regulable expression system driven by Pm/XylS 
inducible by benzoate. This strain was suggested to be an interesting biotechnological 
candidate for scaling up process (De Eugenio et al., 2010a). In the M4 strain, the 
expression levels of phaZ are under the control of a constitutive strong promoter (14g) 
without the need of external inductor and its chromosomal location is known due to the 
specific integration event using mini-Tn7 system compared to mini-Tn5 in the case of 
KTZ1 strain, that it was inserted randomly. Thus, the M4 strain could also be an 
interesting tool for large-scale production of HAs and further biotechnological 
applications. 
It could be concluded that by modulating the carbon flux through the PHA cycle, 
Pseudomonas putida physiology could be varied. PHA metabolism balances global 
biomass, including PHA carbon/energy storage, cell division and energy spillage. It acts 
as a metabolic buffer cycle by absorbing and releasing carbon as required. Thus, PHA 
is not only a source of carbon during carbon starvation (Obruca et al., 2016b), but rather 
a key element in resource balancing that guarantees efficient growth.  
The impact of PHA cycle in cell physiology and stress resistance has been studied 
previously in several microorganisms (Introduction section 1.5 and reviewed recently by 
(Obruca et al., 2018)). There are controversial studies on whether just the presence of 
PHA granule (Goh et al., 2014), or the ability to accumulate and/or mobilize the PHA 
could attribute to stress resistance. For instance, it was reported that just the presence 
of PHA granules provided protection against oxidative stress provoked by photoactivated 
TiO2 in Delftia acidovorans. Additionally, it cannot be discarded that phasins were 
involved in conferring resistance to stress (due to the chaperone-like activity), apart from 
their primary function to cover the PHA granule. This might contribute to the protective 
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mechanism of PHA in their natural producers. Protective effect of the PHA granules was 
observed in engineered strains where the phasins and depolymerase were absent 
(Wang et al., 2009; Goh et al., 2014). Thus, in this work it is proposed that PHA cycle in 
P. putida KT2440 contributes to metabolic robustness.  
 
5.2 Chapter 2: Isocitrate dehydrogenase isoenzymes play a 
crutial role in P. putida KT2440 robustness 
 
Among the alternative mechanisms of robustness, the gene functional redundancy 
properties have been proposed (Kitano, 2004; Nogales et al., 2017). The existence of 
more than one similar mechanisms that can replace each other when needed, such as 
response to environmental perturbations, guarantees the integrity of the whole system. 
In this work, the presence and physiological roles of isocitrate dehydrogenase 
isoenzymes (PIDH) in P. putida KT2440 have been studied. 
Isocitrate dehydrogenase is a key enzyme of the TCA cycle, highly conserved and 
widely observed from bacteria to humans. Generally speaking, there are two isocitrate 
dehydrogenases; the NADP+-dependent IDH and NAD+-dependent IDH (majorly found 
in eukaryotic organisms). NADP+-dependent IDH could either form a dimeric structure 
composed of identical subunits of 40-50 kDa or/and monomeric one with molecular 
weight of 80-100 kDa (Gálvez and Gadal, 1995).  
From evolutionary studies, it was suggested that the eubacterial NADP+-isocitrate 
dehydrogenase was evolved from NAD+-IDH about 3.5 billion years ago as a result of an 
adaptive event (Dean and Golding, 1997). Most prokaryotic IDHs (PIDH) are NADP+-
dependent. It has been proposed that this coenzyme discrimination has a biological 
significance. For instance, bacteria able to grow on acetate, generate up to 90% of the 
NADPH necessary for biosynthesis by using NADP+-PIDH. However, bacteria harboring 
NAD+-IDH variants such as the obligate methylotroph Methylobacillus flagellatus are not 
able to grow on acetate and lack either a respiratory chain or a complete TCA cycle due 
to absence of an α-ketoglutarate dehydrogenase (Romkina and Kiriukhin, 2017). 
Following this different cofactor usage, in the recent years, there is a great interest 
towards the coenzyme specificity swapping by site-directed mutagenesis such as on E. 
coli or Bifidobacterium longum (Huang et al., 2016; Armingol et al., 2018). This was 
possible due to the identification of the amino acid that confers NADP+-coenzyme 
specificity based on the available crystal data (Tables 11-12). In fact, the key amino acid 
responsible for the NADP+-specificity are for the dimeric ICD of E. coli Arg292´, Lys344, 




Tyr345 (Chen et al., 1997; Chen and Yang, 2000), while for the monomeric IDH of A. 
vinelandii were the Arg358, Lys588, His589 and Arg649 (Yasutake et al., 2002, 2003).  
Furthermore, the majority of prokaryotes tend to have only one type of PIDH mostly 
dimeric, such as E. coli, or monomeric, such as A. vinelandii. Multiple alignment of the 
dimeric and monomeric PIDH from the widely studied organisms was performed (Figures 
41-42). These two types of PIDH share only 8% of identity in amino acid structure-based 
sequence alignment. This could apply that both PIDH have evolved convergently. 
However, Yasutake and collaborators, suggested that monomeric IDH may have evolved 
through the duplication of domains (B-C) in an ancestral dimeric ICD. Using the available 
crystal data of A. vinelandii, it was observed that the amino acid residues responsible for 
the binding of isocitrate and metal cation are identical between the monomeric and 
dimeric PIDH (Figures 41-43 and Tables 11-12). The interaction of the monomeric IDH 
with NADP+ should be different from the dimeric ICD, since the amino acid residues are 
not completely identical in both PIDH (Yasutake et al., 2002, 2003). 
Interestingly, some organisms possess both types of PIDH such as C. maris, C. 
psychrerythraea strain NRC1004 or 34H and P. psychrophila (Ochiai et al., 1979; Maki 
et al., 2006; Matsuo et al., 2010). Having two PIDH was majorly found in psychrophilic 
microorganisms, providing them probably advantage to survive in these extreme 
environments (Ochiai et al., 1979; Ishii et al., 1993; Suzuki et al., 1995; Watanabe et al., 
2005; Yasuda et al., 2013; Kobayashi and Takada, 2014). Studies on the C. maris and 
C. phychrerythraea concluded that the dimeric ICD were typical mesophilic and acetate 
induced enzymes, while the monomeric IDH were cold-adapted and thermolabile. 
Furthermore, different promoters independently regulated the two PIDH (see Figure 37 
for their DNA chromosomal location). However, this cannot be taking as an universal 
rule. For instance, in the case of P. psychrophila both PIDH were mesophilic enzymes 
with slight inductions by cold or acetate in the expression of monomeric and dimeric 
PIDH, respectively (Matsuo et al., 2010).  
At the beginning of this study, we found interesting the fact that P. putida KT2440 
also possesses two PIDH, despite the fact that it is mainly a characteristic observed in 
psychrophiles. Until now, there is not enough information available about these PIDHs 
in pseudomonads and has not been studied on P. putida KT2440. We confirmed that 
both PIDH genes were transcriptionally active in P. putida and the expression of these 
enzymes was carbon source dependent (Figures 38-39). Additionally, it seems like there 
is a clear preference towards the monomeric idh, since it exhibited higher transcription 
levels than the dimeric icd in all the conditions tested by qRT-PCR experiments (Figure 
39).  
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In order to study the physiological importance of this enzyme duplication, we 
proposed to construct single and double deletion mutants of these PIDH. Unfortunately, 
only the dimeric ICD deletion mutant was obtained (PP_4011), resulting to MM18 strain. 
A similar result was observed in Mycobacterium tuberculosis, where Murina and 
collaborators concluded that maybe the monomeric isocitrate dehydrogenase is 
essential for the microorganism growth (Murima et al., 2016). However, checking for 
gene essentiality studies in P. aeruginosa, different transposon insertions mutants were 
identified, suggesting that the monomeric idh in P. aeruginosa and probably in P. putida 
is not an essential gene (Jacobs et al., 2003; Lewenza, 2005). Moreover, the PIDH are 
not among the conditionally essential genes for growth identified in P. putida KT2440 
(Molina-Henares et al., 2010). Finally, there are not considered as possible bottleneck 
for the strain performance, since there were not among the 300 genes deleted by 
Martínez and collaborators (Martínez-García et al., 2014).  
Phenotypic evaluation of growth performance of dimeric icd deletion mutant, MM18 
strain using several carbon sources, resulted in no major differences when compared to 
wild type strain (Figure 40). Since several deletions attempts of the monomeric IDH were 
fruitless, we tried to get closer to the metabolic role of these enzymes through enzymatic 
approaches. Thus, the monomeric idh and dimeric icd genes of P. putida were 
heterologously overexpressed in E.coli by using pET29a vectors and His tagged 
purification of both PIDH was performed. In this work, we addressed the identification 
and confirmation of the catalytic sites determinant for the enzymatic activity of the 
monomeric IDH. Therefore, by site-directed mutagenesis on Ser133Ala, Asn136Ala and 
Arg140Ala in the monomeric IDH (PP_4012mut strain; Figures 43-44 and Table 13), the 
enzymatic activity was lost completely, demonstrating that these predicted amino acid 
residues were critical for the IDH enzymatic activity in P. putida KT2440. Previous work 
on C. glutamicum, demonstrated that the mutant Lys253Met in the monomeric IDH, lost 
its enzymatic activity too (Chen and Yang, 2000). 
During the realization of this study, two interesting works have been published in 
M. tuberculosis and P. aeruginosa possessing both PIDH (Murima et al., 2016; Crousilles 
et al., 2018). Comparing the monomeric IDH of both organisms to that of P. putida, 60.3% 
(M. tuberculosis) and 66.3% (P. aeruginosa) of identity was observed. Under standard 
assay conditions, the monomeric IDH had more specific activity than the dimeric ICD, 
which is in accordance to previous observations in P. psychrophila (82.1% identity) 
(Matsuo et al., 2010). Furthermore, the monomeric IDH (PP_4012) presented higher 
values of turnover (kcat) and catalytic activity (kcat/Km) than the dimeric ICD (PP_4011). 
However, opposite results have been described in P. aeruginosa (Crousilles et al., 2018). 




between monomeric and dimeric isoenzymes, which is in accordance to previous 
observations in P. aeruginosa (Crousilles et al., 2018). The low Km values for NADP+ 
indicate the clear preference towards it. Finally, higher Km values for isocitrate have 
been observed in the monomeric IDH compared to the dimeric one. These km values for 
isocitrate in the case of the monomeric IDH have been higher than the previously 
reported in C. glutamicum, A. vinelandii and P. aeruginosa (Chen and Yang, 2000; 
Watanabe et al., 2005; Crousilles et al., 2018).  
In the recent years, there is also an interest on determining the key amino acid 
residues responsible for the thermal properties of the monomeric IDH (Watanabe et al., 
2005; Matsuo et al., 2010; Kobayashi and Takada, 2014). Matsuo and collaborators 
identified some different key amino acid residues between the mesophilic and cold-
adapted monomeric IDH of P. psychrophila and C. maris (and C. psychrerythraea) 
respectively (Matsuo et al., 2010). Between those amino acids His158Asn, Pro490Glu, 
Glu595Lys and Pro709Ala, but only the Glu55Lys resulted in the decreased 
thermolability, suggesting that Glu55 is involved in the mesophilic properties of P. 
psychrophila monomeric IDH. All these residues are also conserved in P. putida KT2440, 
explaining the mesophilic properties of monomeric IDH. A recent update of the amino 
acids responsible for the thermal properties in C. maris y P. psychrophila is available 
(Nagai and Takada, 2019).  
So far, it is not clear why P. putida KT2440 has two PIDH and how it is regulated 
the competition for isocitrate by ICL and the two PIDH. In the recent work by Crousilles 
and collaborators in P. aeruginosa showed that the AceK, encoding the ICD 
kinase/phosphatase, phosphorylates and inactivates at 75% the dimeric ICD and not the 
monomeric IDH. This is due to structural differences on the P-loop and AceK recognition 
segment which are absent in monomeric IDH (Crousilles et al., 2018). They also 
proposed a “rheostatic control”, where high amounts of gluconeogenic precursors such 
as succinate and glyoxylate could inhibit ICL and activate the AceK phosphatase activity 
by stimulation of ICD activity and therefore greater flux through the TCA cycle for 
biomass production. However, the opposite result is obtained with low amounts of 
oxaloacetate and pyruvate that inhibit ICD by activating ICL when there is an increase 
demand of gluconeogenesis. Finally, another “rheostat mechanism” was described in M. 
tuberculosis that also possesses ICL, ICD and IDH but lacks AceK (absence of ICD 
phosphorylation) (Murima et al., 2016). Murima and collaborators demonstrated that only 
the monomeric IDH has an important physiological role under all the conditions tested 
and there is a “cross-activation” of the IDH by the glyoxylate partitioning the flux between 
the TCA cycle and the glyoxylate shunt. It is possible that this is the case for the 
  Integrated Discussion 
                                                                             171 
 
monomeric IDH of P. putida KT2440. Further investigation needs to be realized in order 
to figure out the physiological importance of the two PIDH in P. putida KT2440.   
 
5.3 Chapter 3: P. putida KT2440 strains overproducing PHA 
from PHA unrelated carbon sources 
 
PHA are accumulated in microorganisms as energy and carbon source stores 
under unbalanced nutritional conditions, mainly including an excess of carbon together 
the lack of other nutrients (such as phosphorus, nitrogen, and oxygen). A large effort has 
been done to optimize the production of PHA by using chemical or metabolic engineering 
approaches.  
Over the past decade, one crucial design principle for metabolic engineering and 
computational strain design is to couple cellular growth with the production of a desired 
functionality (metabolite/growth). The goal is to make the desired metabolite a mandatory 
by-product of growth and its production an integral part of the organism´s metabolic 
function. Thus, growth of the organism becomes a driving force of production (von Kamp 
and Klamt, 2017). This dependent production usually possesses a burden on the 
organism resulting to longer lag phases and less growth rates than the wild type strains. 
In this way, without coupling the functionality that is needed for production, it could be 
lost from a production strain, that adapts to a higher growth rate at this functionality. 
Finally, when a growth-coupled strain has been designed, its production capabilities 
could be improved through ALE by selecting for maximum growth or desired metabolite 
production. A variety of E. coli mutant strains has successfully been constructed using 
growth coupling approaches for the production of lactic acid (Fong et al., 2005a), ethanol 
(Trinh and Srienc, 2009), malonyl-CoA (Xu et al., 2011) and itaconic acid (Harder et al., 
2016), among others.  
In this Doctoral Thesis, growth-coupled strategies were used to obtain PHA 
overproducer P. putida strains. Previously other works involving Pseudomonas strains 
have been described. For instance, the growth of Pseudomonas pseudoalcaligenes in 
jewelry industry wastewater containing cyanide was coupled to PHA production in batch 
reactors (Manso Cobos et al., 2015). Recently, in P. putida KT2440 coupling the growth 
to PHA production was realized on fed-batch cultures from a mixture of fatty acids (Andin 
et al., 2017). In this work, the P. putida growth was coupled to PHA production by using 
non-PHA related carbon sources, such as aromatic compounds derived from lignin or 
PET degradation processes. The mutant strains are forced to produce PHA in order to 




Our growth coupled designs were based on blocking the succinate and acetyl-CoA 
metabolism, the TCA cycle, the PHA metabolism and amino acid metabolism. These 
deletions focused on rerouting the carbon flux towards the PHA production (Figure 54). 
An in vivo validation of the sequential deletion mutants was realized after 24 h of growth 
using M63 minimal medium supplemented by 3 mM octanoate and 5 mM 4-
hydroxybenzoate (Figure 60 and Table 22). Key reactions that led to a PHA production 
increase were succinyl-CoA synthase sucC, D and isocitrate lyase aceA. Even though, 
the beneficiary role of aceA to PHA production was previously proposed (Klinke et al., 
2000), the deletion of sucCD genes related to improved PHA capabilitites. Finally, the 
resulting MM16 strain produced 4.8 times more PHA than the wild type strain, in terms 
of % of CDW (Figure 60 and Table 22) under balanced growth conditions and this PHA 
originated from the β-oxidation pathway (Table 23).  
As confirmed by qRT-PCR experiments (Figure 61), the transcription levels of key 
enzymes for PHA production from non-fatty acid precursors were downregulated in 
MM16 strain compared to KT2440 and KT40Z strains. This phenotype was expected, as 
metabolic models do not take into account regulation processes. In order to obtain an 
optimized expression of  the key enzymes responsible for PHA production, the phaC1, 
phaF, phaG and PP_0763 genes were overexpressed under the constitutive SynPro16 
promoter, using Golden-Gate Moclo approaches (Figures 64-65) (Engler and 
Marillonnet, 2011; Tiso et al., 2016). The resulting MT1 and MT2 strains were tested for 
PHA production using M63 minimal medium supplemented with aromatic compounds 
derived of lignin or PET hydrolysis (Figure 66 and Tables 24-26). MT1 accumulated 14.7-
19.7% of PHA/CDW under these conditions compared to 4.1-7.8% of MT2 and traces of 
KT2440 (Table 26).  
Previous work in E. coli have shown that the co-expression of acyl-CoA ligase 
PP_0763 with phaG from P. putida KT2440 led to an increase on the PHA production 
from glucose, as sole carbon source (Q. Wang et al., 2012). Recently, recombinant P. 
putida strains have been obtained, able to produce high yields of PHA from aromatic 
compounds and lignin. In fact, these strains lacked the phaZ and the fadBA genes, 
involved in PHA depolymerization and β-oxidation pathway, respectively (Salvachúa et 
al., 2020). Additionally, in order to increase the flux towards PHA production, Salvachúa 
and collaborators, realized a codon-optimized overexpression of the phaC1, phaC2 
synthases, phaG and PP_0763 genes. This construct was overexpressed under the Ptac 
promoter and chromosomically integrated in the PP_0545 region of P. putida (Salvachúa 
et al., 2020). These recombinant microorganisms reached significant amounts of PHA 
(0.95 g/L) after 72 h of growth under N limited conditions supplemented by p-coumaric 
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acid (C/N ratio: 55.6 mol/mol, Table 33). To favor the PHA production fed-batch and high-
cell-density approaches were applied (Salvachúa et al., 2020). 
Growth and PHA production from lignin derived and enriched compounds (APL) 
combined with nitrogen limitation have been studied before in P. putida KT2440 (Linger 
et al., 2014; Salvachúa et al., 2015; Beckham et al., 2016; Ravi et al., 2017) and P. putida 
Gpo1 and P. putida JCM 13063 strains (Tomizawa et al., 2014). Selected examples 
describing PHA production from lignin-derived aromatic substrates are listed in the Table 
33.  
In fact, during the realization of this study, several works have been published 
using different lignin derived substrates. Two different studies have been performed in 
P. putida A514 focusing on lignin valorization towards PHA production (Lin et al., 2016; 
X. Wang et al., 2018). These authors designed three functional modules affecting the 
dye peroxidase-based enzymatic system, several peripheral and central catabolism 
pathways and up–down regulated the β-oxidation and the de novo fatty acid synthesis, 
respectively. As a result, they reached up to 37% (under N excess) and 73% (under N 
limitation) of cell dry weight PHA production from M9 minimal medium supplemented 
with 15 mM vanillic acid. However, this study provided incomplete data as far as it 
concerns the conditions of PHA production and its corresponding characterization. The 
P. putida A514 strain was proposed as a more robust bacteria than other P. putida strains 
(such as CA-3) for PHA production under N excess (Lin et al., 2016). However, this 
Doctoral Thesis is the first study in P. putida KT2440 where PHA production is obtained 
from lignin derivated compounds without N limitation. The second study on P. putida 
A514 is more complete than the previous one, providing a battery of strains 
overexpressing the phaJ4 phaC1 genes or phaG alkK phaC1 genes under the 
constitutive Pvan or strong inducible PxylA promoter. The authors provide promising 
results under N excess and limitation conditions supplied by 15 mM vanillic acid (X. 
Wang et al., 2018). Some of these results are listed in the Table 33.  
In our work, the PHA properties characterization, suggested that the strains MT1 
and MT2 had the same PHA productivity (PHA production in g/L), even though the MT1 
strain reached higher %PHA/CDW. The low residual biomass of MT1 strain is a 
drawback compared to MT2 and wild type strain and an aspect to consider for further 
scale up processes. Therefore, MT1 strain is a great candidate for PHA production using 
several aromatic substrates derived from PET or lignin degradation. However, further 
strain optimization and possible ALE experiments should be performed to ameliorate 
certain growth parameters such as growth rate, biomass yield and PHA production (Fong 




















Batch (72 h) 0.21 Traces <1 (Tomizawa 
et al., 2014) 
P. putida Gpo1 Vanillic acid 
(59.5) 
Batch (72 h) 0.14 Traces <1 (Tomizawa 
et al., 2014) 
P. putida A514 Vanillic acid 
(14.9) 
Batch (50) 0.66 0.01 1.7 (X. Wang et 
al., 2018) 




Batch (50) 0.71 0.25 34.4 (X. Wang et 
al., 2018) 
P. putida A514 Vanillic acid 
(14.9) 
Batch (50) 0.13 0.02 17.3 (X. Wang et 
al., 2018) 




Batch (50) 0.18 0.01 66.3 (X. Wang et 
al., 2018) 
P. putida Gpo1 p-coumaric 
acid (61) 
Batch (72 h) 0.27 Traces <1 (Tomizawa 
et al., 2014) 
P. putida KT2440 p-coumaric 
acid (12.2) 
Batch (48 h) 0.47 0.16 34 (Linger et 
al., 2014) 




Batch (72 h) 0.38 0.16 41 (Salvachúa 
et al., 2020) 






0.48 0.24 50 (Salvachúa 
et al., 2020) 





HCD (85 h) 
1.76 0.95 54.2 (Salvachúa 
et al., 2020) 
P. putida Gpo1 Ferulic acid 
(51.5) 
Batch (72 h) 0.15 Traces <1 (Tomizawa 
et al., 2014) 
P. putida KT2440 Ferulic acid 
(10.3) 
Batch (48 h) 0.44 0.17 39 (Linger et 
al., 2014) 
P. putida Gpo1 4HBz (72.4) Batch (72 h) 0.22 Traces <1 (Tomizawa 
et al., 2014) 
Table 33. Selected examples describing mcl-PHA production from lignin-derived aromatic substrates 
using native and engineered pseudomonads strains. In all the cases N limitation was used except in the 
case of P. putida A514 strain (shown by shaded grey color).  
Nowadays, there is an increasing interest on the development of sustainable 
approaches towards PHA synthesis. For industrial scale PHA production, a significant 
factor to consider is the cost of the process. Several variables contribute to this cost such 
as the type of substrate, the microbial fermentation and the PHA extraction approaches, 
among others. The carbon substrate price account for about 50% of the overall 
production costs (Koller et al., 2010; Gomez et al., 2012). The choice of the adequate 
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carbon source strongly depends on the location of the inteded production plant, in order 
to save costs for transportation and facilities. Furthermore, the seasonal availability and 
in sufficient quantity of to be used resources are other factors to consider (Koller et al., 
2010). Thus, the need for PHA production from cheap substrates has arised, using waste 
streams alternatives, highly available in Europe. Moving towards economic feasibility, 
the PHA production prices are estimated below 2-3 €/kg (Koller and Braunegg, 2018). 
Previous works in different bacterial species successfully led to PHA production from 
industrial and agricultural substrates that do not require extensive purification steps, such 
as milk whey (Nikel et al., 2006; Bustamante et al., 2019), sugarcane molasses (Park et 
al., 2015; Löwe et al., 2017a; Löwe et al., 2017b) and biodiesel derived glycerol (Escapa 
et al., 2013; Fu et al., 2014; Beckers et al., 2016). Similarly, in this Doctoral Thesis we 
provided recombinant P. putida KT2440 microorganisms capable to transform 
inexpensive and available carbon sources to PHA production such as glycerol and 
sucrose.  
Over the last decade, it was observed an increased biodiesel production in several 
countries all over the world, with 85% coming from the European Union (www.ebb-
eu.org/studiesreports/EMISIA_Contribution_Biofuels_transport_sustainability.pdf). As a 
consequence, considerable amounts of its major side stream, glycerol have been 
generated, leading to a significant decrease in glycerol price (10 kg of crude glycerol is 
generated for every 100 kg of biodiesel produced). Thus, in order to improve the viability 
of biofuel industry, glycerol was applied as the preferred substrate in microbial 
fermentation processes (recently reviewed (Poblete‐Castro et al., 2019)). It has been 
demonstrated that glycerol facilitates the polymer synthesis over glucose or lactose, due 
to its higher degree of reduction (γ=4.7 vs γ=4 in glucose). Thus, since less carbon has 
to be oxidized into CO2 for reducing power generation, higher substrate yield could be 
available for PHA production (Gomez et al., 2012; Poblete‐Castro et al., 2019). There 
are several studies realized in pseudomonads, testing the impact of glycerol on growth 
performance, metabolic response, PHA production among others. The activation of both 
glucolytic and gluconeogenic pathways has been proposed by transcriptomic analyses 
using glycerol as carbon source (Nikel et al., 2014a). Some of the genes transcriptionally 
upregulated were the glycerol transport and catabolic genes (such as glp gene cluster) 
and an activation of gluconeogenic response has been observed. Additionally, 
alternative pathways for carbon processing have been downregulated including TCA 
cycle and gluconate/2-ketogluconate loop for hexoses oxidation (Nikel et al., 2014a).    
In order to expand the carbon substrates for PHA production, the engineered P. 
putida, MT1 and MT2 strains were used for further phenotypic analyses and PHA 




(Figures 68-70 and Tables 28-31).  Since glucose is not a PHA related substrate, P. 
putida KT2440 is able to reach from 13.4 to almost 25% PHA under PHA accumulation 
condition (Poblete-Castro et al., 2013; Fonseca et al., 2014). However, as it would be 
expected and previously reported, wild-type strain produced insignificant amount of PHA 
(less than 2%) under balanced growth conditions (Figure 68 and Table 28). Interestingly, 
the MT2 and MT1 strains reached up to 14% and 27.5% PHA production after 24 h of 
growth using 10 mM glucose, compared to the insignificant PHA amount observed by 
the wild type strain (C/N ratio: 2 mol/mol, Figure 68 and Table 28).  
Several P. putida recombinant strains were also tested for PHA productions using 
glycerol as carbon source. P. putida KT2440 grows slowly and with long lag phase, when 
glycerol is applied as sole carbon source (Wang and Nomura, 2010; Escapa et al., 2013). 
This long lag-phase can be avoided by co-feeding strategies, by supplying small 
amounts of octanoate and glucose, or by creating a glpR regulator knock-out mutant 
(Escapa et al., 2013). In this work, co-substrate of 1 mM or 1.33 mM of octanoate or 
glucose were applied, respectively allowing faster growth and higher PHA production 
(C/N ratio: 2.26 mol/mol; Figures 69-70 and Tables 30-31). In fact, MT2 and MT1 strains, 
reached up to 9.7% and 30% PHA/CDW after 24 h of growth using 20 mM glycerol 
supplemented by 1.33 mM glucose, while similar amounts of PHA were reached with 
octanoate adding (Figure 69 and Table 30).  
Selected bibliographic examples describing PHA production from glycerol are 
listed in the Table 34. A variety of PHA pattern was observed, probably due to the 










P. putida GO16 Fed-batch (48 h) 6.3 33 0.16 (Kenny et al., 2012) 
P. putida LS46 Batch (72 h) 0.6 16.3 0.02 (Fu et al., 2014) 
P. mosselii TO7 Batch (48 h) 1.3 9.9* N.A. (Liu et al., 2018) 
P. putida KT2440 Batch (72 h) 1.5 34.5 0.05 (Poblete-Castro et al., 
2014) 
P. putida KT2440 
ΔphaZ 
Batch (72 h) 2.0 46.8 0.07 (Poblete-Castro et al., 
2014) 
P. putida KT2440 Batch (46 h) 0.15 19 N.A. (Escapa et al., 2013) 
P. putida KT2440 
ΔglpR 
Batch (46 h) 0.34 34 N.A. (Escapa et al., 2013) 
Table 34. Selected examples describing mcl-PHA production from glycerol using native and 
engineered pseudomonads strains. * The %PHA varies depending glycerol concentration reaching up to 
48% when 12% glycerol was used. N.A.: not determined. 
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Wastes from lignocellulosic feedstocks, starch, or sugar industry such as molasses 
are abundant for industrial biotechnology demands. Since the sugar extraction is not 
economically viable process, low-grade molasses (inappropriate for food applications) 
have been used as alternative carbon substrates for PHA production by diverse Gram 
negative and positive bacteria (Gomez et al., 2012). Recently, recombinant C. necator 
strains reached up to 20% and 73% of PHA/CDW production, when cultured under 
defined medium containing 20 g/L sucrose (Park et al., 2015). During the realization of 
this work, engineered P. putida KT2440 strains were obtained conferring sucrose 
consumption (Löwe et al., 2017a). For this purpose, broad-host range mini-transposons 
were constructed bearing cscA and cscB genes of E. coli W encoding for the sucrose 
invertase and the sucrose permease, respectively. Interestingly, based on this system 
these authors successfully produced 0.16 g/L PHA applying a synthetic bacterial co-
culture composed of two-biomodules. From one hand the cyanobacterial strain 
Synechococcus elongatus bearing cscB gene, able to fix CO2 and convert it to sucrose 
and export it to the culture supernatant by the help of CscB. From the other hand, P. 
putida cscAcscB can efficiently metabolize the secreted sucrose and produce PHA 
(Löwe et al., 2017a). Aimed by these studies, similar recombinant P. putida strains were 
obtained in this Doctoral Thesis (MT9-MT11 strains; Figures 62 and 71) leading up to 
34.5% of PHA/CDW production using 5 mM sucrose under balanced medium conditions 
(Figure 72 and Table 32). So far, these are encouraging results for further scale-up 
approaches, however, further strains optimization need to be realized.  
Summing up, in this Doctoral Thesis, interactive designs combining the advances 
in synthetic and systems biology were applied in order to achieve the planned objectives. 
Then, recombinant microorganisms capable of producing high amounts of (R)-HAs were 
provided and P. putida´s physiology was varied depending on the PHA cycle dosis. The 
significance of the isocitrate dehydrogenase isoenzymes in the P. putida KT2440 
physiology leading to robustness properties, was studied. Finally, aimed by cutting edge 
synthetic biology approaches, a high number of gene knockouts and knockins was 
carried out, in order to systematically remove all the potential competing pathways and 
to reroute the carbon flux towards PHA production. Therefore, recombinant 
microorganisms capable of producing high amounts of PHA from unrelated and 
inexpensive carbon sources were provided. In fact, we used recalcitrant carbon sources 
derived from PET, PU or lignin hydrolysis (4-hydroxybenzoic acid, vanillic acid, p-
coumaric acid and phenylacetic acid) and cheap-abundant substrates (glucose, sucrose 
and glycerol). Furthermore, the engineered organisms are able to produce PHA in the 
absence of nutritional limitations. This constitutes a first evidence of P. putida producing 




envisioned PHA production bioprocess supported by these strains constitutes a 
significant improvement with respect to wild type strain.  However, further strains 
optimization, via metabolic engineering and ALE approaches, is a necessity for future 
scale-up processes. 
 







  Conclusions 




1. By finely modulating the carbon flux through the PHA cycle, we can gradually 
vary important physiological parameters in P. putida. Strains harboring high constitutive 
PhaZ depolymerase levels tend to have one log increase in the viable cell number, 
smaller cell size and increased (R)-HAs production compared to the wild type strain.  
2. High flux through the pha cycle drives a residual oxidative metabolism under 
stationary phase. This metabolism provides an increased capability of P. putida as 
biocatalyst at stationary phase.  
3. M4 P. putida strain, harboring the highest flux through PhaZ depolymerase, is a 
highly valuable biotechnological strain, as source of enantiopure (R)-HAs. 
4. P. putida has two genes coding for isocitrate dehydrogenase that are 
transcriptionally active under the conditions tested. The expression of these genes is 
carbon-source-dependent and there is a clear preference towards the monomeric IDH 
production. The presence of both isoenzymes likely responds to a robustness 
mechanism, focusing on functional redundancy.  
5. The biochemical characterization confirms the enzymatic functionality of both 
enzymes. Km values for the NADP+ could indicate clear preference towards this cofactor, 
compared to NAD+. Furthermore, we provide here the first experimental evidence 
supporting the role of residues Ser133, Asn136 and Arg140, as essential for the 
monomeric IDH activity.  
6. Genetic evidence based on the several fruitless deletion attempts of the 
monomeric idh, strongly suggested that this isoenzyme is an essential gene for P. putida 
under various growth conditions, irrespective of the functionality of the dimeric isoform. 
7. Model-driven designs of PHA-growth-coupled overproducing strains using 
complex polymers such as PET, lignin, PU and its monomers substrates have been 
successfully obtained in silico. PET4 is the best design for further in vivo implementation 
in terms of PHA yield, biomass-coupled product yield, number of knockouts and 
physiological feasibility. 
8. MM16 growth–coupled strain can efficiently produce PHA under balanced growth 
conditions due to the engineering carbon flux rerouting towards PHA production. While 
the PHA is produced in this strain via β-oxidation pathway, de novo fatty acid 
biosynthesis pathway is hampered by regulatory constraints under these culture 
conditions.  
9. MT1 strain is a great candidate for PHA production using several recalcitrant 




production. The superior performance of MT1 was achieved by avoiding the natural 
regulation of PHA gene cluster and by engineering a growth-coupled and constitutive 
expression of optimized synthetic genes required for PHA production.  
10. By expanding the natural metabolic versatility of P. putida towards new carbon 
sources, by using synthetic biology approaches, it has been possible to construct a P. 
putida strain, MT9, overproducing PHA using inexpensive and abundant disaccharides, 
such as sucrose, as carbon source under balanced growth conditions, reaching up to 
35% of PHA/cell dry weight production.  
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6     CONCLUSIONES 
 
1. La modulación precisa del flujo de carbono a través del ciclo de PHA permite 
variar parámetros fisiológicos clave en P. putida gradualmente de forma controlada. Las 
cepas que producen constitutivamente altos niveles de PhaZ tienden a aumentar un log 
el número de células viables, tienen un tamaño de célula más pequeño y presentan una 
mayor producción de (R)-HA, en comparación con la cepa de tipo salvaje.  
2. Un alto flujo metabólico a través del ciclo del PHA favorece la emergencia de un 
metabolismo oxidativo residual en la fase estacionaria. Esto proporciona a P. putida una 
mayor capacidad como biocatalizador en esta fase de crecimiento. 
3. La cepa P. putida M4, que presenta el flujo de carbono más alto dirigido por la 
despolimerasa PhaZ, es una cepa muy valiosa como fuente de (R)-HA desde un punto 
de vista biotecnológico. 
4. P. putida tiene dos genes que codifican la isocitrato deshidrogenasa, que son 
transcripcionalmente activos en las condiciones probadas, y su expresión depende de 
la fuente de carbono. Los resultados indican que existe una clara preferencia hacia la 
producción de la IDH monomérica. La presencia de ambas isoenzimas probablemente 
responde a un mecanismo de robustez basado en redundancia funcional.  
5. La caracterización bioquímica confirma la funcionalidad de ambas enzimas. Los 
valores de Km para NADP+, indica una clara preferencia hacia este cofactor en lugar de 
NAD+. Este trabajo proporciona la primera evidencia experimental que apoya el papel 
de los residuos Ser133, Asn136 y Arg140, como esenciales para la actividad 
monomérica de la IDH.  
6. Evidencias genéticas basadas en varios intentos fallidos de eliminación de la IDH 
monomérica sugieren que esta isoenzima es un gen esencial para P. putida en diversas 
condiciones de crecimiento. Esta esencialidad es independiente de la funcionalidad de 
la isoforma dimérica.  
7. Utilizando como base un modelo metabólico a escala genómica, se han obtenido 
con éxito diseños in silico de cepas super-productoras de PHA, en las que la producción 
está acoplada al crecimiento bacteriano. Las fuentes de carbono utilizadas en los 
diseños son polímeros complejos como PET, lignina, PU y sus sustratos de monómeros. 
PET4 es el mejor diseño para su posterior implementación in vivo en términos de 
rendimiento de PHA, rendimiento acoplado en la biomasa, en el número de deleciones 
y en la viabilidad fisiológica.  
8. La cepa MM16 presenta un re-direccionamiento del flujo de carbono que le 




crecimiento equilibradas. El PHA se produce en esta cepa a través de la vía de β-
oxidación. Sin embargo, la vía de biosíntesis de novo de ácidos grasos está disminuida 
por restricciones reguladoras en estas condiciones de cultivo.  
9. La cepa MT1 es un candidato óptimo para la producción de PHA a partir de varios 
sustratos recalcitrantes en condiciones de crecimiento equilibrado, alcanzando hasta un 
20% de producción de PHA respecto al peso seco total. Este alto rendimiento alcanzado 
por la cepa MT1 se logró al anular la regulación natural de los genes pha, y el posterior 
diseño e implementación de un sistema de expresión constitutiva, y acoplada al 
crecimiento, de los genes necesarios para la producción de PHA que previamente 
fueron optimizados y sintetizados.  
10. Mediante la expansión de la versatilidad metabólica natural de P. putida hacia la 
utilización de nuevas fuentes de carbono, utilizando aproximaciones de biología 
sintética, ha sido posible construir la cepa de P. putida MT9 que produce PHA utilizando 
como fuente de carbono disacáridos abundantes y económicos como la sacarosa en 
condiciones de crecimiento equilibrado. La producción alcanza hasta un 35% de PHA 
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Gene Enzymatic activity Annotation 
fadL Long chain fatty acid transporter (LCFAs) PP_1689 
? Short chain fatty acid transporter PP_3124 
fadD Acyl-CoA synthetase PP_2213/PP_4549 / PP_4550 
















fadA 3-ketoacyl-CoA thiolase PP_2137/PP_2215/PP_4636 
phaJ Enoyl-CoA hydratase, R strereoselectivity PP_0580/PP_4552/PP_4817 
fabG 3-oxoacyl-ACP reductase subunit PP_1914 
Table S 1. Gene names, enzymatic activities and genes ID of P. putida KT2440 involved in β-oxidation 
pathway. 
Pathway Gene Enzymatic activity Annotation 
EMP 
glk glucokinase PP_1011 
pgi-1 / pgi-2 Glucose-6-P isomerase PP_1808  
PP_4701 
fbp Fructose 1,6-biphosphate PP_5040 




tpiA Triose phosphate isomerase PP_4715 






pgk Phosphoglycerate kinase PP_4963 




























rpe Ribulose-5-P-3-epimerase PP_0415 
rpiA Ribose-5-P-3-epimerase PP_5150 
tktA Transketolase PP_4965 
talA Transaldolase B PP_2168 
Peripheral 
gcd Glucose dehydrogenase PP_1444 




oprB-1 Carbohydrate-selective porin PP_1019 







gntP D-gluconate transporter PP_3417 
gnuk Gluconate kinase PP_3416 
kguT 2-ketogluconate transporter, 
putative 
PP_3377 




Table S 2. Genes, enzymatic activities and P. putida KT2440 genome database annotation involved in the 
EMP (Embden-Meyerhof-Parnas Pathway), ED (Entner-Doudoroff), PPP (Pentose phosphate pathway) and 
peripheral pathways.  
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Gene Enzymatic activity Annotation 
oprB-1 Carbohydrate-selective porin PP_1019 
glpF Aquaglyceroporin PP_1076 
glpK Glycerol kinase PP_1075 
glpD Aerobic glycerol-3-phosphate 
dehydrogenase 
PP_1073 
glpR DNA-binding transcriptional repressor PP_1074 
Table S 3. The involved genes, their enzymatic activity and their corresponding P. putida KT2440 database 
annotation are listed for the glycerol catabolism pathways. 
Pathway Gene Enzymatic activity Annotation 
β-ketoadipate 








pcaB 3-carboxy-cis,cis-muconate cycloisomerase  PP_1379 
pcaD 3-oxoadipate enol-lactonase PP_1380 
pcaC 4-carboxymuconolactone decarboxylase  PP_1381   
pcaF beta-ketoadipyl-CoA thiolase PP_1377 
pcaR pca regulon transcriptional regulator PP_1375 
pcaK 4-hydroxybenzoate transporter PP_1376 
pcaT alpha-ketoglutarate permease PP_1378 
pcaP porin PP_1382 
Peripheral 
ech enoyl-CoA hydratase/aldolase PP_2217 
fcs feruloyl-CoA-synthetase PP_3356 
vdh vanillin dehydrogenase PP_3357 
vanA vanillate O-demethylase oxygenase subunit PP_3736 
vanB vanillate O-demethylase oxidoreductase PP_3737 
vanR transcriptional regulator VanR PP_3738 
gaIP-IV porin like PP_3739 
vanK MFS transporter PP_3740 
pobA 4-hydroxybenzoate 3-monooxygenase PP_3537 
pobR transcriptional regulator PP_3538 
Phenylacetate 
Degradation 
paaE ring 1,2-phenylacetyl-CoA epoxidase 
reductase subunit 
PP_3274 
paaD 1,2-phenylacetyl-CoA epoxidase subunit D  PP_3275 
paaC ring 1,2-phenylacetyl-CoA epoxidase 
subunit beta 
PP_3276 






paaA ring 1,2-phenylacetyl-CoA epoxidase 
subunit alpha 
PP_3278 




paaI hydroxyphenylacetyl-CoA thioesterase PP_3281 




paaF enoyl-CoA hydratase/isomerase PP_3284 
paaY phenylacetate degradation pathway 
detoxifying thioesterase 
PP_3285 
paaX DNA-binding transcriptional repressor PaaX PP_3286 
phaK phenylacetic acid-specific porin PP_3271 
Table S 4. The involved genes, their enzymatic activity and their corresponding P. putida KT2440 database 
annotation are listed for the aromatic compounds catabolism pathways.  
Pathway Gene Enzymatic activity Annotation 
TCA 
gltA citrate synthase PP_4194 
acnA-I/II 
acnB 
aconitate hydratase PP_2112/PP_2336 
PP_2339 
icd/idh NADP+-dependent isocitrate 
dehydrogenase   
PP_4011/PP_4012 
lpdG Dihydrolipoyl dehydrogenase (E3) PP_4187 




sucA 2-oxoglutarate dehydrogenase 
subunit E1 
PP_4189  
sucD succinyl-CoA synthetase subunit 
alpha 
PP_4185 
sucC bifunctional succinyl-CoA synthetase 
subunit beta/glutaryl-CoA synthetase 
subunit beta 
PP_4186 
scpC propionyl-CoA:succinate CoA 








fumA class 1 fumarate hydratase PP_0897 
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class 2 fumarate hydratase PP_0944/PP_1755 
mdh malate dehydrogenase PP_0654 




aceA isocitrate lyase PP_4116 
glcB malate synthase G PP_0356 
maeB malic enzyme B PP_5085 
Table S 5. The involved genes, their enzymatic activity and their corresponding P. putida KT2440 database 
annotation are listed for the TCA cycle and the glyoxylate shunt.  
Gene Enzymatic activity Annotation 
accABCD accABCD complex: Acetyl-CoA carboxylase PP_1607/PP_0559/PP_0558 
/PP_1996 
fabD Malonyl-CoA transacylase PP_1913 
fabB 3-oxoacyl-ACP-synthase PP_4175 
fabF beta-ketoacyl-ACP-synthase II PP_1916/PP_3303 
fabH 3-ketoacyl-ACP-synthase III PP_4379/PP_4545 
fabG 3-oxoacyl-ACP-reductase subunit PP_0581/PP_1852/PP_1914 
(fabG)/PP_2540/ PP_2783 
fabA 3R-3-hydroxydecanoyl-ACP dehydratase PP_4174 
fabZ 3-hydroxyacyl-ACP dehydratase FabZ PP_1602 
? Enoyl-ACP reductase  PP_1852 
phaG 3-hydroxyacyl-CoA-ACP transferase PP_1408 
? 3-hydroxyacyl-CoA ligase PP_0763 
Table S 6. The involved genes, their enzymatic activity and their corresponding P. putida KT2440 database 



















pBG-For CAAGGTTCTGGACCAGTTGCG Sequencing pBG 
plasmids 
- 
pBG-Rev GGTTTTCCCAGTCACGACGC Sequencing pBG 
plasmids 
- 
pBGXX-Sec CCCGAGGCATAGGCTGTAC Sequencing pBG 
plasmids 
- 
pBG-Sec-Rev GGCAACCGAGCGTTCTGAAC Sequencing pBG 
plasmids 
- 
5-Pput-glmSUP AGTCAGAGTTACGGAATTGTAGG Verification of Tn7 
insertion  
- 
3-Tn7L ATTAGCTTACGACGCTACACCC Verification of Tn7 
insertion 
- 







RK134 GCTAGCGCCCGAATTAGCC Cloning PCR 
RK135 TTTGGATCCACGACTTCCATT Cloning PCR 
RK136 AAGGCGACTACGACTTCCATT Sequencing primer, 
Genome PCR 
verification 
RK137 GCATTGCAAGGTTCTAGGCAAG Sequencing primer, 
Genome PCR 
verification 
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RK143 ACCCTACTGTTGCACTCGAA Sequencing primer, 
Genome PCR 
verification 
RK144 GAAGGAAGAGCTCACGTCGG Sequencing primer, 
Genome PCR 
verification 


















RK150 AAGCGCAAACGTCATAAAGCC Sequencing primer, 
Genome PCR 
verification 
RK151 TGTACGTAGGCATGCAGCAC Sequencing primer, 
Genome PCR 
verification 





















A1-For-Sec-ins TCGCATTAGACCAAAGATGTAGT Sequencing primer, 
Genome PCR 
verification 















A3-For-Sec CAGGTTTGACGATGCTTTCAC Sequencing primer, 
Genome PCR 
verification 
A3-For-Sec-ins TTGGTGCTGGTGGTGGATGA Sequencing primer, 
Genome PCR 
verification 















A-Sec AATCCATTGGTGTGTAGTCATCG Sequencing primer, 
Genome PCR 
verification 
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phaC1-For GCATCACTTGTACCGCACTGG Sequencing primer, 
Genome PCR 
verification 















MM97 GCTGATCGACCTGCAGATTGTC Sequencing primer, 
Genome PCR 
verification 
MM98 CTGGACCTGATTACCGACAACAG Sequencing primer, 
Genome PCR 
verification 
















MM104 CCGTGTACCTCAAGCTGGAATG Sequencing primer, 
Genome PCR 
verification 























MM116 GTGTGTGGCAGATGAAACCA Sequencing primer, 
Genome PCR 
verification 
MM117 TAATCAGATTGCTACGCTGGGTT Sequencing primer, 
Genome PCR 
verification 















MM90 CGGGTGATCTCTTCGGTGAAA Sequencing primer, 
Genome PCR 
verification 
MM91 GCGATGGATCCTTGTGCAAATG Sequencing primer, 
Genome PCR 
verification 
MM92 CCACTCGCCTGTATCATCTTTCA Sequencing primer, 
Genome PCR 
verification 







TS2F GCTCATGAGTGGTGGAAAACCGC Cloning PCR 
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FdPHA TCCCGAGAGATTCTGCCCAT Sequencing primer, 
Genome PCR 
verification 






















Level 0, phaF_ 




Level 0, phaF_ 
Golden Gate MoClo 
RK175 TTTGAAGACAGAtcgACCACTTCG
CGGGTGTCGG 
Level 0, phaF_ 
Golden Gate MoClo 
RK176 TTTGAAGACAGaagcTCAGATCAG
GGTACCGGTGCC 
Level 0, phaF_ 
Golden Gate MoClo 
MM170 GCTTCTCGATCTGCTTGGTCA qRT-PCR_phaF 
gene 











Level 0, phaG_ 




Level 0, phaG_ 






Level 0, phaG_ 
Golden Gate MoClo 
MM206 TTTGAAGACGTaagcTCAGATGGC
AAATGCATGCT 
Level 0, phaG_ 
Golden Gate MoClo 
MM174 TGTCCAGGCTGCTCACATG qRT-PCR_phaG 
gene 




Level 0, PP_0763_ 




Level 0, PP_0763_ 
Golden Gate MoClo 
MM209 TTTGAAGACGTGgacCGCGTGGTG
CTGGTC 
Level 0, PP_0763_ 
Golden Gate MoClo 
MM210 TTTGAAGACGTcCtcCAGGTCGAG
CGAGGAAA 
Level 0, PP_0763_ 
Golden Gate MoClo 
MM211 TTTGAAGACCAgaGgACCTGATCA
GCCGCCA 
Level 0, PP_0763_ 
Golden Gate MoClo 
MM212 TTTGAAGACCAaagcTTACAACGTG
GAAAGGAACGCG 
Level 0, PP_0763_ 
Golden Gate MoClo 
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R24 AGCGGATAACAATTTCACACAGGA Sequencing primer, 
PCR verification 
- 
T7prom TAATACGACTCACTATAGGG pET29a (+) 
sequencing primer 
- 
TT7 GCTAGTTATTGCTCAGCGG pET29a (+) 
sequencing primer 
- 
Table S 7. Oligonucleotides used in this work. Underlined sequence means the restriction site for 
restriction enzymes, bold small red letters means the fusion sites used in level 0 golden gate process, with 
bold capital letters the point mutations are shown. The following restriction enzymes were used: AvrII 
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Pathway Reactions KT2440 Δpha KT40Z M1 M2 M3 M4 
EMP 
PGI 0.0 -0.1 -0.1 -0.1 0.0 0.0 0.0 
FBP 0.3 0.4 0.6 0.5 0.3 0.3 0.3 
FBA -0.3 -0.4 -0.6 -0.5 -0.3 -0.3 -0.3 
TPI -0.4 -0.6 -0.7 -0.6 -0.4 -0.4 -0.4 
Pay-off 
 
GAPD -0.8 -1.2 -1.4 -1.2 -0.8 -0.8 -0.8 
PGK 0.8 1.2 1.4 1.2 0.8 0.8 0.8 
PGM 1.4 1.9 2.2 1.9 1.4 1.4 1.4 
ENO -1.4 -1.9 -2.2 -1.9 -1.4 -1.4 -1.4 
PYK 0.2 0.3 0.4 0.3 0.2 0.2 0.2 
PPS 0.0 0.1 0.2 0.1 0.0 0.0 0.0 
PDHa 0.0 0.0 0.0 0.0 0.0 0.0 0.0 
PDHbr 0.0 0.0 0.0 0.0 0.0 0.0 0.0 
PDHcr 0.1 1.8 3.3 2.8 0.0 0.1 0.0 
ED 
EDA 0.0 0.0 0.1 0.0 0.0 0.0 0.0 
EDD 0.0 0.0 0.1 0.0 0.0 0.0 0.0 
Gluconeogenesis 
PPC 0.0 0.1 0.1 0.0 0.0 0.0 0.0 
PPCK 1.9 2.5 3.0 2.6 1.8 1.9 1.8 
OAADC 0.5 0.5 0.5 0.5 0.6 0.6 0.6 
PC 0.0 0.1 0.2 0.2 0.0 0.0 0.0 
ME2 0.3 0.2 0.2 0.3 0.2 0.2 0.2 
PPP 
G6PDH2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 
GND 0.0 0.0 0.1 0.0 0.0 0.0 0.0 
RPE -0.3 -0.3 -0.3 -0.3 -0.3 -0.3 -0.3 
RPI -0.3 -0.3 -0.3 -0.3 -0.2 -0.3 -0.2 
TKT1 -0.1 0.0 0.0 0.0 -0.1 -0.1 -0.1 
TKT2 -0.2 -0.2 -0.2 -0.2 -0.2 -0.2 -0.2 
TALA -0.1 0.0 0.0 0.0 -0.1 -0.1 -0.1 
TCA 
CS 4.0 6.5 8.5 7.5 3.9 4.0 3.9 
ACONTa 4.0 6.5 8.5 7.5 3.9 4.0 3.9 
ACONTb 4.0 6.5 8.5 7.5 3.9 4.0 3.9 
ICDHyr 0.5 2.3 3.7 3.2 0.4 0.5 0.4 
AKGDa 0.1 1.8 3.2 2.7 0.0 0.1 0.0 
AKGDbr 0.1 1.8 3.2 2.7 0.0 0.1 0.0 
SUCDi 3.6 6.2 8.4 7.3 3.5 3.6 3.5 
FUM 3.9 6.8 9.1 7.9 3.8 4.0 3.8 
MDH 7.2 10.6 13.2 11.5 7.1 7.3 7.1 
MDH2 0.0 0.1 0.1 0.1 0.0 0.0 0.0 
ICL 3.5 4.2 4.8 4.3 3.4 3.6 3.4 




de novo fatty acid 
biosynthesis 
ACCOAC 0.4 1.4 2.2 1.8 0.4 0.4 0.4 
MCOATA 0.4 1.4 2.2 1.8 0.4 0.4 0.4 
MACPD 0.0 0.1 0.1 0.1 0.0 0.0 0.0 
ACOATA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 
KAS15 0.0 0.0 0.0 0.0 0.0 0.0 0.0 
3OAR80 0.0 0.0 0.0 0.1 0.0 0.0 0.0 
3HAACOAT8
0 -0.1 -0.1 -0.1 -0.1 -0.1 -0.1 -0.1 
EAR80y 0.1 0.2 0.2 0.2 0.1 0.1 0.1 




4.0 2.9 4.0 5.0 3.2 3.2 3.3 
ACOAD1f 2.0 2.8 3.4 3.0 2.0 2.1 2.0 
ACOAD2f 2.0 2.8 3.4 3.0 2.0 2.1 2.0 
ACOAD3f 4.0 2.9 4.1 5.1 3.2 3.2 3.3 
ECOAH3 -1.8 -5.3 -2.0 -1.8 -4.3 -4.3 -3.8 
RHACOAR8
0 
-0.2 2.5 -1.5 -1.3 2.3 2.2 1.8 
RECOAH3 -2.2 2.4 -2.2 -3.4 1.0 1.0 0.5 
HACD3i 1.8 5.3 2.0 1.8 4.3 4.3 3.8 
KAT3 2.0 2.8 3.4 3.0 2.0 2.1 2.0 
RECOAH3 -2.2 2.4 -2.2 -3.4 1.0 1.0 0.5 
PHA cycle 
PHAP2C80 1.9 0.0 0.6 2.0 1.1 1.1 1.2 
PHADPC80 1.1 0.0 0.0 1.3 1.1 1.1 1.2 
ACSPHAC80 0.0 0.0 0.0 0.0 0.0 0.0 0.0 
EX_R_3hoct
a(e) 
1.1 0.0 0.0 1.3 1.1 1.1 1.2 
sink_PHAg -0.8 0.0 -0.6 -0.7 0.0 0.0 0.0 
Exchange 
reactions 
EX_h(e) 0.2 0.4 -0.7 -0.7 0.9 0.9 0.9 
EX_octa(e) -4.0 -2.9 -4.0 -5.0 -3.2 -3.2 -3.3 
EX_co2(e) 3.9 8.7 12.7 10.9 3.7 3.9 3.7 










NADTRHD 0.4 1.6 0.6 0.7 0.6 0.5 0.6 
CYTBDpp 0.0 0.1 1.4 0.9 0.0 0.0 0.0 
CYTBO3_4p
p 
16.3 24.8 31.8 26.4 14.2 14.9 14.6 
CYO1_KT 4.9 7.1 9.0 11.0 5.8 5.8 5.5 
NADH16pp 9.3 14.0 14.3 11.4 9.1 9.4 9.1 
ATPS4rpp 26.9 38.1 44.8 40.9 25.6 26.5 25.7 
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Table S 8. Carbon flux distribution during phase A. The median values of reaction fluxes (mmol·gDW-
1·h-1) were obtained by random sampling of Monte Carlo using the condition-specific models of the phase A. 
The reactions affecting key metabolic pathways, such as EMP, Pay-off, ED, Gluconeogenesis, PPP, TCA, 
key exchange reactions, PHA cycle, Fatty acid cycle, reactions are shown. For the model reaction 
nomenclature extra information can be found in the following link https://drive.google.com/file/d/1L-
iVLsONX9qiReDmjVgRS_eDTL6sfJa9/view.  
Pathway Reactions KT2440 Δpha KT40Z M1 M2 M3 M4 
EMP 
PGI -0.2 -0.2 -0.2 -0.1 -0.2 -0.2 -0.1 
FBP 0.4 0.5 0.4 0.3 0.3 0.4 0.3 
FBA -0.4 -0.5 -0.4 -0.3 -0.3 -0.4 -0.3 
TPI -0.5 -0.6 -0.5 -0.4 -0.5 -0.5 -0.4 
Pay-off 
 
GAPD -0.9 -1.1 -0.9 -0.8 -0.8 -0.9 -0.6 
PGK 0.9 1.1 0.9 0.8 0.8 0.9 0.6 
PGM 1.6 1.9 1.7 1.3 1.4 1.6 1.1 
ENO -1.6 -1.9 -1.7 -1.3 -1.4 -1.6 -1.1 
PYK 0.1 0.2 0.2 0.2 0.1 0.1 0.1 
PPS 0.1 0.2 0.2 0.1 0.1 0.1 0.1 
PDHa 0.0 0.1 0.0 0.0 0.0 0.0 0.0 
PDHbr 0.0 0.1 0.0 0.0 0.0 0.0 0.0 
PDHcr 3.8 4.2 4.4 3.2 3.7 3.8 2.7 
ED 
EDA 0.1 0.1 0.1 0.1 0.1 0.1 0.0 
EDD 0.1 0.1 0.1 0.1 0.1 0.1 0.0 
Gluconeogenesis 
PPC 0.1 0.1 0.1 0.0 0.1 0.1 0.0 
PPCK 2.0 2.5 2.1 1.7 1.8 1.9 1.4 
OAADC 0.2 0.3 0.2 0.2 0.1 0.2 0.1 
PC 0.4 0.6 0.4 0.3 0.4 0.4 0.3 
ME2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 
PPP 
G6PDH2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 
GND 0.1 0.1 0.1 0.0 0.0 0.1 0.0 
RPE -0.1 -0.1 -0.1 -0.1 -0.1 -0.1 -0.1 
RPI -0.1 -0.2 -0.2 -0.1 -0.1 -0.1 -0.1 
TKT1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 
TKT2 -0.1 -0.1 -0.1 -0.1 -0.1 -0.1 -0.1 
TALA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 
TCA 
CS 6.6 7.4 7.3 5.6 6.0 6.4 4.6 
ACONTa 6.6 7.4 7.3 5.6 6.0 6.4 4.6 
ACONTb 6.6 7.4 7.3 5.6 6.0 6.4 4.6 
ICDHyr 4.0 4.4 4.5 3.3 3.8 3.9 2.8 
AKGDa 3.7 4.1 4.3 3.1 3.6 3.7 2.6 




SUCDi 6.9 7.7 7.5 5.7 6.3 6.6 4.7 
FUM 7.4 8.3 8.2 6.5 6.8 7.1 5.1 
MDH 9.3 10.6 10.3 8.2 8.4 8.9 6.5 
MDH2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 
ICL 2.5 2.9 2.6 2.2 2.2 2.3 1.8 
MALS 2.3 2.7 2.4 2.0 2.0 2.2 1.6 
de novo fatty acid 
biosynthesis 
ACCOAC 2.4 2.8 2.4 1.7 2.2 2.2 1.6 
MCOATA 2.4 2.8 2.4 1.7 2.2 2.2 1.6 
MACPD 0.1 0.1 0.1 0.0 0.1 0.1 0.1 
ACOATA 0.0 -0.1 0.0 0.0 0.0 0.0 0.0 
KAS15 0.0 0.0 0.0 0.0 0.0 0.0 0.0 
3OAR80 0.1 0.1 0.1 0.1 0.1 0.1 0.0 
3HAACOAT8
0 -0.1 -0.1 -0.1 0.0 0.0 0.0 0.0 
EAR80y 0.1 0.2 0.2 0.1 0.1 0.1 0.1 
3OAS80 0.1 0.1 0.1 0.1 0.1 0.1 0.0 
β-oxidation 
FACOAL80t2
pp 3.8 2.5 3.3 3.2 2.6 3.0 2.2 
ACOAD1f 2.2 2.6 2.4 1.9 2.0 2.2 1.6 
ACOAD2f 2.2 2.5 2.4 1.9 2.0 2.1 1.6 
ACOAD3f 3.9 2.6 3.5 3.2 2.7 3.0 2.3 
ECOAH3 -4.4 -4.9 -1.9 -2.1 -1.9 -2.4 -2.3 
RHACOAR8
0 2.1 2.3 -0.6 0.1 -0.2 0.2 0.7 
RECOAH3 0.4 2.2 -1.6 -1.2 -0.9 -0.8 0.0 
HACD3i 4.4 4.9 1.9 2.1 1.9 2.4 2.3 
KAT3 2.2 2.5 2.4 1.9 2.0 2.1 1.6 
RECOAH3 0.4 2.2 -1.6 -1.2 -0.9 -0.8 0.0 
PHA cycle 
PHAP2C80 1.7 0.0 1.0 1.3 0.7 0.9 0.7 
PHADPC80 0.2 0.0 0.0 0.4 0.7 0.9 0.7 
ACSPHAC80 0.1 0.0 0.0 0.0 0.1 0.1 0.0 
EX_R_3hoct
a(e) 0.1 0.0 0.0 0.4 0.7 0.9 0.7 
sink_PHAg -1.5 0.0 -0.9 -0.9 0.0 0.0 0.0 
Exchange 
reactions 
EX_h(e) -2.8 -1.3 -2.3 -1.7 -1.2 -1.3 -0.8 
EX_octa(e)' -3.8 -2.5 -3.3 -3.2 -2.6 -3.0 -2.2 
EX_co2(e) 12.7 13.9 13.7 10.1 11.7 12.3 8.6 
EX_o2(e) 









NADTRHD 0.5 1.5 0.3 0.3 0.6 0.7 0.5 
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CYTBDpp 2.2 1.9 5.9 2.0 2.0 2.1 1.3 
CYTBO3_4p
p 21.4 27.1 23.7 20.9 20.8 21.8 16.0 
CYO1_KT 12.0 9.6 8.1 6.4 9.2 9.8 6.9 
NADH16pp 9.1 16.9 15.6 9.6 10.8 11.2 8.2 
ATPS4rpp 34.0 41.1 35.2 28.2 30.8 31.9 23.9 
Table S 9. Carbon flux distribution during phase B. The median values of reaction fluxes (mmol·gDW-
1·h-1) were obtained by random sampling of Monte Carlo using the condition-specific models of the phase B. 
The reactions affecting key metabolic pathways, such as EMP, Pay-off, ED, Gluconeogenesis, PPP, TCA, 
key exchange reactions, PHA cycle, Fatty acid cycle, reactions are shown. For the model reaction 
nomenclature extra information can be found in the following link https://drive.google.com/file/d/1L-
iVLsONX9qiReDmjVgRS_eDTL6sfJa9/view.  
Pathway Reactions KT2440 Δpha KT40Z M1 M2 M3 M4 
EMP 
PGI 0.0 -0.1 0.0 0.0 -0.1 0.0 -0.1 
FBP 0.0 0.2 0.0 0.0 0.1 0.1 0.1 
FBA 0.0 -0.2 0.0 0.0 -0.1 -0.1 -0.1 
TPI 0.0 -0.2 0.0 0.0 -0.2 -0.1 -0.2 
Pay-off 
 
GAPD 0.0 -0.4 0.0 0.0 -0.3 -0.2 -0.3 
PGK 0.0 0.4 0.0 0.0 0.3 0.2 0.3 
PGM 0.0 0.7 0.0 0.1 0.6 0.4 0.6 
ENO 0.0 -0.7 0.0 -0.1 -0.6 -0.4 -0.6 
PYK 0.0 0.1 0.0 0.0 0.1 0.0 0.0 
PPS 0.0 0.1 0.0 0.0 0.0 0.0 0.1 
PDHa 0.0 0.0 0.0 0.0 0.0 0.0 0.0 
PDHbr 0.0 0.0 0.0 0.0 0.0 0.0 0.0 
PDHcr 0.1 1.8 0.2 0.3 1.5 1.0 1.7 
ED 
EDA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 
EDD 0.0 0.0 0.0 0.0 0.0 0.0 0.0 
Gluconeogenesis 
PPC 0.0 0.0 0.0 0.0 0.0 0.0 0.0 
PPCK 0.0 0.9 0.0 0.1 0.7 0.5 0.7 
OAADC 0.0 0.0 0.0 0.0 0.1 0.0 0.0 
PC 0.0 0.2 0.0 0.0 0.2 0.1 0.2 
ME2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 
PPP 
G6PDH2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 
GND 0.0 0.0 0.0 0.0 0.0 0.0 0.0 
RPE 0.0 0.0 0.0 0.0 0.0 0.0 0.0 
RPI 0.0 -0.1 0.0 0.0 0.0 0.0 0.0 
TKT1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 
TKT2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 





CS 0.1 2.8 0.3 0.4 2.3 1.7 2.6 
ACONTa 0.1 2.8 0.3 0.4 2.3 1.7 2.6 
ACONTb 0.1 2.8 0.3 0.4 2.3 1.7 2.6 
ICDHyr 0.1 1.8 0.2 0.3 1.5 1.1 1.7 
AKGDa 0.1 1.7 0.2 0.3 1.4 1.0 1.6 
AKGDbr 0.1 1.7 0.2 0.3 1.4 1.0 1.6 
SUCDi 0.1 3.0 0.3 0.4 2.5 1.7 2.7 
FUM 0.1 3.2 0.3 0.4 2.7 1.8 2.9 
MDH 0.1 3.9 0.3 0.5 3.3 2.3 3.5 
MDH2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 
ICL 0.0 1.0 0.1 0.1 0.8 0.6 0.8 
MALS 0.0 0.9 0.0 0.1 0.8 0.5 0.8 
de novo fatty acid 
biosynthesis 
ACCOAC 0.0 1.2 0.1 0.1 0.8 0.5 1.0 
MCOATA 0.0 1.2 0.1 0.1 0.8 0.5 1.0 
MACPD 0.0 0.1 0.0 0.0 0.0 0.0 0.0 
ACOATA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 
KAS15 0.0 0.0 0.0 0.0 0.0 0.0 0.0 
3OAR80 0.0 0.0 0.0 0.0 0.0 0.0 0.0 
3HAACOAT8
0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 
EAR80y 0.0 0.1 0.0 0.0 0.0 0.0 0.0 
3OAS80 0.0 0.0 0.0 0.0 0.0 0.0 0.0 
β-oxidation 
FACOAL80t2
pp 0.3 0.9 0.6 0.3 0.8 0.6 0.8 
ACOAD1f 0.0 0.9 0.1 0.1 0.8 0.6 0.8 
ACOAD2f 0.0 0.9 0.1 0.1 0.8 0.6 0.8 
ACOAD3f 0.3 0.9 0.6 0.3 0.9 0.7 0.9 
ECOAH3 -3.0 -7.7 -2.5 -3.2 -4.3 -2.5 -5.2 
RHACOAR8
0 3.0 6.7 2.4 3.0 3.5 2.0 4.3 
RECOAH3 2.7 6.7 1.9 2.9 3.4 1.8 4.2 
HACD3i 3.0 7.7 2.5 3.2 4.3 2.5 5.2 
KAT3 0.0 0.9 0.1 0.1 0.8 0.6 0.8 
RECOAH3 2.7 6.7 1.9 2.9 3.4 1.8 4.2 
PHA cycle 
PHAP2C80 0.3 0.0 0.5 0.2 0.1 0.1 0.1 
PHADPC80 0.0 0.0 0.0 0.0 0.1 0.1 0.1 
ACSPHAC80 0.0 0.0 0.0 0.0 0.0 0.0 0.0 
EX_R_3hoct
a(e) 0.0 0.0 0.0 0.0 0.1 0.1 0.1 
sink_PHAg -0.3 0.0 -0.5 -0.2 0.0 0.0 0.0 
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EX_h(e) -0.3 -0.6 -0.6 -0.3 -0.5 -0.3 -0.6 
EX_octa(e)' -0.3 -0.9 -0.6 -0.3 -0.8 -0.6 -0.8 
EX_co2(e) 0.2 5.6 0.5 0.7 4.6 3.1 5.2 
EX_o2(e) -0.5 -8.2 -1.0 -1.2 -6.9 -4.7 -7.6 
Energy 
conservation 
NADTRHD 0.3 1.2 0.4 0.4 0.4 0.5 0.4 
CYTBDpp 0.0 0.6 0.0 0.2 0.8 0.5 1.3 
CYTBO3_4p
p 0.7 10.4 0.6 1.3 6.9 6.5 8.6 
CYO1_KT 0.3 3.9 1.2 0.6 4.6 1.8 3.7 
NADH16pp 0.4 6.6 0.7 0.9 4.2 3.5 5.8 
ATPS4rpp 1.2 15.9 2.1 2.3 11.9 8.0 13.2 
Table S 10. Carbon flux distribution during phase C. The median values of reaction fluxes (mmol·gDW-
1·h-1) were obtained by random sampling of Monte Carlo using the condition-specific models of the phase C. 
The reactions affecting key metabolic pathways, such as EMP, Pay-off, ED, Gluconeogenesis, PPP, TCA, 
key exchange reactions, PHA cycle, Fatty acid cycle, reactions are shown. For the model reaction 








Escherichia coli (Cozzone and El-Mansi, 2005; Watanabe et al., 2005) 
Bacillus subtilis (Singh et al., 2001, 2002) 
Bacillus stearothermophilus (Howard and Becker) 
Methylobacillus flagellatus (Romkina and Kiriukhin, 2017) 
Thermus thermophilus HB8 (Eguchi et al., 1989) 
Streptococcus mutans (Wang et al., 2013) 
Ostreococcus lucimarinus 
CCE9901 
(Wang et al., 2015) 
Micromonas sp RCC299 (Wang et al., 2015) 
Bifidobacterium longum (Huang et al., 2016) 
Zymomonas mobilis (P. Wang et al., 2012) 
Monomeric IDH 
Corynebacterium glutamicum (Eikmanns et al., 1995; Chen and Yang, 2000) 
Azotobacter vinelandii (Yasutake et al., 2002, 2003; Watanabe et al., 2005) 
Psychromonas marina (Hirota et al., 2017) 
Vibrio parahaemolyticus (Fukunaga et al., 1987) 
Acinetobacter calcoaceticus (Reeves et al., 1983, 1986) 
Acinetobacter baumannii (P. Wang et al., 2018) 
Rhizobium meliloti (McDermott and Kahn, 1992), 
Streptomyces lividans TK54 (Zhang et al., 2009) 
Desulfobacter vibrioformis (Steen et al., 1998) 
Chlorobium limicola (Kanao et al., 2002) 
Monomeric and Dimeric IDH 
Colwellia maris (formally Vibrio sp 
ABE-1) 
(Ochiai et al., 1979; Ishii et al., 1993; Suzuki et al., 
1995; Watanabe et al., 2005; Yasuda et al., 2013; 
Kobayashi and Takada, 2014) 
Colwellia psychrerythraea 
NRC1004 
(Maki et al., 2006; Kobayashi and Takada, 2014) 
Colwellia psychrerythraea 34H (Suzuki and Takada, 2016) 
Mycobacterium tuberculosis (Murima et al., 2016) 
Mycobacterium bovis (Murima et al., 2016) 
Cupriavidus necator (Wang et al., 2003) 
Xyllela fastidiosa (Lv et al., 2018) 
Pseudomonas nautica (Roy and Packard, 1998) 
Pseudomonas psychrophila (Matsuo et al., 2010) 
Pseudomonas aeruginosa PAO1 (Crousilles et al., 2018) 
Table S 11. Selected examples of bacteria with dimeric, monomeric and both NADP+ isocitrate 
dehydrogenase are listed.  
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Growth-coupled designs using terephthalate as substrate 
 
The GDLS algorithm using iMM1412 was applied using an uptake rate of TPHTA 
of 4.725 mmol·gDW-1·h-1 and the default parameters for GDLS. The optimal GDLS path 
results are shown in Table S12 and Figure S1.   
 
Figure S 1. A. Production envelopes for wild-type and TPHTA P. putida knockout strains belonging to more 
promising GDLS path. The production envelopes for each overproducer design are shown as a function of 
the biomass production rate of the wild-type P. putida network using TPHTA as sole carbon source (black 
lines). TPHTA1 (blue), TPHTA2 (green), TPHTA3 (magenta), TPHTA4 (red). B. Production of biomass (blue) 
and PHA (grey) of design TPHTA4 as predicted with dynamic FBA is shown in the center and right panels, 
respectively, as a function of time and TPHTA uptake (green). 
Design TPHTA1 TPHTA2 TPHTA3 TPHTA4 
Uptake rate  
(mmol·gDW-1·h-1) 
4.73 4.73 4.73 4.73 
Knockouts 9 11 14 *14 
Growth rate (h-1) 0.35 0.22 0.21 0.21 
Production Rate (min-max) 0.00 0.84 0.96 1.22 
Residual Biomass (g/L) 0.70 0.47 0.44 0.44 
PHA  (mM) 0.00 1.78 2.04 2.04 
PHA Biomass (g/L) 0.00 0.28 0.32 0.32 
Yp/s (mmol/mmol) 0.00 0.18 0.20 0.26 
BCPY (mmol·gDW-1·h-1) 0.00 0.18 0.20 0.25 
Biomass PHA (%) 0.00 37.80 42.16 42.16 
Table S 12. Properties of the PHA growth-coupled overproducer designs using TPHTA as substrate 
at 10 mM (1.64 g/L). * Indicates additional flux constraints. Uptake rate (mmol·gDW -1·h-1); Growth rate (h-
1); Production rate (mmol·gDW-1·h-1); Yp/s, Product yield (mmol product/mmol substrate); BCPY, Biomass 





Growth-coupled designs using EG as substrate 
 
The GDLS algorithm using iMM1412 was applied using an uptake rate of EG of 
13.16-13.60 mmol·gDW-1·h-1 (without other nutrient limitations) using default parameters 
for GDLS. The optimal GDLS path results are shown in the Table S13 and Figure S2.   
 
Figure S 2. A. Production envelopes for wild-type and EG P. putida knockout strains belonging to more 
promising GDLS path. The production envelopes for each overproducer design are shown as a function of 
the biomass production rate of the wild-type P. putida network using EG as sole carbon source (black lines). 
EG1 (blue), EG2 (green), EG3 (magenta), EG4 (red). B. Production of biomass (blue) and PHA (grey) of 
design EG4 as predicted with dynamic FBA is shown in the center and right panels, respectively, as a 
function of time and EG uptake (green). 
Design EG1 EG2 EG3 EG4 
Uptake rate  
(mmol·gDW-1·h-1) 
13.60 13.26 13.16 13.53 
Knockouts 10 20 22 26 
Growth rate (h-1) 0.31 0.22 0.20 0.17 
Production Rate (min-
max) 
0.00 0.26 0.33 0.53 
Residual Biomass (g/L) 0.20 0.20 0.16 0.16 
PHA  (mM) 0.00 0.20 0.25 0.39 
PHA Biomass (g/L) 0.00 0.03 0.04 0.06 
Yp/s (mmol/mmol) 0.00 0.02 0.02 0.04 
BCPY (mmol·gDW-1·h-1) 0.00 0.06 0.06 0.09 
Biomass PHA (%) 0.00 13.49 19.44 27.50 
Table S 13. Properties of the PHA growth-coupled overproducer designs using EG as substrate at 
10 mM (0.62 g/L). Uptake rate (mmol·gDW-1·h-1); Growth rate (h-1); Production rate (mmol·gDW-1·h-1); Yp/s, 
Product yield (mmol product/mmol substrate); BCPY, Biomass coupled product yield (mmol·gDW-1·h-1). 
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Growth-coupled designs using PU as substrate 
 
The GDLS algorithm using iMM1412 was applied using an uptake rate of PU of 1.4 
mmol·gDW-1·h-1 using default parameters for GDLS. The optimal GDLS path results are 
shown in the Table S14 and Figure S3.   
 
Figure S 3. A. Production envelopes for wild-type and PU P. putida knockout strains belonging to more 
promising GDLS path. The production envelopes for each overproducer design are shown as a function of 
the biomass production rate of the wild-type P. putida network using PU as sole carbon source (black lines). 
PU1 (blue), PU2 (green), PU3 (magenta), PU4 (red). B. Production of biomass (blue) and PHA (grey) of 
design PU4 as predicted with dynamic FBA is shown in the center and right panels, respectively, as a 
function of time and PU uptake (green). 
Design PU1 PU2 PU3 PU4 
Uptake rate  
(mmol·gDW-1·h-1) 
1.40 1.40 1.40 1.40 
Knockouts 8 11 15 *15 
Growth rate (h-1) 0.53 0.38 0.34 0.34 
Production Rate (min-
max) 
0 - 0.07 0.72 1.07 1.07 
Residual Biomass (g/L) 3.07 2.30 2.09 2.09 
PHA  (mM) N.D. 5.17 7.65 7.65 
PHA Biomass (g/L) N.D. 0.82 1.22 1.22 
Yp/s (mmol/mmol) 0 - 0.05 0.51 0.76 0.76 
BCPY (mmol·gDW-1·h-1) 0 - 0.04 0.27 0.36 0.36 
Biomass PHA (%) N.D. 26.30 36.79 36.79 
Table S 14. Properties of the PHA growth-coupled overproducer designs using PU as substrate at 
10 mM (4.94 g/L). * Indicates additional flux constraints. (N.D.: not determined). Uptake rate (mmol·gDW -
1·h-1); Growth rate (h-1); Production rate (mmol·gDW-1·h-1); Yp/s, Product yield (mmol product/mmol 




Growth-coupled designs using ADIPATE as substrate 
 
The GDLS algorithm using iMM1412 was applied using an uptake rate of ADIPATE 
of 6.3 mmol·gDW-1·h-1 using the default parameters for GDLS. The optimal GDLS path 
results are shown in the Table S15 and Figure S4 .   
 
Figure S 4. A. Production envelopes for wild-type and ADIPATE P. putida knockout strains belonging to 
more promising GDLS path. The production envelopes for each overproducer design are shown as a 
function of the biomass production rate of the wild-type P. putida network using ADIPATE as sole carbon 
source (black lines). ADIPATE1 (blue), ADIPATE2 (green), ADIPATE3 (magenta), ADIPATE4 (cyan), 
ADIPATE5 (red). B. Production of biomass (blue) and PHA (grey) of design ADIPATE5 as predicted with 
dynamic FBA is shown in the center and right panels, respectively, as a function of time and ADIPATE 
uptake (green). 
Design ADIPATE1 ADIPATE2 ADIPATE3 ADIPATE4 ADIPATE5 
Uptake rate  
(mmol·gDW-1·h-1) 
6.30 6.30 6.30 6.30 6.30 
Knockouts 8 11 15 16 *16 
Growth rate (h-1) 0.45 0.35 0.28 0.30 0.30 
Production Rate 
(min-max) 
0 - 0.83 0 - 1.10 1.75 1.64 1.64 
Residual Biomass 
(g/L) 
0.63 0.52 0.44 0.47 0.47 
PHA  (mM) N.D. N.D. 2.80 2.69 2.69 
PHA Biomass (g/L) N.D. N.D. 0.45 0.43 0.43 
Yp/s (mmol/mmol) 0 - 0.13 0 - 0.18 0.28 0.26 0.26 
BCPY  
(mmol·gDW-1·h-1) 
0 - 0.37 0 - 0.39 0.49 0.49 0.49 
Biomass PHA (%) N.D. N.D. 50.19 47.46 47.46 
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Table S 15. Properties of the PHA growth-coupled overproducer designs using ADIPATE as 
substrate at 10 mM (1.44 g/L). * Indicates additional flux constraints. (N.D.: not determined). Uptake rate 
(mmol·gDW-1·h-1); Growth rate (h-1); Production rate (mmol·gDW-1·h-1); Yp/s, Product yield (mmol 
product/mmol substrate); BCPY, Biomass coupled product yield (mmol·gDW -1·h-1). 
 
Growth-coupled designs using MDI as substrate 
 
The GDLS algorithm using iMM1412 was applied using an uptake rate of MDI of 
2.52 mmol·gDW-1·h-1 and using the default parameters for GDLS. The optimal GDLS 
path results are shown in the Table S16 and Figure S5.   
 
Figure S 5. A. Production envelopes for wild-type and MDI P. putida knockout strains belonging to more 
promising GDLS path. The production envelopes for each overproducer design are shown as a function of 
the biomass production rate of the wild-type P. putida network using MDI as sole carbon source (black lines). 
MDI1 (blue), MDI2 (green), MDI3 (magenta), MDI4 (cyan), MDI5 (red). B. Production of biomass (blue) and 
PHA (grey) of design MDI5 as predicted with dynamic FBA is shown in the center and right panels, 
respectively, as a function of time and MDI uptake (green). 
Design MDI1 MDI2 MDI3 MDI4 MDI5 
Uptake rate  
(mmol·gDW-1·h-1) 
2.52 2.52 2.52 2.52 2.52 
Knockouts 8 9 10 21 *21 
Growth rate (h-1) 0.32 0.27 0.26 0.25 0.25 
Production Rate (min-max) 0.00 1.02 1.11 1.16 1.16 
Residual Biomass (g/L) 1.15 0.99 0.94 0.93 0.93 
PHA  (mM) 0.00 4.06 4.43 4.62 4.62 
PHA Biomass (g/L) 0.00 0.65 0.70 0.73 0.73 
Yp/s (mmol/mmol) 0.00 0.41 0.44 0.46 0.46 
BCPY (mmol·gDW-1·h-1) 0.00 0.28 0.28 0.29 0.29 




Table S 16. Properties of the PHA growth-coupled overproducer designs using MDI as substrate at 
10 mM (0.62 g/L).  * Indicates additional flux constraints. Uptake rate (mmol·gDW -1·h-1); Growth rate (h-1); 
Production rate (mmol·gDW-1·h-1); Yp/s, Product yield (mmol product/mmol substrate); BCPY, Biomass 
coupled product yield (mmol·gDW-1·h-1). 
Growth-coupled designs using PAC as substrate 
The GDLS algorithm using iMM1412 was applied using an uptake rate of PAC of 
4.725 mmol·gDW-1·h-1 and using the default parameters for GDLS. The optimal GDLS 
path results are shown in the Table S17 and Figure S6.   
 
Figure S 6. A. Production envelopes for wild-type and PAC P. putida knockout strains belonging to more 
promising GDLS path. The production envelopes for each overproducer design are shown as a function of 
the biomass production rate of the wild-type P. putida network using PAC as sole carbon source (black 
lines). PAC1 (blue), PAC2 (green), PAC3 (magenta), PAC4 (cyan), PAC5 (red). B. Production of biomass 
(blue) and PHA (grey) of design PAC5 as predicted with dynamic FBA is shown in the center and right 
panels, respectively, as a function of time and PAC uptake (green). 
Design PAC1 PAC2 PAC3 PAC4 PAC5 
Uptake rate  
(mmol·gDW-1·h-1) 
4.73 4.73 4.73 4.73 4.73 
Knockouts 7 8 9 15 *17 
Growth rate (h-1) 0.36 0.34 0.20 0.31 0.27 
Production Rate (min-max) 0 - 1.16 0 - 1.31 0 - 1.82 0 - 1.44 1.35 
Residual Biomass (g/L) 0.71 0.66 0.43 0.61 0.56 
PHA  (mM) N.D. N.D. N.D. N.D. 2.89 
PHA Biomass (g/L) N.D. N.D. N.D. N.D. 0.46 
Yp/s (mmol/mmol) 0 - 0.25 0 - 0.28 0 - 0.39 0 - 0.31 0.28 
BCPY (mmol·gDW-1·h-1) 0 - 0.42 0 - 0.44 0 - 0.36 0 - 0.44 0.36 
Biomass PHA (%) N.D. N.D. N.D. N.D. 44.87 
Table S 17. Properties of the PHA growth-coupled overproducer designs using PAC as substrate at 
10 mM (1.35 g/L). * Indicates additional flux constraints. (N.D.: not determined). Uptake rate (mmol·gDW -
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1·h-1); Growth rate (h-1); Production rate (mmol·gDW-1·h-1); Yp/s, Product yield (mmol product/mmol 
substrate); BCPY, Biomass coupled product yield (mmol·gDW-1·h-1). 
 
Growth-coupled designs using 14BDO as substrate 
The GDLS algorithm using iMM1412 was applied using an uptake rate of 14DBO 
of 9.45 mmol·gDW-1·h-1 and using the default parameters for GDLS. The optimal GDLS 
path results are shown in the Table S18 and Figure S7.   
 
Figure S 7. A. Production envelopes for wild-type and 14BDO P. putida knockout strains belonging to more 
promising GDLS path. The production envelopes for each overproducer design are shown as a function of 
the biomass production rate of the wild-type P. putida network using 14DBO as sole carbon source (black 
lines). 14DBO1 (blue), 14DBO2 (green), 14DBO3 (magenta), 14DBO4 (cyan), 14DBO5 (red). B. Production 
of biomass (blue) and PHA (grey) of design 14DBO5 as predicted with dynamic FBA is shown in the center 
and right panels, respectively, as a function of time and 14DBO uptake (green).  
Design 14BDO1 14BDO2 14BDO3 14BDO4 
Uptake rate (mmol·gDW-1·h-1) 9.45 9.45 9.45 9.45 
Knockouts 8 9 11 *17 
Growth rate (h-1) 0.60 0.57 0.31 0.31 
Production Rate (min-max) 0 - 0.92 0 - 1.11 0 - 1.63 1.63 
Residual Biomass (g/L) 0.54 0.51 0.33 0.33 
PHA  (mM) N.D. N.D. N.D. 1.72 
PHA Biomass (g/L) N.D. N.D. N.D. 0.27 
Yp/s (mmol/mmol) 0 - 0.10 0 - 0.12 0 - 0.17 0.17 
BCPY (mmol·gDW-1·h-1) 0 - 0.55 0 - 0.63 0 - 0.50 0.51 
Biomass PHA (%) ND ND ND 45.01 
Table S 18. Properties of the PHA growth-coupled overproducer designs using 14DBO as substrate 
at 10 mM (0.9 g/L). * Indicates additional flux constraints. (N. D.: not determined). Uptake rate (mmol·gDW -
1·h-1); Growth rate (h-1); Production rate (mmol·gDW-1·h-1); Yp/s, Product yield (mmol product/mmol 
substrate); BCPY, Biomass coupled product yield (mmol·gDW-1·h-1). 
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